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Toxoplasma gondii (T. gondii) is an obligate intracellular apicomplexan protozoan 
parasite that infects about one-third of the world population, with estimated medical costs and 
loss of productivity in the USA alone amounting to about US$3.1 billion annually. Additionally, 
in the USA, T. gondii is the second leading cause of death due to food-borne pathogens. Current 
drugs against T. gondii are limited by hypersensitivity and toxicity and are ineffective against the 
encysted stage of the parasite. Coupled with the lack of T. gondii vaccine for humans, there is an 
urgent need to develop safe and effective therapeutic and prophylactic agents against T. gondii. 
Rats, like immunocompetent humans, develop a chronic infection, but vary in their 
susceptibilities to T. gondii infection depending on the rat strain. Compared to the T. gondii-
susceptible Brown Norway (BN) rat, the Lewis (LEW) rat is extremely resistant to T. gondii: few 
to no parasites are found post-infection, no antibody to T. gondii is produced, and there is no 
congenital transmission. Importantly, the LEW rat inhibits proliferation of T. gondii within 
parasitophorous vacuoles (PV) in peritoneal macrophages, a phenomenon linked to rapid death 
of both parasites and infected host cells. The resemblance in progression of toxoplasmosis 
between rats and humans, and the refractoriness of the LEW rat to T. gondii infection when 
compared to the susceptible BN rat, provide an opportunity to use the two rat strains as models 
for deciphering host molecular mechanisms that mediate resistance to T. gondii. This can 
potentially unveil new strategies for developing effective therapies and vaccines against T. 
gondii infection. It is evident that the robust resistance of the LEW rat to T. gondii involves 
undefined mechanisms that rapidly kill the parasites within the parasitophorous vacuole very 
early in infection, irrespective of parasite strain, and independent of IFN-γ activation. Thus, to 
unravel molecular factors directing the resistance of the LEW rat to T. gondii, we performed 
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RNA sequencing analysis of peritoneal cells extracted from the LEW and BN rats, with or 
without T. gondii Type I RH strain infection. We found that, compared to both the infected and 
uninfected BN rats, the infected and uninfected LEW rats had inherently higher transcript levels 
of several cytochrome enzymes. On the other hand, compared to the T. gondii-infected BN rat, 
the infected LEW rat had lower transcript levels for several antioxidant enzymes. When we 
measured levels of reactive oxygen species (ROS), we found that both infected and uninfected 
LEW rat peritoneal cells contained significantly higher ROS levels than the BN rat’s cells, 
consistent with the higher transcript levels of cytochrome enzymes (that catalyze generation of 
ROS), with concomitant lower transcript levels of antioxidant enzymes (that detoxify ROS). 
Intriguingly, we observed that scavenging of ROS from infected LEW rats’ peritoneal cells 
reduced the cells’ refractoriness to T. gondii, suggesting that the LEW rat maintains inherent 
oxidative stress that contributes to rapid killing of invading T. gondii. Additionally, we found 
that, compared to the T. gondii-infected BN rats, the infected LEW rats’ peritoneal cells had 
higher transcript levels for several GTPase of the Immunity-Associated Proteins (GIMAPs). 
GIMAPs are relatively recently described novel protein family of putative small GTPases that 
are conserved and expressed prominently in mammalian (including human) immune cells. Their 
functions and molecular mechanisms in mammalian host innate immunity against intracellular 
pathogens are yet to be deciphered. By bioinformatic analyses, we found that all those GIMAPs, 
contain a GTP-binding site motif A (P-loop) that is required for oligomerization of effector 
molecules to membranous structures. In addition, one of the GIMAPs contained an N-
myristoylation motif that is important for protein–protein/lipid interaction and plays an essential 
role in membrane targeting. Importantly, we found that all those GIMAPs possess an LC3-
interacting region (LIR) that is important for recruitment of molecules to phagosomal 
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membranes. To elucidate the roles of GIMAPs during T. gondii infection, we engineered LEW 
rat-derived GIMAPs for stable inducible expression in a rat macrophage cell line, NR8383 
(derived from a T. gondii-susceptible Sprague Dawley rat). We observed that over-expressed 
GIMAPs localized to the T. gondii parasitophorous vacuole membrane (PVM), and induced 
translocation of lysosomes to the PVM, with concomitant inhibition of T. gondii growth in the 
NR8383 cells, suggesting that GIMAPs contribute to the robust refractoriness of the LEW rat to 
T. gondiii infection. To determine the molecular networks of GIMAPs in inhibiting T. gondii 
growth, we engineered NR8383 cells for expression of either HA- or FLAG-tagged GIMAPs. 
Using the tagged GIMAPs as baits we performed immunoprecipitation assays coupled with 
mass-spectrometry analyses. Notably, we found that GIMAP 6 interacts with Tripartite Motif 
Protein 21 (TRIM21) that has E3 ubiquitin ligase activity, while GIMAP 4 and GIMAP 5 both 
interact with Vesicle-Associated Membrane Protein 8 (VAMP8), with GIMAP 4 also interacting 
with GIMAP 6. To determine the roles of TRIM21 and VAMP8, we performed RNA interference 
knockdown assays for TRIM21 and VAMP8 in LEW rat primary peritoneal cells with T. gondii 
infection. We found that, individual knockdown of TRIM21 and VAMP8 reduce the refractoriness 
of the LEW rat cells to T. gondii infection. TRIM21, through its E3 ligase activity is thought to 
facilitate tethering of effector molecules onto the T. gondii parasitophorous vacuolar membrane 
(PVM), leading to restriction of parasite growth. On the other hand, VAMP8 is a SNARE protein 
that has been shown to localize on lysosomal membranes and is required for phagosome-lysosome 
fusion. Thus, the interaction of GIMAP 4 and GIMAP 5 (that both localize on the PVM) with 
VAMP8 suggests that they function to facilitate the fusion of lysosomes to the otherwise 
nonfusogenic PVM, leading to parasite death in infected cells. Together, our findings have 
unveiled novel protective innate immune responses to T. gondii infection that will be crucially 
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important in developing strategies for designing new effective therapies and vaccines against T. 
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CHAPTER 1: LITERATURE REVIEW 
1.1 INTRODUCTION  
1.1.1 Toxoplasma gondii infections. 
 Toxoplasma gondii (T. gondii) is an obligate intracellular Apicomplexan protozoan 
parasite (K. Kim & Weiss, 2004). T. gondii infects a wide range of warm blooded animals 
including cats, rodents, humans, and birds throughout the world (Dubey, 2008). Feline species 
are definitive hosts, which allow the development of the sexual stage of T. gondii in the 
intestines. Oocysts are passed out of the intestines with feces in un-sporulated forms by acutely 
infected cats as shown Figure 1.1 (Pittman & Knoll, 2015). In warm and humid environments, 
excreted oocysts sporulate, and when ingested by a host, sporozoites are released and transform 
into the tachyzoite stage in the host’s gastrointestinal track (Jones & Dubey, 2012). The 
tachyzoites can infect the intestinal epithelial cells of the intermediate hosts such as rodents, 
livestock, and humans. Within intestinal cells, they replicate and disseminate to invade a wide 
variety of host cells (Pittman & Knoll, 2015). Ultimately, the tachyzoites can disseminate 
throughout the entire body including the central nervous system (CNS), facilitated by their 
ability to infect migratory cells such as macrophages and dendritic cells (Mendez & Koshy, 
2017). Under host immune pressure, the tachyzoite stage transforms into the slow growing 
bradyzoite stage of T. gondii in tissue cysts (Chew, Wah, Ambu, & Segarra, 2012; Dubey & 
Jones, 2008). The bradyzoites are often found in muscle and brain tissue of infected hosts, and 
can be infectious to other hosts when ingested through contaminated raw or undercooked meat 
(Tenter, Heckeroth, & Weiss, 2000). 
T. gondii is considered as one of the leading cause of foodborne illnesses and death in the 
U.S. (Scallan et al., 2011). Around one-third of the world population is chronically infected by 
this parasite (Dubey & Dubey, 2010). Estimated annual cost of illness and associated quality of 
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adjusted life by T. gondii infection amount to about $3 billion (Hoffmann, Batz, & Morris, 2012). 
T. gondii infection is primarily asymptomatic in immunocompetent humans (Montoya & 
Liesenfeld, 2004). However, it can be life-threatening in pregnant women and 
immunocompromised individuals such as those who are infected with HIV or undergoing cancer 
treatment (Montoya & Liesenfeld, 2004). 
 
1.2 HOST IMMUNE RESPONSES TO TOXOPLASMA GONDII INFECTION 
1.2.1 Host protective responses against Toxoplasma gondii. 
The host innate immune system detects invading T. gondii through pathogen recognition 
receptors (PRRs) such as Toll-like receptors (TLRs) (Denkers, 2010; Sher, Tosh, & Jankovic, 
2017; Yarovinsky & Sher, 2006). After host infection by T. gondii, chemokines including MIP-2 
and MCP-1 from resident cells, and cytokines including interleukin-1 (IL-1), IL-12 from 
dendritic cells can recruit more host immune cells to the infection site (Ju, Chockalingam, & 
Leifer, 2009; Sukhumavasi, Egan, & Denkers, 2007). Chemokines and cytokines activate 
immune effector cells which subsequently produce more cytokines including IFN-γ that has been 
shown to be crucial for controlling T. gondii infection (Yarovinsky, 2014). Host cells sensitized 
by IFN-γ through its receptors, activate host defense mechanisms via host effector molecules 
including immunity-related GTPase (IRGs) and guanylate binding proteins (GBPs) that play 
crucial roles in mediating host resistance to T. gondii (Hunn, Feng, Sher, & Howard, 2011). 
Host effector GTPases including p47-IRGs (Irgb, Irgm), p65-GBPs, and Mx proteins 
disrupt the parasitophorous vacuole membrane (PVM) that protects intracellular T. gondii (Hunn 
et al., 2011; B. H. Kim, Shenoy, Kumar, Bradfield, & MacMicking, 2012). After T. gondii 
infection, GBPs mediate ubiquitination of the PVM by facilitating the translocation of TRAF6 
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and TRIM21 to the PVM (Clough & Frickel, 2017). Subsequent accumulation of ubiquitin, 
together with autophagy related proteins such as ATGs, LC3 homologs, and GABARAP 
homologs on the PVM, then lead to disruption of its integrity, thereby exposing intracellular T. 
gondii parasites to host defense effector molecules (Clough & Frickel, 2017; Haldar et al., 2015; 
Pilla-Moffett, Barber, Taylor, & Coers, 2016).  
Further, IFN-γ-induced indoleamine 2,3-dioxygenase (IDO), through tryptophan 
deprivation, inhibits proliferation of intracellular tryptophan-auxotrophic T. gondii (Yarovinsky, 
2014). IFN-γ also plays important roles in generation of reactive oxygen species (ROS) such as 
superoxide anion, hydrogen peroxide, hydroxyl radicals, as well as nitric oxide production 
mediated by inducible nitric oxide synthase (iNOS) (Hunter & Sibley, 2012). Additionally, 
oxidation of arachidonic acid by 12-lipoygenase (12-LOX) generates reactive oxygen species, 
that are important in host resistance to T. gondii infection (Witola et al., 2014).  
 
1.2.2 Chemokine ligands and receptors. 
Chemokines and their receptors play a critical role in orchestrating the host innate 
immunity against intracellular microbial pathogens (Hunter & Sibley, 2012; Sokol & Luster, 
2015). Chemokines mediate chemotaxis, an important host innate immune mechanism for 
rapidly recruiting immune cells to infection sites (Sokol & Luster, 2015). Resident cells and 
immune cells detect either pathogen-associated molecular patterns (PAMP) or danger signals-
associated molecular patterns (DAMP), and then release chemokines which are detected by 
chemokine receptors expressed on immune cells. For example, CXCR3-expressing CD4+ T cells 
are essential in activating inflammatory monocytes for controlling T. gondii infection (Cohen et 
al., 2013). The activated inflammatory monocytes activate host effector molecules against T. 
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gondii infection in the intestines of the hosts (Cohen et al., 2013). Up-regulation of chemokines 
signaling pathway leads to expression of host effector molecules that are important in controlling 
parasite growth and survival (Gopal, Birdsell, & Monroy, 2011). 
 
1.2.3 Host GTPases. 
GTPases comprise of two superclasses: large G proteins and small GTPases (Leipe, Wolf, 
Koonin, & Aravind, 2002). Large G proteins superclass are heterotrimeric including α, β and γ 
subunits, and they interact with G protein-coupled receptors (GPCR) such as the epinephrine 
receptor (Oldham & Hamm, 2006). On the other hand, small GTPases are monomeric and can 
function independently. They possess a typical Walker A motif (P-loop, G1 motif), and a Walker 
B motif with conserved glycine residues (G3 and G4 motifs) (Krucken et al., 2004). Further, 
small GTPases possess additional domains that mediate self-association, lipid binding and 
recruitment of binding partners (S. M. Ferguson & De Camilli, 2012; Praefcke & McMahon, 
2004).  
Small GTPases can be further divided into two classes: SIMIBI (signal 
recognition/MinD/BioD) and TRAFAC (translation factor-related) (Leipe et al., 2002). TRAFAC 
class has many superfamily members including Ras, Septin, EF-TU, Era, Tocs, and Dynamin 
superfamily (Leipe et al., 2002; Schwefel et al., 2010; Wennerberg, Rossman, & Der, 2005). 
Dynamin-like GTPases consist of several subfamilies including IRGs, Mx proteins and GBPs. 
They undergo conformational changes upon activation by GTP (Hunn et al., 2011). These 
GTPases including IRGs and GBPs have been reported to target and disrupt intracellular PVM, 
leading to the restriction of intracellular T. gondii growth. The IRGs have two subfamily 
members: GKS IRG (i.e. Irgb, Irgd) and GMS IRG (i.e. Irgm1, Irgm2, Irgm3). Irgb and Irgd 
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possess a conserved GxxxxGKS (glycine-x-x-x-x-glycine-lysine-serine, where x represents any 
amino acid) motif, while Irgm1, 2, and 3 proteins possess GxxxxGMS motif (glycine-xxxx-
glycine-methionine-serine) (Coers, 2013). While the IFN-γ inducible IRGs mediate the 
intracellular inhibition of Type I T. gondii in mice, humans do not have functional IRG orthologs 
in the genome (Gazzinelli, Mendonca-Neto, Lilue, Howard, & Sher, 2014). 
 
1.2.4 Host GTPases of the immunity-associated proteins (GIMAPs). 
GTPases of the immunity-associated proteins (GIMAPs) are found in vertebrates, plants, 
viruses, and protostome invertebrates (Nitta & Takahama, 2007; S. M. Zhang, Loker, & Sullivan, 
2016). GIMAP gene family clusters in rat chromosome 4, mouse chromosome 6, or human 
chromosome 7 (S. Filen & Lahesmaa, 2010). Structural analysis of GIMAPs demonstrated a 
close relationship to Dynamin protein family in terms of nucleotide coordination and 
dimerization mode (Schwefel et al., 2010). In humans, the GIMAP subfamily genes are located 
in 7q36.1 of chromosome 7 (Stamm, Krucken, Schmitt-Wrede, Benten, & Wunderlich, 2002). 
Each of the seven human GIMAPs have a molecular weight of around 33 kDa, with the 
exception of GIMAP 8 which has a molecular weight of 75 kDa because it contains three G 
domains in the N-terminus and a C-terminal extension (Dion et al., 2005; Schwefel et al., 2013). 
GIMAP 4 has intrinsic GTPase activity with affinity for GDP and GTP, and requires 
magnesium (Cambot, Aresta, Kahn-Perles, de Gunzburg, & Romeo, 2002). In the carboxyl 
terminal region of GIMAP 4, a functional calmodulin binding IQ domain has been reported 
(Schnell, Demolliere, van den Berk, & Jacobs, 2006). GIMAP 4 has been shown to localize in 
several subcellular compartments including in the cytoskeletal elements, the endoplasmic 
reticulum, trans-golgi network, golgi apparatus, and cytosol (Heinonen, Kanduri, Lahdesmaki, 
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Lahesmaa, & Henttinen, 2015; Krucken et al., 2004). The expression of GIMAP 4 is induced by 
proinflammatory cytokines including IL-12 (J. J. Filen et al., 2009). In turn, GIMAP 4 regulates 
the secretion of cytokines such as IFN-γ in human helper T lymphocytes (Heinonen et al., 2015). 
Further, GIMAP 4, along with GIMAP 3 and GIMAP 5, are thought to regulate mitochondria-
mediated apoptosis in lymphocytes by possibly interacting with Bcl-2 family proteins (Nitta & 
Takahama, 2007). Compared to other inbred rat strains, the Brown Norway rat has 21 amino 
acids truncation in the C-terminal sequence of GIMAP 4 protein, and a deletion of about 1800 bp 
in the 3’-untranslated region of the gene sequence, with the transcript lacking a poly(A) tail. 
These characteristics of GIMAP 4 are thought to contribute to lower expression level of GIMAP 
4 in the Brown Norway rat than in the Lewis rat (Carter et al., 2007).  
Human GIMAP 5 contains a single C-terminal transmembrane helix, which can anchor it 
to the lysosomal compartments (Endale, Aksoylar, & Hoebe, 2015). Rats lacking GIMAP 5 in T-
cells display mitochondrial dysfunction (Keita, Leblanc, Andrews, & Ramanathan, 2007). In 
addition, diabetes-prone inbred BB rat carries a frameshift in the GIMAP 5 gene leading to 
sequence variation from other rat strains (Hornum, Romer, & Markholst, 2002).  
Genomic analysis showed that GIMAP 6 has GTP-binding site motif A (GxxxxGKS), P-
loop, AIG-type1 G domains, a conserved GTP binding activity, and ATPase activity (Ho & Tsai, 
2017). Human GIMAP 6 has both N- and C-terminal extensions from internal G domain, while 
rat GIMAP 6 has longer N-terminus extension, but with a shorter C-terminus than in humans. 
GIMAP 6 has a LIR (LC3 interacting region) motif which facilitates tethering to LC3 family 
members such as LC3 homologs and GABARAP homologs. Human GIMAP 6, which is 
localized to autophagosomes, interacts with human GABARAPL2, suggesting that GIMAPs play 




1.3 MODULATION OF HOST IMMUNE RESPONSE BY TOXOPLASMA GONDII 
T. gondii has successfully evolved to counteract the host innate immune defense 
mechanisms (Gazzinelli et al., 2014). As an obligate intracellular parasite, T. gondii actively 
invades host cells during which it gets enveloped in a host cell-derived membrane called the 
parasitophorous vacuole membrane (PVM) (Dupont, Christian, & Hunter, 2012). Inside the 
PVM, T. gondii expresses molecules derived from its secretory organelles to further modify the 
membrane and circumvent host immune responses (Melo, Jensen, & Saeij, 2011). While inside 
the host-derived PVM, T. gondii can avoid lysosomal fusion and degradation (Sibley, Weidner, 
& Krahenbuhl, 1985; Sinai & Joiner, 1997).  
While initial host responses to T. gondii infection are important in controlling the 
infection, there is compelling evidence that T. gondii-secreted effector molecules modulate host 
inflammatory pathways to the parasite’s advantage (Peixoto et al., 2010). The establishment of T. 
gondii infection is orchestrated by sequential discharge of proteins from the parasite secretory 
organelles namely micronemes, rhoptries and dense granules (Dubey, Lindsay, & Speer, 1998). 
Microneme proteins facilitate parasite attachment to host cell and invasion, whereas rhoptries 
and dense granule proteins convert the host cell into a suitable environment for parasite survival 
and growth (Blader & Saeij, 2009). Type I strain T. gondii-secreted rhoptry protein, ROP18, 
phosphorylates and inactivates host IRGs, preventing their accumulation on the PVM,  and thus 
protecting the parasite from IRG -dependent intracellular killing (Fentress et al., 2010; Steinfeldt 
et al., 2010). ROP18 phosphorylates host cell transcription factor ATF6β (leading to proteasomal 
degradation of ATF6β), resulting in reduced production of IFN- by CD8+ T cells (Yamamoto et 
al., 2011). Type I and III strains of T. gondii suppress the production of IFN- through blocking 
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the translocation of NF-κB to the nucleus, thus preventing the downstream MyD88 pathway of 
triggering IL-12 transcription upon parasite antigen stimulation of TLR (Butcher, Kim, Johnson, 
& Denkers, 2001; L. Kim et al., 2006; Shapira, Speirs, Gerstein, Caamano, & Hunter, 2002). On 
the contrary, a dense granule protein, GRA15, in Type II strains of T. gondii promotes the 
translocation of NF-κB to the nucleus through yet unknown mechanisms (Rosowski et al., 2011), 
thus activating pro-inflammatory responses including IL-12 production. This would explain why 
Type II strains are less virulent than Type I and III strains. T. gondii has been generally classified 
into three genetic lineages including Type I, II, III (Sibley & Boothroyd, 1992). Type I strains 
cause lethal infection in laboratory mice strains, while type II and III strains are less virulent 
compared to Type I strains (Sibley, Khan, Ajioka, & Rosenthal, 2009).  
T. gondii invasion of macrophages induces suppressor of cytokine signaling protein-1 
(SOCS1), a potent inhibitor of IFN- (Zimmermann, Murray, Heeg, & Dalpke, 2006). Type I T. 
gondii down-regulates NO by secreting ROP16 (a kinase that activates STAT6) leading to 
augmentation of host cell arginase-1, that in turn degrades host cell arginine, a precursor for NO 
(Butcher et al., 2011).  ROP16 has also been demonstrated to abrogate the IL-12 response of 
infected macrophages stimulated with TLR agonists (Saeij et al., 2007), and to inhibit NF-kB 
transcriptional activity (Rosowski et al., 2011), likely through activation of STAT3/6 (Saeij et al., 
2007), thus dampening TLR-induced cytokine production.  
Rhoptry protein, ROP38, is thought to regulate MAPK signaling pathways leading to 
inhibition of IL-12 production (Peixoto et al., 2010). However, the direct host molecules 
interacting with ROP38 are yet to be elucidated. A very well-known phenomenon is that host 
cells infected with T. gondii (irrespective of strain) fail to induce activation of STAT1 by IFN- 
(Zimmermann et al., 2006). STAT1 is a transcriptional factor for expression of many genes 
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involved in T. gondii killing including iNOS, IRGs and autophagy. Although T. gondii rhoptry 
protein, ROP5, is thought to be one of the effectors involved (Melo et al., 2011), the actual T. 
gondii effectors that are engaged in this phenomenon are yet to be deciphered. 
Dense granule proteins (GRAs) are members of T. gondii excretory/secretory proteins 
(Ngo, Hoppe, & Joiner, 2000). Over 20 secreted GRAs have been reported in T. gondii. Some of 
these GRAs have been shown to be targeted to either the parasitophorous vacuolar space, the 
PVM or the intravacuolar tubular network where they play significant roles in the biogenesis and 
modification of the parasitophorous vacuole (PV) interfacing the host cell (Sheiner & Soldati-
Favre, 2008). GRA22 possesses a signal peptide for targeting to the PV and has been found to 
regulate egress of intracellular T. gondii parasites from the vacuole (Okada et al., 2013). GRA16 
is one of the few GRAs that are exported to host cell cytosol, where it migrates to host cell 
nucleus and positively modulates genes involved in cell-cycle progression, and the p53 tumor 
suppressor pathway relating to parasite virulence and pathogenesis (Bougdour et al., 2013).  
 
1.4 HOST GENETIC FACTORS ASSOCIATED WITH RESISTANCE TO 
TOXOPLASMA GONDII INFECTION 
Host genetic variations have been shown to influence the clinical outcome of T. gondii 
infection (Scholthof, 2007). T. gondii has the ability to infect a wide range of mammalian species 
including humans and rodents, with the clinical outcome of infection in immunocompetent 
humans being often asymptomatic (McAuley, 2014). Rats appear to be rather similar to humans 
in terms of resistance to acute infection, but vary in their susceptibility/resistance to T. gondii 
depending on the rat strain (Dubey, 1996). The progression of toxoplasmosis differs among in-
bred rat strains, with resistant strains including LEW, WF, WK, BDIX, LOU rats, while 
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susceptible strains include BN, DA, F344, OM, SD rats (Cavailles et al., 2014; Fournie et al., 
2001; Sergent et al., 2005). The Lewis (LEW) rat, for example, is extremely resistant to T. gondii 
infection: few to no parasites are found post-infection, no antibody to T. gondii is produced, and 
there is no occurrence of congenital transmission (Sergent et al., 2005). To the contrary, Brown 
Norway (BN) rats and some other inbred strains are evidently susceptible to toxoplasmosis. By 
comparison of resistant and susceptible rat strains, a rat genome region called the Toxo1 locus 
has been shown to influence the outcome of T. gondii infection (Cavailles et al., 2006). In a 
study using LEW/BN congenic rats, it was shown that a 7.6 megabases long Toxo1 locus on rat 
chromosome 10 mediates the T. gondii resistance phenotype in the LEW rat (Cavailles et al., 
2006). 
Pursuant to the identification of the Toxo1 locus in the LEW rat, two genes called NALP1 
(NLRP1) and ALOX12 in the orthologous Toxo1 locus on chromosome 17 in the human genome 
have been shown to possess alleles linked to susceptibility to congenital toxoplasmosis (Witola 
et al., 2014; Witola et al., 2011). Importantly, NLRP1 proteins from Toxoplasma-resistant and 
Toxoplasma-sensitive inbred rats differ in an 8 amino acids polymorphic region in the N-
terminus of the protein (Newman et al., 2010). Subsequently, knockdown of NLRP1 has been 
demonstrated to enhance the proliferation of T. gondii in a human monocytic cell line, mediated 
through a decrease in infected cell pyroptosis and inflammatory cytokine production (Witola et 
al., 2011). This has also been observed in macrophages of Toxoplasma-resistant rats with NLRP1 
knockdown (Cirelli et al., 2014). NLRP1 inflammasome can be activated by intracellular 
pathogens (Martinon, Burns, & Tschopp, 2002; Ting, Willingham, & Bergstralh, 2008), leading 
to maturation of caspase-1, a proteolytic enzyme that cleaves and activates pro-IL-1β and pro-IL-
18 (Franchi, Warner, Viani, & Nunez, 2009; Meylan, Tschopp, & Karin, 2006). Upon maturation, 
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IL-1β activates IL-1 receptor, to signal through MyD88 adaptor leading to initiation of NF-κB 
and MAP kinase pathways, that in turn activate transcription of a range of molecules involved in 
fighting infection (Bowie & O'Neill, 2000; Creagh & O'Neill, 2006; Dinarello, 2005). Together, 
these findings suggest that NLRP1-mediated signaling is important for activation of molecules 
contributing to the Toxoplasma-resistance phenotype in the LEW rat. Intriguingly, while in mice 
IFNγ-inducible IRGs mediate killing of Type I T. gondii only, in LEW rat, the Toxo1 locus-
mediated resistance to T. gondii does not operate via the IRG-dependent system, and is not IFN-γ 
dependent, but it kills both Type I and II T. gondii through yet to be defined mechanisms 
(Cavailles et al., 2014). 
 
1.5 HYPOTHESIS AND OBJECTIVES OF THE THESIS 
1.5.1 Hypothesis. 
The refractoriness of the Lewis (LEW) rat to T. gondii infection when compared to the 
susceptible Brown Norway (BN) rat provides an opportunity to use the two rat strains as models 
for deciphering host molecular mechanisms that mediate resistance to T. gondii. We hypothesize 
that the natural resistance of the LEW rat strain to T. gondii is a complex trait involving 
combined effector molecules that are more up-regulated and activated in the LEW rat than in the 
BN rat, leading to differential activation of yet undefined pathways that directly control parasite 
survival and proliferation within the LEW rat cells. Therefore, comparison of global 
transcriptomes of the LEW and BN rat strains, with or without T. gondii infection, would unveil 
candidate effector molecules, and set the stage for elucidation of molecular mechanisms 





Objective 1: To identify effector molecules mitigating resistance to T. gondii infection in the 
LEW rat, and characterize their molecular mechanisms. Overview: To unravel molecular 
factors directing the resistance of the LEW rat to T. gondii infection, we performed RNA 
sequencing analysis of peritoneal cells extracted from the LEW and BN rats, with or without T. 
gondii Type I RH strain infection. We identified genes that were differentially expressed (FDR, 
0.05) in the LEW rat when compared to the BN rat and performed bioinformatic analyses to 
determine their characteristic features. Using forward genetics, immunological, biochemical, and 
cell biological approaches, we functionally characterized the role of candidate genes and 
identified novel molecular networks that they engage to mitigate the refractoriness of the LEW 
rat to T. gondii infection. 
 
Objective 2: To determine the molecular partners for anti-Toxoplasma effector molecules 
and delineate their roles during T. gondii infection. Overview: Here, our working hypothesis 
was that, starting early in infection, upregulated effector molecules are recruited with their 
interacting partners to the parasitophorous vacuole (PV) where they orchestrate the killing of 
intracellular T. gondii. Thus, we focused on identifying proteins that partner with LEW rat’s 
upregulated candidate effector molecules in response to T. gondii infection. Using LEW rat-
derived effector molecules bearing HA or FLAG tags engineered for inducible expression in a 
macrophage cell, we identified partner proteins by immunoprecipitation assays coupled with 
mass-spectrometry analyses. By reverse genetics and in vitro infection assays, we determined the 






Figure 1.1: Life cycle of Toxoplasma gondii. Adopted from Fig. 1.1 in Chapter 1: The history 
and life cycle of Toxoplasma gondii (Dubey, 2014).   
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CHAPTER 2: INHERENT OXIDATIVE STRESS IN LEWIS RAT MEDIATES 
RESISTANCE TO TOXOPLASMOSIS 
2.1 ABSTRACT 
The course of Toxoplasma gondii infection in rats closely resembles that in humans. 
However, compared to the Brown Norway (BN) rat, the Lewis (LEW) rat is extremely resistant 
to T. gondii infection. Thus, we performed RNA sequencing analysis of the LEW rat versus the 
BN rat, with or without T. gondii infection, in order to unravel molecular factors directing robust 
and rapid early T. gondii-killing mechanisms in the LEW rat. We found that compared to the 
uninfected BN rat, the uninfected LEW rat has inherently higher transcript levels of cytochrome 
enzymes (Cyp2d3, Cyp2d5, and Cybrd1, which catalyze generation of reactive oxygen species 
[ROS]), with concomitant higher levels of ROS. Interestingly, despite having higher levels of 
ROS, the LEW rat had lower transcript levels for antioxidant enzymes (lactoperoxidase, 
microsomal glutathione S-transferase 2 and 3, glutathione S-transferase peroxidase kappa 1, and 
glutathione peroxidase) than the BN rat, suggesting that the LEW rat maintains cellular oxidative 
stress that it tolerates. Corroboratively, we found that scavenging of superoxide anion by Mn(III) 
tetrakis (4-benzoic acid) porphyrin (MnTBAP) decreased the refractoriness of LEW rat 
peritoneal cells to T. gondii infection, resulting in proliferation of parasites in LEW rat peritoneal 
cells which, in turn, led to augmented cell death in the infected cells. Together, our results 
indicate that the LEW rat maintains inherent cellular oxidative stress that contributes to 
resistance to invading T. gondii, and thus unveil new avenues for developing therapeutic agents 
targeting induction of host cell oxidative stress as a mechanism for killing T. gondii. 
 
This chapter has appeared as an article in Infection and Immunity ® (IAI). The original citation is: Witola WH*, 
Kim CY*, Zhang X. Inherent Oxidative Stress in the Lewis Rat Is Associated with Resistance to Toxoplasmosis. 
Infection and immunity. 2017;85(10). doi: 10.1128/IAI.00289-17. PubMed PMID: 28739829; PubMed Central 





Toxoplasma gondii is a remarkably successful protozoan parasite capable of infecting 
virtually all mammalian species, with about one-third of the world human population estimated 
to be infected. T. gondii infection and clinical outcome vary among species (Sepulveda-Arias et 
al., 2008), depending on, among others, the immune status and genetic predisposition of the host 
(Kempf et al., 1999; Witola et al., 2014; Witola et al., 2011). Unlike mice, rats are known to 
resist the development of clinical toxoplasmosis upon infection with T. gondii (Evans, 
Strassmann, Lee, & Sapolsky, 2014; Li et al., 2012). The phenomenon of T. gondii infection in 
rats closely mirrors the clinical progression of the infection in immunocompetent humans (Darcy 
& Zenner, 1993; Zenner et al., 1999). This resemblance in the progression of toxoplasmosis 
between rats and humans warrants the use of rats as quintessential animal models for elucidating 
T. gondii infection in humans (Darcy & Zenner, 1993; Zenner et al., 1999). 
Among rat strains, variations in resistance/susceptibility to toxoplasmosis have been 
reported. For instance, compared to the Brown Norway (BN) rat, the Lewis (LEW) rat is 
extremely resistant to T. gondii infection (Sergent et al., 2005). This refractoriness of the LEW 
rat to toxoplasmosis has been associated with a rat genomic locus named Toxo1 on chromosome 
10 (Cavailles et al., 2006). Pursuant to this, two genes called NLRP1 and ALOX1 in the 
orthologous Toxo1 locus on chromosome 17 in the human genome have been demonstrated to 
possess alleles linked to susceptibility to human congenital toxoplasmosis (Witola et al., 2014; 
Witola et al., 2011). The inhibition of intracellular T. gondii growth in LEW rat peritoneal 
macrophages (Cavailles et al., 2006) has been linked to rapid death of both parasites and infected 
host cells (Cavailles et al., 2014). This mode of clearance of parasites in LEW rat cells suggests 
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the involvement of a rapid and vigorous killing response at the site of infection, thus impeding 
the dissemination of the parasites in the host animal. 
Reactive oxygen species (ROS) such as hydrogen peroxide, superoxide radicals, and 
hydroxyl radicals are highly reactive metabolites of molecular oxygen in mammalian cells 
(Andreyev, Kushnareva, & Starkov, 2005). Cytochrome P450 (CYP) enzymes catalyze the 
endogenous oxygenation of organic substrates through the reduction of molecular oxygen in 
mammalian CYP-dependent microsomal and mitochondrial electron transport chains (Alfadda & 
Sallam, 2012; Halliwell, 2006; Hrycay & Bandiera, 2015). During these enzymatic reactions, 
ROS are generated if the transfer of oxygen to a substrate is not tightly controlled (Rodriguez-
Antona & Ingelman-Sundberg, 2006). In healthy cells, production of ROS takes place at a 
controlled rate because excessive intracellular amounts of ROS can lead to a state called 
oxidative stress (Sies, 2014). Augmented oxidative stress can be toxic to cells, resulting in 
oxidative damage of cellular membranes and macromolecules, and thus leading to cellular 
apoptosis and death (Lennon, Martin, & Cotter, 1991). Generation of ROS has been shown to be 
upregulated during microbial infection in immune effector cells, including neutrophils, 
eosinophils, and macrophages, resulting in oxidative stress that is toxic to the invading pathogens 
(Nathan & Shiloh, 2000). 
In the present study, we endeavored to perform a global transcriptome analysis of the 
LEW rat versus the BN rat, with or without T. gondii infection, in order to unravel the molecular 
mechanisms directing a robust and rapid early innate immune response that mitigates the 
infection. We provide evidence that the LEW rat has inherent higher expression of cytochrome 
genes than the BN rat. Because cytochrome enzymes are involved in the generation of 
intracellular ROS that have been shown to be important in killing intracellular pathogens 
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(Nathan & Shiloh, 2000), we investigated whether the inherent high expression of cytochrome 
genes in the LEW rat contributes to its robust resistance to T. gondii infection. Using in vitro 
assays, we show that in comparison to those of the BN rat, the LEW rat primary peritoneal cells 
have augmented ROS levels that are associated with resistance to T. gondii infection. 
 
2.3 RESULTS 
2.3.1 Progression of T. gondii in LEW versus BN rat peritoneal cells. 
To determine the earliest time point at which there is a striking difference in the 
progression of T. gondii infection in the LEW versus BN rats, peritoneal cells were extracted 
from T. gondii-infected and uninfected LEW and BN rats and maintained in culture, and 
analyzed by fluorescence microscopy to detect yellow fluorescent protein (YFP) fluorescence 
from T. gondii tachyzoites at different progressive time-points of culture. In peritoneal cells from 
the infected BN rats, parasites progressively proliferated over time, while extremely few to no 
parasites could be observed in the cells derived from the infected LEW rats at both 24 h and 48 h 
post-harvest time points (Figure 2.1). This was consistent with the previously reported 
phenotypes of the BN and LEW rats in response to T. gondii infection (Cavailles et al., 2006; 
Sergent et al., 2005). 
 
2.3.2 Differentially expressed genes in peritoneal cells of LEW versus BN rats. 
For RNA sequencing, freshly extracted peritoneal cells from LEW and BN rats infected 
or uninfected with T. gondii Type 1 RH strain for 24 h, were used for extraction of RNA. All 
RNA samples extracted from the BN and LEW rats, and used for RNA sequencing had RNA 
integrity numbers (RINs) of 9.5/10 and above, as determined with an Agilent Bioanalyzer. These 
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RNA samples met the purity and integrity level for RNA sequencing, for which a minimum RIN 
value is 7.0. For analysis of the generated RNA sequencing data, the rat reference genome 
database used was a mixed-strain assembly based on mixed female BN/SsNHsdMCW and male 
SHR mice, although it apparently did not include any LEW rat strain. Nevertheless, the 
alignment metrics showed only negligible differences between the LEW samples and the BN 
samples (not aligned, 1.3% versus 1.2%; multiply aligned, 9.8% versus 8.9%), such that any 
strain differences in sequence were minor enough to be ignored overall. The weighted gene 
correlation network analysis (WGCNA) on 6,942 rat genes that had a one-way analysis of 
variance (ANOVA) false-discover rate (FDR, P < 0.2) was run. A liberal cutoff was used to 
focus on the genes that showed patterns related to the four experimental groups (T. gondii-
infected and uninfected LEW and BN rat groups; n = 4 per group) but minimize the problems 
associated with running WGCNA on genes that showed only a few expression patterns in total. 
Preprocessing of the combined raw read counts using the R (v 3.3.0) and Bioconductor packages 
generated reads ranging from 13.1 to 18.3 million per sample (rat) that aligned uniquely within 
32,662 rat genes and 8,637 T. gondii genes. About 12,749 rat genes and 890 Toxoplasma genes 
met the criteria for further analysis using EdgeR's (v 3.14.0) negative binomial generalized linear 
model with likelihood ratio tests and tagwise dispersion estimates.  
By ANOVA FDR (P< 0.2), 6,942 genes with moderate evidence for differential 
expression were selected. Using blockwise modules, this resulted in 55 modules, each of which 
contained genes clustered based on their expression patterns. Genes that did not fit any of the 55 
module patterns were clustered in a separate module. From the modules generated, cytochrome 
genes (Cyp2d3, Cyp2d5, and Cybrd1) were clustered in one module and were found to be 
expressed significantly higher in the LEW rats (both infected and uninfected) than in the BN rats 
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(both infected and uninfected) (Table 2.1). By comparison analysis of the RNA sequence data, 
among the genes that were significantly (FDR, P <0.05) differentially expressed, the two 
cytochrome P450 family genes Cyp2d3 and Cyp2d5 were found to be 464.43-fold and 221.12-
fold upregulated, respectively, in the infected LEW rats compared to the infected BN rats (Table 
2.1). Interestingly, in the uninfected rats, Cyp2d3 and Cyp2d5 were 1072.80-fold and 402.16-
fold upregulated, respectively, in the LEW compared to the BN rats (Table 2.1), suggesting that 
their expression was not induced by infection but was inherently higher in the LEW rat than in 
the BN rat. Additionally, the cytochrome-b reductase 1 gene (Cybrd1) was found to be 
upregulated (3.64-fold) in the infected LEW rats compared to the infected BN rats. However, 
unlike Cyp2d3 and Cyp2d5, Cybrd1 upregulation was augmented by infection of the rats with T. 
gondii (Table 2.1). In contrast, LEW rats had lower transcript levels for some antioxidant 
enzymes than the BN rats (Table 2.2). These antioxidant enzymes included lactoperoxidase 
(LPO), microsomal glutathione S-transferase-2 (Mgst2), microsomal glutathione S-transferase-1 
(Mgst1), glutathione S-transferase kappa 1 (Gstk1), and glutathione peroxidase (Gpx4). When 
the infected LEW rat was compared to the uninfected LEW rat, T. gondii infection was found to 
be associated with the downregulation of the genes for the antioxidant enzymes, while there was 
no apparent effect in the BN rat (Table 2.2). 
 
2.3.3 LEW rat peritoneal cells contain inherently higher ROS levels than BN rat peritoneal 
cells. 
Because cytochrome enzymes are involved in the generation of intracellular ROS, we 
endeavored to investigate whether the LEW rat peritoneal cells, which had higher expression of 
cytochrome enzymes (Cyp2d3, Cyp2d5, and Cybrd1), would also contain higher levels of ROS 
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than the BN rat cells. We measured the relative levels of ROS using the CellROX Deep Red 
reagent in both T. gondii-infected and uninfected freshly isolated peritoneal cells from the LEW 
and BN rats. We found that both the infected and uninfected peritoneal cells of the LEW rat 
contained significantly (P < 0.05) higher levels of ROS than the uninfected or infected BN rat 
cells (Figure 2.2A and C). This corroborated the higher expression levels of cytochrome 
enzymes in the LEW rat than in the BN rat (Table 2.1). By quantification of the numbers of 
infected and uninfected cells in the microscopic images for the cultures in which ROS levels 
were measured, we found that the LEW rat-derived cultures had fewer than 2% infected 
peritoneal cells, while the BN rat-derived cultures had about 40% infected peritoneal cells 
(Figure 2.2B and D). This was consistent with the LEW rat's refractoriness to T. gondii infection 
(Figure 2.1). 
 
2.3.4 Scavenging of ROS decreases LEW rat peritoneal cell resistance to T. gondii infection. 
We hypothesized that the high level of ROS that we observed in the LEW rat peritoneal 
cells played a role in resistance to T. gondii infection. Mammalian phagocytic cells are known to 
produce large amounts of superoxide anion, which is a precursor for other highly reactive ROS 
such as hydrogen peroxide, hydroxyl radicals, and peroxynitrite. Therefore, to investigate 
whether superoxide anion was playing a role in the LEW rat's refractoriness to T. gondii, we 
infected LEW and BN rat peritoneal cells in the presence or absence of various concentrations of 
Mn(III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) (a superoxide scavenger) at a multiplicity 
of infection (MOI) of 1:4 (lower than the MOI used for the assay for Figure 2.2 to avoid 
overgrowth of parasites due to a prolonged culture period) and analyzed the proliferation of 
intracellular parasites in culture. We observed that while untreated LEW peritoneal cells had 
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extremely few to no observable parasites at the various time points, the MnTBAP-treated LEW 
peritoneal cells showed a significant (P < 0.05) increase in the number of observable intracellular 
parasites as well as the number of infected cells, proportional to the concentration of MnTBAP 
added to the cells (Figure 2.3A). In LEW peritoneal cells treated with 50 and 100 μM MnTBAP, 
parasites progressively increased in number and peaked at about 56 h post-infection, while in the 
cells with 150 μM MnTBAP, parasite growth peaked at 18 h post-infection and thereafter 
declined to the level in the LEW rat peritoneal cells with 50 μM MnTBAP (Figure 2.3A). These 
findings indicated that scavenging of ROS from peritoneal cells by MnTBAP decreased the 
resistance of LEW cells to T. gondii infection. By measuring ROS levels in uninfected LEW and 
BN rat peritoneal cells, we found that indeed, MnTBAP treatment decreased the levels of 
intracellular ROS in a concentration-dependent manner. As expected, in all the infected BN rat 
peritoneal cells with or without various concentrations of MnTBAP, parasites progressively 
proliferated over time (Figure 2.4B). Notably, at 18 h post-infection, the amount of parasites in 
the BN rat peritoneal cells treated with 150 μM MnTBAP was significantly (P < 0.05) higher 
than that in other cells (Figure 2.3B). 
To ascertain that scavenging of ROS not only increased survival of parasites but also 
resulted in parasite proliferation in the infected LEW peritoneal cells, we quantified the average 
number of parasites per parasitophorous vacuole (PV) in the microscopic images from which the 
data described in Figure 2.3 were derived. We found a time-dependent and MnTBAP 
concentration-dependent increase in the number of parasites in the MnTBAP-treated LEW rat 
peritoneal cells (Figure 2.4A). On the other hand, treatment of BN peritoneal cells with 
MnTBAP did not have a significant effect on the number of parasites per PV, as both treated and 
untreated cells allowed a progressive increase in the number of parasites at similar rates (Figure 
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2.4B). Using the WST1 reagent, analysis of the toxic concentrations of MnTBAP in uninfected 
LEW and BN rat peritoneal cells showed that MnTBAP had 50% inhibitory concentrations (IC50) 
of 200 ± 12.2 μM and 215 ± 15.3 μM, respectively. This indicated that the highest concentration 
(150 μM) of MnTBAP used for scavenging ROS in the cell cultures was below the toxic levels 
to significantly affect the viability of the cells. 
 
2.3.5 Increase in T. gondii growth in MnTBAP-treated LEW peritoneal cells augments cell 
death. 
The resistance phenotype of the LEW rat peritoneal macrophages to T. gondii infection 
has been associated with the rapid death of both parasites and infected host cells (Cavailles et al., 
2014; Cavailles et al., 2006). Thus, we endeavored to investigate whether the increase in T. 
gondii growth in LEW rat peritoneal cells treated with MnTBAP would lead to a higher cell 
death rate in the LEW than in the BN rat peritoneal cells. Using propidium iodide (PI) staining to 
detect dead cells, we observed that infected LEW rat peritoneal cells treated with MnTBAP had a 
higher rate of cell death than the untreated cells (Figure 2.5A). The rate of cell death 
corresponded to the rate of parasite growth in the cells. Comparatively, the infected BN rat 
peritoneal cells treated with equivalent concentrations of MnTBAP supported a higher parasite 
growth rate but yet had a lower rate of cell death than observed in the LEW rat peritoneal cells 
(Figure 2.5B). Because we had earlier determined that the concentrations of MnTBAP used in 
the assays were nontoxic to the cells, the augmentation in cell death could be associated with 
increased parasite growth in the LEW rat cells. Therefore, from the microscopic images used to 
derive the data shown in Figure 2.5, we randomly selected 50 cells per microscopic field and 
determined the percentage of cells that were both propidium iodide positive (dead cells) and 
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contained T. gondii parasites intracellularly. Additionally, we also derived the percentage of cells 
that were positive for propidium iodide but did not contain T. gondii parasites intracellularly. We 
found that, for the LEW rat cells, the MnTBAP-treated cultures had significantly more dead cells 
containing intracellular parasites, as well as dead cells without intracellular parasites, than 
untreated cultures (Figure 2.6A). On the other hand, when comparing the MnTBAP-treated and 
untreated BN peritoneal cells, there was no observable significant difference in the number of 
dead cells containing intracellular parasites or in the number of dead cells without intracellular 
parasites (Figure 2.6B). Together, these findings suggested that the MnTBAP-induced parasite 
proliferation in LEW peritoneal cells significantly contributed to host cell death. 
 
2.4 DISCUSSION 
The LEW rat is extremely resistant to T. gondii infection, to the extent that invading 
parasites are rapidly killed by the host innate immune responses without the generation of anti-T. 
gondii antibodies in the host (Sergent et al., 2005). This kind of resistance phenotype indicates 
the involvement of inherently swift and aggressive killing mechanisms. In our attempts to 
elucidate the molecular mechanisms underlying the robust resistance of the LEW rat to T. gondii 
infection, we performed a global transcriptome analysis of T. gondii-infected and uninfected 
LEW rats versus T. gondii-infected and uninfected BN rats. In RNA sequencing, the quality of 
the RNA samples used is critical, considering that RNA is rapidly digested in the presence of the 
nearly ubiquitous RNase enzymes. Degraded RNA can result in shorter fragments of RNA that 
can compromise the sequencing results. Therefore, prior to sequencing, we evaluated the quality 
of all the RNA samples and used only samples with an RNA integrity number (RIN) of 9.5 or 
above, on a scale of 1 to 10 with 1 being totally degraded RNA and 10 being intact RNA 
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(Schroeder et al., 2006). Previous data from our sequencing facility at the University of Illinois at 
Urbana-Champaign have demonstrated that RNA samples with a RIN of 7 and above (as 
determined with an Agilent Bioanalyzer) provide reliable and consistent RNA sequencing results 
(unpublished data). The RIN is an important tool for validating RNA samples used in gene 
expression measurement experiments (Schroeder et al., 2006). 
Our data show that compared to the BN rat, the uninfected LEW rat has inherently higher 
transcript levels of Cyp2d3, Cyp25, and Cybrd1 that are maintained even during infection with T. 
gondii. These findings were corroborated by our observation that both the uninfected and 
infected LEW rat peritoneal cells contained higher levels of ROS than the BN rat peritoneal cells. 
Cyp2d3 and Cyp2d5 are cytochrome P450 family proteins that catalyze the microsomal and 
mitochondrial electron transport chains leading to the generation of ROS (including superoxide 
radical anion, hydroxyl radical, and hydrogen peroxide) in mammalian cells (Hrycay & Bandiera, 
2015). The Cybrd1 gene is a member of the cytochrome-b561 gene family that encodes an iron-
regulated protein (Oakhill, Marritt, Gareta, Cammack, & McKie, 2008). It can catalyze the 
reduction of ferric iron to form ferrous iron, which reacts with hydrogen peroxide to produce a 
hydroxyl radical via the Fenton reaction (Hrycay & Bandiera, 2015). In the normal physiological 
state, cellular ROS are detoxified by cellular antioxidant enzymes to prevent the development of 
oxidative stress, which is deleterious to cells (Wiseman & Halliwell, 1996). Interestingly, in the 
present study, we found that despite having high expression of cytochrome enzymes, with the 
associated high levels of ROS, the LEW rat had lower transcript levels of antioxidant enzymes 
than the BN rat. This implied that the LEW rat maintained cellular microenvironmental oxidative 
stress which it is able to tolerate. During microbial invasion, immune effector cells, including 
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neutrophils, eosinophils, and macrophages, have been shown to generate an oxidative burst that 
is toxic to the invading pathogen (Maraldi, 2013; Nathan & Shiloh, 2000). 
Based on our findings it is logical that in the LEW rat cells, the high expression of 
cytochrome enzymes with concomitantly high ROS levels, but without augmented expression of 
antioxidant enzymes, creates a toxic cellular environment that rapidly and effectively kills 
invading T. gondii tachyzoites. Indeed, generation of ROS in infected mammalian cells has been 
reported to limit intracellular T. gondii growth and survival (Aline, Bout, & Dimier-Poisson, 
2002; Buzoni-Gatel & Werts, 2006; Miller, Wen, Dunford, Wang, & Suzuki, 2006; Murray, 
Rubin, Carriero, Harris, & Jaffee, 1985), but the involvement of ROS as a critical component for 
killing T. gondii during or shortly after host cell invasion remains poorly elucidated. Although T. 
gondii has been shown to express antioxidant enzymes that might protect it from a host cell 
oxidative burst after invasion (Ding, Kwok, Schluter, Clayton, & Soldati, 2004), it is likely this 
is not sufficient or comes too late to prevent toxic effects of the inherently high ROS content in 
LEW rat cells. Despite previous reports that increased generation of nitric oxide (NO) during T. 
gondii infection plays a role in controlling the infection (Li et al., 2012), we did not observe a 
significant difference in the expression levels of the inducible nitric oxide (iNOS) gene between 
the infected LEW and BN rats, indicating that neither rat strain had an advantage over the other 
in the utilization of NO in fighting T. gondii infection. 
Further, we found that scavenging of superoxide anion by MnTBAP led to a decrease in 
the refractoriness of the LEW rat peritoneal cells to T. gondii infection, resulting in establishment 
of infection and proliferation of the parasites in the cells. Mindful of the fact that the LEW rat 
peritoneal cells rapidly kill T. gondii, in our experimental setup, we first treated the cells with 
MnTBAP for 30 min to allow scavenging of ROS to occur prior to inoculating the cultures with 
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T. gondii tachyzoites. MnTBAP acts as a superoxide dismutase mimetic that can rapidly 
scavenge cellular superoxide anion within a few minutes (Bleeke, Zhang, Madamanchi, 
Patterson, & Faber, 2004; Gauuan et al., 2002). Superoxide anion has been shown to be produced 
in large quantities by phagocytic cells and is a precursor for other highly reactive ROS such as 
hydrogen peroxide, hydroxyl radicals, and peroxynitrite (Hrycay & Bandiera, 2015). Thus, 
scavenging superoxide in cells would in turn decrease other intracellular ROS. ROS in 
phagocytic cells have been shown to induce the recruitment of autophagy components to 
phagosomes, which may facilitate lysosomal fusion (Huang et al., 2009; Sanjuan et al., 2007). In 
the case of intracellular T. gondii, lysosomal fusion of the nonfusogenic parasitophorous vacuole 
leads to killing of the intracellular parasites (Andrade, Wessendarp, Gubbels, Striepen, & 
Subauste, 2006). Consistent with our observation that scavenging ROS augments parasite 
survival and growth in the LEW rat peritoneal cells, others (Cavailles et al., 2014) have 
demonstrated the involvement of ROS and caspase-1 in a T. gondii killing mechanism that is 
linked to the Toxo1 locus in the LEW rat. 
We found that the decrease in resistance to T. gondii infection associated with scavenging 
of superoxide in LEW rat cells significantly augmented parasite growth and the rate of infected 
host cell death. Along with the increase in the death of infected cells, we observed a significant 
increase in the death of uninfected cells as well, suggesting a bystander host cell killing 
phenomenon. The killing of bystander non-infected host cells during T. gondii infection has been 
reported previously and has been associated with cell lytic factors released from dying infected 
cells as well as the effect of nitric oxide (Nishikawa et al., 2007). However, in the BN peritoneal 
cells, even though parasites grew progressively, with a notable increase in the proportion of 
dying infected cells, the proportion of dead uninfected cells was comparatively lower than those 
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observed in the LEW rat cells. This indicated that the mechanism underlying the resistance of the 
LEW rat to T. gondii infection is multifaceted, involving the rapid killing of both the invading 
parasite and the infected cells, thus effectively curtailing the dissemination of the infection. 
Underscoring this hypothesis, previous studies have found that a highly conserved Toxo1 
genomic locus in T. gondii-resistant rats (including the LEW rat), contains genes (NLRP1 and 
ALOX12) that have been shown to be involved in innate immunity mechanisms for the rapid 
killing of T. gondii parasites and infected host cells by macrophages (Cavailles et al., 2014; 
Cavailles et al., 2006; Ewald, Chavarria-Smith, & Boothroyd, 2014; Witola et al., 2014; Witola 
et al., 2011). Cellular invasion by pathogens activates the NLRP1 inflammasome, which leads to 
initiation of pyroptosis, a caspase-1-dependent highly inflammatory cell death process often 
observed during infection with cytosolic pathogens (Tschopp, Martinon, & Burns, 2003), 
including T. gondii infection (Cavailles et al., 2014). 
In conclusion, this study provides evidence that the LEW rat cells have inherently high 
levels of ROS that are involved in the killing of invading T. gondii parasites and thus contribute 
to the natural resistance of the LEW rat to T. gondii infection. Despite the deleterious effects of 
high levels of ROS on the normal physiological state of cells, our findings suggest new avenues 
for developing therapeutic agents by targeting the induction of oxidative stress as a mechanism 
for controlling T. gondii infections. Indeed an effective veterinary drug in current use called 
monensin, which has potent activity against coccidian protozoa, has been shown to cause cellular 
oxidative stress (Charvat & Arrizabalaga, 2016), suggesting that its mode of action against 





2.5 MATERIALS AND METHODS 
2.5.1 Culture and purification of T. gondii tachyzoites. 
Confluent monolayers of human foreskin fibroblasts (HFF) were maintained in Iscove's 
modified Dulbecco's medium supplemented with 10% (vol/vol) heat-inactivated fetal bovine 
serum, 1% (vol/vol) GlutaMAX, and 1% (vol/vol) penicillin-streptomycin-amphotericin B 
(Fungizone) (Life Technologies) at 37°C with 5% CO2. T. gondii RH strain parasites were 
cultured in the HFF cells. To isolate T. gondii tachyzoites, HFF (cultured in T-75 flasks) in 
which T. gondii had proliferated were scraped off the culture flask and resuspended in 10 ml 
culture medium, and parasites were extruded by passing the cell suspension twice through a 25-
gauge needle. The extruded parasites were isolated from cell debris by passing through a 3-μm 
filter, followed by washing the filtered parasites three times in sterile phosphate-buffered saline 
(PBS). The final parasite concentration was determined by counting using a hemocytometer. 
 
2.5.2 Infection of rats and isolation of peritoneal cells. 
The care and use of rats for experimental procedures in this study were performed 
following a protocol approved by the University of Illinois at Urbana-Champaign Institutional 
Animal Care and Use Committee. Four-week-old male (Brown Norway) BN and Lewis (LEW) 
rats were purchased from Charles River and allowed to acclimatize for 10 days. Following 
acclimatization, for each rat strain, four animals in the treatment group were each inoculated 
intraperitoneally with 3.5 × 106 freshly isolated T. gondii RH strain tachyzoites constitutively 
expressing cytosolic yellow fluorescent protein (YFP) (Gubbels, Li, & Striepen, 2003) in 0.5 ml 
sterile PBS, while the control group of four animals were each inoculated with 0.5 ml of sterile 
PBS only. The rats were sacrificed at 24 h post-infection by CO2 asphyxiation and peritoneal 
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cells isolated immediately by peritoneal lavage with 20 ml of unsupplemented RPMI medium. 
The cells were washed three times in RPMI medium and counted with a hemocytometer. Part of 
the freshly isolated peritoneal cells from T. gondii-infected LEW and BN rats were seeded in 24-
well plates at a density of 8.5 × 105/well in supplemented RPMI medium (with 10% fetal bovine 
serum, 2.05 mM L-glutamine, 1× nonessential amino acids [Sigma], and 1% penicillin-
streptomycin [Life Technologies]) and analyzed by fluorescence microscopy to detect YFP 
fluorescence from T. gondii tachyzoites at 24 h and 48 h post-culture. 
 
2.5.3 RNA extraction from rat peritoneal cells. 
For each rat, 1 × 107 peritoneal cells were used for total RNA extraction using the 
RNeasy minikit (Qiagen) following the manufacturer's instructions. The extracted RNA was 
quantified using a Qubit 3.0 fluorometer RNA BR kit (Life Technologies) and the quality 
determined using an Agilent 2100 Bioanalyzer (Agilent Technologies). RNA samples were 
stored at −80°C until use. 
 
2.5.4 Library preparation and RNA sequencing. 
RNA samples from individual animals were submitted for RNA sequencing (4 individual 
samples per treatment group). RNA library preparation and sequencing were performed at the 
Roy J. Carver Biotechnology Center's High Throughput Sequencing and Genotyping Unit of the 
University of Illinois at Urbana-Champaign. Briefly, the RNA sequencing libraries were 
prepared with Illumina's TruSeq Stranded mRNAseq Sample Prep kit (Illumina) following the 
manufacturer's instructions. The libraries were quantitated by fluorometry (Qubit), run on a 
Bioanalyzer for fragment analysis, diluted to 10 nM, and quantified by quantitative PCR (qPCR). 
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The libraries were sequenced from one end of the fragments on a HiSeq2500 using a HiSeq SBS 
sequencing kit version 4. Trimmomatic (version 0.33) was used to trim any residual adapter 
content and low-quality bases. Fastq files were generated and demultiplexed with the bcl2fastq 
v2.17.1.14 conversion software (Illumina). The quality-scores line in fastq files used an ASCII 
offset of 33 known as Sanger scores. All gene counts were generated using Feature Counts in the 
Sub-read (version 1.5.0) package. Gene annotations, including Gene Ontology terms, were 
downloaded from Ensembl release 84 for Rnor_6.0 and ToxoDB.org release 28 for T. gondii 
GT1. The number of reads mapping to each rat chromosome and to the T. gondii genome were 
calculated using the Samtools (v. 1.3) idxstats tool. 
 
2.5.5 Measurement of levels of ROS in rat peritoneal cells. 
Freshly isolated peritoneal cells from BN and LEW rats were seeded in 96-well plates at 
a density of 3.5 × 105/well in 200 μl RPMI medium supplemented with 10% fetal bovine serum, 
2.05 mM L-glutamine, 1× nonessential amino acids (Sigma), and 1% penicillin-streptomycin. 
For each rat strain's peritoneal cells, triplicate wells were either maintained uninfected or infected 
with T. gondii RH strain at a multiplicity of infection (MOI) ratio of 1:1 and incubated at 37°C 
with CO2 and humidity for 16 h. After 16 h, 5 μM (final concentration) CellROX Deep Red 
reagent (Life Technologies) was added to all wells and the cultures incubated for a further 30 
min. The cultures were then washed three times in PBS by carefully aspirating out 150 μl of 
medium and replacing it with 150 μl of PBS, followed by centrifugation of the plates at 300 × g 
for 5 min. After the last wash, 150 μl of PBS was added and the cells analyzed by fluorescence 
microscopy to determine the fluorescence generated by the reaction of the CellROX reagent with 
ROS. Fluorescence quantification per microscopic field (magnification, ×20) was done using 
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ImageJ version 1.37v software (NIH). From the microscopic images of the cultures, 100 cells 
were randomly counted per microscopic field and the percentage of infected and uninfected cells 
calculated. 
 
2.5.6 Determination of effect of MnTBAP on T. gondii growth in LEW and BN rat 
peritoneal cells. 
Freshly isolated peritoneal cells from BN and LEW rats were seeded at a density of 8.5 × 
105/well in 24-well plates in 1 ml of supplemented RPMI medium. Triplicate wells were treated 
with a superoxide scavenger, Mn (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP), at a final 
concentration of 0, 50, 100, or 150 μM, incubated for 30 min, and then infected with YFP-
expressing T. gondii RH strain at an MOI ratio of 1:4 (1 parasite to 4 cells), followed by 
incubation at 37°C with 5% CO2 and humidity. At 18 h, 32 h, and 56 h of incubation, the 
cultures were analyzed by fluorescence microscopy using the fluorescein isothiocyanate (FITC) 
channel to measure the parasite YFP fluorescence. After each of the 18-h and 32-h time points of 
analysis, 500 μl of medium was aspirated from each well and replaced with an equivalent 
volume of fresh medium containing fresh MnTBAP at the respective final concentration. 
Fluorescence quantification was done using ImageJ version 1.37v software (NIH). The number 
of tachyzoites per parasitophorous vacuole in T. gondii-infected LEW and BN rat peritoneal cells 
during treatment with or without the superoxide scavenger MnTBAP was determined from the 






2.5.7 Cell viability assay using Propidium Iodide. 
Freshly isolated peritoneal cells from BN and LEW rats were seeded in 96-well plates at 
a density of 3.5 × 105/well in 200 μl of supplemented RPMI medium. Triplicate wells were 
treated with MnTBAP at a final concentration of 0, 50, 100, or 150 μM, incubated for 30 min, 
and then infected with YFP-expressing T. gondii RH strain at a MOI ratio of 1:4 (1 parasite to 4 
cells), followed by incubation at 37°C with 5% CO2 and humidity. Cells treated with MnTBAP 
but without T. gondii infection were also cultured. For each category of cultures, three plates 
were set for reading at time points of 0 h, 18 h, and 32 h post-infection. For the plates designated 
for reading at 0 h post-infection, immediately after inoculating the parasites into the cells, the 
plates were centrifuged to sediment the cells, and then 150 μl of medium was removed from each 
well and replaced with an equal volume of fresh medium containing propidium iodide (PI) at a 
final concentration of 20 μg/ml, followed by incubation in darkness at 37°C for 5 min. The cells 
were washed three times with PBS by aspirating out 150 μl of the medium and replacing it with 
150 μl of PBS, followed by centrifugation of the plates to sediment the cells. After the last wash, 
150 μl of PBS was added and the wells analyzed by fluorescence microscopy using the Texas 
Red channel to detect PI fluorescence and the FITC channel to detect YFP-expressing T. gondii. 
The plates designated for reading at 18 h and 32 h post-infection were processed and analyzed in 
the same way at the respective time points. Fluorescence quantification was done using ImageJ 
version 1.37v software (NIH). The relative fluorescence was derived by subtracting the 
quantified fluorescence of the uninfected cultures from that of the infected cultures. In 
microscopic images taken at 0 h, 18 h, and 32 h post-infection, 50 cells were randomly counted 
per ×20 microscopic field, and the percentage of cells with a combination of red fluorescence (PI 
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positive) and green fluorescence (T. gondii-infected), as well as the percentage of cells that were 
PI positive but negative for T. gondii infection, was calculated. 
 
2.5.8 Cell viability assay using cell proliferation reagent WST-1. 
Freshly isolated peritoneal cells from BN and LEW rats were seeded in 96-well plates at 
a density of 3.5 × 105/well in 200 μl of supplemented RPMI medium (without red phenol). 
Triplicate wells were treated with MnTBAP at final concentrations of 0, 25, 50, 75, 100, 125, 
150, 175, 200, 250, and 300 μM, and incubated at 37°C with 5% CO2 and humidity. After 24 h 
of culture, a colorimetric assay using the cell proliferation reagent WST-1 (Roche) for the 
quantification of cell viability was performed on the cultures by adding 20 μl of the WST-1 
reagent to each well. After mixing, the plates were wrapped in aluminum foil and incubated for 1 
h at 37 C with 5% CO2. After 1 h of incubation, 150 μl of the medium from each well was 
transferred to a new 96-well plate, and quantification of the formazan dye produced by 
metabolically active cells was read as absorbance at a wavelength of 420 nm using a scanning 
multiwell spectrophotometer (Spectra Max 250; Molecular Devices). Three independent assays 
were performed, the dose-response curves of the means from triplicate assays were generated 
using GraphPad Prism software, and the IC50s were derived. 
 
2.5.9 Data analysis. 
For RNA sequencing data, the combined raw read counts were subjected to preprocessing 
and analysis using the R (v 3.3.0) and Bioconductor packages (Gentleman et al., 2004). Analysis 
was done using EdgeR's (v 3.14.0) negative binomial generalized linear model with likelihood 
ratio tests and tagwise dispersion estimates (McCarthy, Chen, & Smyth, 2012; Robinson, 
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McCarthy, & Smyth, 2010). The equivalent of a one-way ANOVA across the four groups was 
calculated for each gene, along with the four logical pairwise comparisons between the groups. 
Multiple-hypothesis test correction was done using the false-discovery rate method. To assess 
the complex patterns of gene expression across the four treatment groups, a weighted gene 
correlation network analysis (WGCNA v 1.51) using the trimmed mean of M-values (TMM)-
normalized log2 counts per million (CPM) values was performed (Langfelder & Horvath, 2008; 
B. Zhang & Horvath, 2005). Heat maps were made separately for rat and Toxoplasma genes with 
ANOVA FDR (P < 0.05) using TMM-normalized log2 CPM values that were scaled to have a 
mean of zero and a standard deviation of one. All statistical analyses on the sequencing data 
were done on log2 scale values and then back-translated from log2 fold change (FC) to regular 
FC. For in vitro assays, data analyses were performed using the two-tailed Student's t test. P 
values of 0.05 or less were considered significant. 
 
2.5.10 Accession number. 
The entire series of RNA sequencing data obtained in this study has been submitted to the 










2.6 FIGURES AND TABLES 
 
 
Figure 2.1: In vitro growth of T. gondii parasites in peritoneal cells isolated from BN and LEW 
rats at 24 h after intraperitoneal infection of the rats. YFP-expressing T. gondii parasites are 




Figure 2.2: (A) Relative reactive oxygen species (ROS) levels in rat peritoneal cells cultured for 
16 h in vitro with (+) or without (−) T. gondii infection. Fluorescence generated by the reaction 
of CellROX Deep Red reagent (Molecular Probes) with cellular ROS is shown on the y axis as 
the mean fluorescence intensity (measured per microscopic field at a magnification of × 20) 
proportional to the level of ROS in the cells. Lew− and Lew+ represent LEW rat peritoneal cells 
without and with T. gondii infection, respectively. BN− and BN+ represent Brown Norway rat 
peritoneal cells without and with T. gondii infection, respectively. (B) Mean percentage of T. 
gondii-infected cells (black bars) and uninfected cells (gray bars) in cultures of LEW rat (LEW 
Cells) and BN rat (BN Cells) peritoneal cells cultured with T. gondii tachyzoites at an MOI of  
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Figure 2.2: (cont.) 
1:1 for 16 h. (C) Representative images depict T. gondii-infected and uninfected LEW and BN 
peritoneal cells stained with CellROX Deep Red Reagent for detecting reactive oxygen species 
(red fluorescence) content in cells, captured at a magnification of × 20 at 16 h postinfection. (D) 
Representative images of LEW and BN peritoneal cells depicting the proportion of infected 
(with parasites fluorescing green) and uninfected cells at 16 h post-infection. The data shown 
represent means from three independent experiments with standard error bars, and the points at 






















Figure 2.3: Effect of the superoxide scavenger Mn(III) tetrakis (4-benzoic acid) porphyrin 
(MnTBAP) on T. gondii survival and growth in rat peritoneal cells cultured in vitro. Freshly 
isolated peritoneal cells from LEW (A) and BN (B) rats were cultured without or with various 
concentrations (50, 100, and 150 μM) of MnTBAP and infected with YFP-expressing T. gondii 
RH tachyzoites. The YFP fluorescence generated by the parasites in culture was measured at 0 h, 
18 h, 32 h, and 56 h postinfection, and the relative mean fluorescence intensities shown on the y  
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Figure 2.3: (cont.) 
axis are proportional to the parasite amount in the cultures. The data shown represent means 
from three independent experiments with standard error bars, and the points at which data are 





Figure 2.4: Analysis of the number of tachyzoites per parasitophorous vacuole in T. gondii-
infected LEW rat (A) and BN rat (B) peritoneal cells during treatment with or without the 
superoxide scavenger MnTBAP in vitro. The mean number of parasites per vacuole was 
determined as an average of parasites in one parasitophorous vacuole for 20 infected cells 
selected randomly from 10 independent microscopic fields (×20 objective). The data shown  
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Figure 2.4: (cont.) 
represent means from three independent experiments with standard error bars, and the points at 
which data are significantly different (P < 0.05) are depicted by asterisks. (C) Representative 
images of infected cells in which parasites per vacuole were counted, containing 1, 2, 3, 4, or 5 


























Figure 2.5: Determination of the viability of T. gondii-infected rat peritoneal cells during 
treatment with the superoxide scavenger MnTBAP in vitro. Freshly isolated peritoneal cells from 
LEW (A) and BN (B) rats were cultured with various concentrations (0, 50, 100, and 150 μM) of 
MnTBAP during infection with T. gondii RH tachyzoites. The fluorescence generated by 
propidium iodide staining of dead cells in the cultures was quantified as relative values from  
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Figure 2.5: (cont.) 
which the background fluorescence of uninfected cells treated with respective MnTBAP 
concentration was subtracted. Dotted, gray, white, and black bars represent propidium iodide 
fluorescence intensity from cells treated with 0, 50, 100, and 150 μM MnTBAP, respectively. 
The data shown represent means from three independent experiments with standard error bars, 























Figure 2.6: Quantification of propidium iodide (PI)-positive cells in T. gondii-infected rat 
peritoneal cells during treatment with or without the superoxide scavenger MnTBAP in vitro. 
Freshly isolated peritoneal cells from LEW (A) and BN (B) rats were cultured with 0 or 100 μM  
MnTBAP and infected with YFP-expressing T. gondii RH tachyzoites. At 0 h, 18 h, and 32 h 
postinfection, the cultures were analyzed by fluorescence microscopy by randomly selecting 50 
cells per ×20 microscopic field and deriving the percentage of those with a combination of red  
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Figure 2.6: (cont.) 
fluorescence (PI positive) and green fluorescence (T. gondii infected) (black bars). In the same 
field, the percentage of cells that were positive for PI but negative for T. gondii infection was 
also determined (white bars). The data shown represent means from three independent 
experiments with standard error bars, and the points at which data are significantly different (P < 





















Table 2.1: Differentially expressed genes for enzymes that catalyze generation of reactive 
oxygen species in LEW vs BN rats.  
Cyp: Cytochrome P450 family; Cybrd: Cytochrome b reductase; NSD: Not significantly different (p < 
0.05); BNToxo and LEWToxo: T. gondii-inoculated BN and LEW rats; BNPBS and LEWPBS: PBS-inoculated 
BN and LEW rats.  
 
 
Table 2.2: Differentially expressed genes for antioxidant enzymes in LEW vs BN rats.  
LPO: Lacto peroxidase; Mgst: Microsomal glutathione S-transferase; Gstk: Glutathione S-transferase 
kappa; Gpx: Glutathione peroxidase; NSD: Not significantly different (p < 0.05); BNToxo and LEWToxo: T. 
gondii-inoculated BN and LEW rats; BNPBS and LEWPBS: PBS-inoculated BN and LEW rats. 
  










ENSRNOG00000029179 Cyp2d3 NSD -2.19 (p < 0.0001) 464.43 (p < 2.03E-49) 1072.80 (p < 8.18E-67) 
ENSRNOG00000029178 Cyp2d5 NSD -1.82 (p < 0.02) 221.12 (p < 3.62E-18)   402.16 (p < 5.07E-26) 
ENSRNOG00000009620 Cybrd1 NSD  1.80 (p < 0.0008)     3.64 (p < 1.08E-11)       1.70 (p < 0.004) 










ENSRNOG00000008422 LPO NSD -5.50 (p < 0.0001) -12.10 (p < 8.14E-8)      NSD 
ENSRNOG00000061857 Mgst2 NSD -5.40 (p < 4.6E-6)   -3.00 (p < 0.002)      NSD 
ENSRNOG00000004245 Mgst3 NSD -3.30 (p < 0.003)   -2.11 (p < 0.05)      NSD 
ENSRNOG00000016484 Gstk1 NSD -2.06 (p < 0.001)   -1.50 (p < 0.05)      NSD 
ENSRNOG00000013604 Gpx4 NSD -1.75 (p < 0.003)   NSD      NSD 
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CHAPTER 3: SMALL GTPASE IMMUNITY ASSOCIATED PROTEINS MEDIATE 
RESISTANCE TO TOXOPLASMA GONDII INFECTION IN LEWIS RAT 
3.1 ABSTRACT 
Rats vary in their susceptibilities to Toxoplasma gondii infection depending on the rat 
strain. Compared to the T. gondii-susceptible Brown Norway (BN) rat, the Lewis (LEW) rat is 
extremely resistant to T. gondii. Thus, these two rat strains are ideal models for elucidating host 
mechanisms that are important for host resistance to T. gondii infection. Therefore, in our efforts 
to unravel molecular factors directing the protective early innate immune response in the LEW 
rat, we performed RNA sequencing analysis of the LEW versus the BN rat, with or without T. 
gondii infection. We identified three candidate small GTPase Immunity Associated Proteins 
(GIMAPs) that were upregulated (false discovery rate, 0.05) in the LEW rat in response to T. 
gondii infection. Subsequently, we engineered T. gondii-susceptible NR8383 rat macrophage 
cells for over-expression of LEW rat-derived candidate GIMAP 4, 5, and 6. By 
immunofluorescence analysis we observed that GIMAP 4, 5, and 6 in T. gondii-infected NR8383 
cells each co-localized with GRA5, a parasite parasitophorous vacuole membrane (PVM) marker 
protein, suggesting their translocation to the PVM. Interestingly, overexpression of each 
candidate GIMAP in T. gondii-infected NR8383 cells induced translocation of LAMP1, a 
lysosome marker protein, to the T. gondii surface membrane. Importantly, overexpression of 
GIMAP 4, 5, or 6 individually inhibited intracellular T. gondii growth, with GIMAP 4 having the 
highest inhibitory effect. Together, our findings indicate that upregulation of GIMAP 4, 5, and 6 
contributes to the robust refractoriness of the LEW rat to T. gondii through induction of 
lysosomal fusion to otherwise nonfusogenic PVM. 
This chapter has appeared as an article in Infection and Immunity ® (IAI). The original citation is: Kim CY, Zhang 
X, Witola WH. Small GTPase immunity associated proteins mediate resistance to Toxoplasma gondii infection in 





 Toxoplasma gondii is a zoonotic apicomplexan protozoan estimated to have infected 
about a third of the world human population (Montoya & Liesenfeld, 2004). The hallmark of T. 
gondii is its ability to induce long-term chronic infections through its interactions with the host, 
leading to conversion of the prolific tachyzoite stage to the quiescent bradyzoite parasite stage 
(Aliberti, 2005). Bradyzoites of T. gondii are not usually harmful in immunocompetent 
individuals, but in immunodeficient hosts they reconvert into cytolytic tachyzoites, resulting in 
reactivation of toxoplasmosis (Phan et al., 2008). Currently, there is no drug to eliminate 
bradyzoites in infected individuals, and the use of drugs against tachyzoites is limited by 
hypersensitivity and toxicity in humans. To date, no vaccine against T. gondii has been 
developed for humans. 
 Rats, like immunocompetent humans, develop a subclinical chronic infection, but vary in 
their susceptibilities to T. gondii infection depending on the rat strain (Dubey et al., 2016). 
Compared to the T. gondii-susceptible Brown Norway (BN) rat, the Lewis (LEW) rat is 
extremely resistant to T. gondii infection and has been demonstrated to inhibit proliferation of T. 
gondii within the parasitophorous vacuoles of infected peritoneal macrophages (Cavailles et al., 
2014), and to rapidly kill both parasites and infected cells (Cavailles et al., 2014). Thus, because 
of the disparity in their responses to T. gondii infection, LEW and BN rats would serve as ideal 
models for dissecting the host molecular mechanisms that are important for host resistance to T. 
gondii infection, with the goal of identifying intervention strategies against the infection. 
 During T. gondii infection, gamma interferon (IFN-γ)-stimulated GTPases, namely,  
guanylate-binding proteins (GBPs) and immunity-related GTPases (IRGs), have been shown to 
limit the infection in humans (Cheng, Colonno, & Yin, 1983) and mice (Boehm et al., 1998), 
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respectively. IRGs in mice control T. gondii intracellular proliferation by binding to the 
parasitophorous vacuolar membrane (PVM) to disrupt its integrity, leading to the release of the 
parasites into host cell cytosol where they are destroyed (Ling et al., 2006). GBPs also act by 
binding to the PVM in T. gondii-infected human cells (Virreira Winter et al., 2011). 
 Members of a relatively recently reported family of small GTPases, called GTPase 
immunity-associated proteins (GIMAPs), are conserved and expressed prominently in 
mammalian (including human) immune cells (S. Filen & Lahesmaa, 2010; Pascall et al., 2013). 
However, their functions and molecular mechanisms in mammalian host innate immunity against 
intracellular pathogens are yet to be deciphered. Herein, we provide evidence that T. gondii 
infection in the LEW rat upregulates expression of GIMAPs that mediate restriction of growth of 




3.3.1 T. gondii infection upregulates expression of the GIMAP 4, 5, and 6 genes in the LEW 
rat. 
Analysis of the extracted rat RNA samples prior to library generation, showed that they 
were all of high quality for RNA sequencing, with RNA integrity numbers (RIN) of 9.5/10 or 
above. Due to the nonavailability of a complete LEW rat reference genome, the generated RNA 
sequences were aligned to the sequence of a mixed-strain genome assembly for female 
BN/SsNHsdMCW and male SHR rats as the reference genome. Importantly, alignment of the 
LEW sequences to this reference genome depicted very negligible differences between the LEW 
and BN rat sequences, and as such, strain differences in sequence were ignored overall. By 
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analysis of variance (ANOVA), using a false discovery rate (FDR) of 0.05, the gene expression 
patterns related to the four experimental groups (T. gondii-infected and uninfected LEW and BN 
rat groups; n = 4 per group) were generated, with the number of reads that aligned uniquely 
within 32,662 rat genes and 8,637 T. gondii genes ranging from 13.1 million to 18.3 million per 
sample. Among these genes, GIMAP 4, GIMAP 5 and GIMAP 6 were found to be expressed at 
significantly higher levels in the T. gondii-infected LEW rats than in the T. gondii-infected BN 
rats (Table 3.1). By a four-way comparison analysis (infected LEW rats versus infected BN rats, 
infected LEW rats versus uninfected LEW rats, infected BN rats versus uninfected BN rats, 
uninfected LEW rats versus uninfected BN rats), it was evident that T. gondii augmented 
expression of the GIMAP genes only in the LEW rats (Table 3.1). Consistently, by real-time 
PCR analysis of the expression of the GIMAP genes in primary peritoneal cells isolated from the 
T. gondii-infected LEW and BN rats, GIMAP 4, GIMAP 5, and GIMAP 6 were found to be 
expressed at 2.6-fold, 7.5-fold, and 3.6-fold higher levels in the infected LEW rats than in the 
infected BN rats (Figure 3.1). On the other hand, there was no significant (P < 0.05) difference in 
the expression levels of all the GIMAP genes between the uninfected LEW rats and the 
uninfected BN rats (Figure 3.1). Interestingly, real-time PCR analysis of the expression of the 
GIMAP genes in nonhematopoietic cells (intestinal epithelial cells) did not show any significant 
differences among the different treatment groups of LEW and BN rats (Figure 3.2). This 
suggested that GIMAP upregulation is restricted to cells of hematopoietic origin. 
Sequence analysis showed that GIMAP 4 coded for a protein with 328 amino acid 
residues, that was 100% identical to the rat GIMAP 4 with GenBank accession number 
AM285343 reported previously (Carter et al., 2007). GIMAP 5 coded for two protein variants, 
herein called GIMAP 5_201 and GIMAP 5_203, with 326 and 308 amino acid residues, 
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respectively. GIMAP 5_201 and GIMAP 5_203 were 100% identical to their respective variant 
rat proteins (GenBank accession numbers NP_001029085.1 and NP_663713.1, respectively) 
reported previously (Hornum et al., 2002). The two GIMAP 5 variants were identical, except in 
the N-terminus, where GIMAP 5_201 had additional 18 amino acid residues, with notable 
differences in amino acid residues depicted in the sequence alignment in Figure 3.3. GIMAP 6 
coded for 304-amino-acids-long protein that was 100% identical to the rat GIMAP 6 in the 
GenBank with accession number ABB03711.1 previously reported. Sequence alignment showed 
that all the GIMAPs had a conserved AIG1-type G domain containing a typical Walker A motif 
(G1), a Walker B motif (G3), as well as G2, G4 and G5 motifs (Figure 3.3), characteristic of 
small GTPases (Krucken et al., 2004). 
 
3.3.2 Overexpression of LEW rat GIMAPs in NR8383 cells restricts parasite growth.  
To determine the role of GIMAP 4, 5, and 6, we engineered a macrophage cell line, 
NR8383 (derived from a T. gondii-susceptible Sprague-Dawley rat strain), for inducible over-
expression of GIMAP 4, 5, or 6 individually, as well as the empty expression vector. By Western 
blotting, we analyzed selected clones of the transgenic NR8383 cells and identified those that 
were doxycycline inducible for overexpression of the GIMAP transgenes (Figure 3.4A to D). By 
densitometric analysis of the protein bands from the Western blots, GIMAP 4, GIMAP 5, and 
GIMAP 6 were expressed at levels about 10-fold, 5-fold, and 8-fold higher, respectively, in the 
induced NR8383 cells than in the uninduced NR8383 cells. Consistently, Western blotting 
showed that the primary peritoneal cells of T. gondii-infected LEW rats had higher expression 
levels of endogenous GIMAP 4, 5, and 6 proteins than those of T. gondii-infected BN rats 
(Figure 3.4E). Densitometric analysis of the protein bands indicated that GIMAP 4, GIMAP 5, 
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and GIMAP 6 were expressed at levels about 5-fold, 8-fold, and 10-fold higher, respectively, in 
the primary peritoneal cells of T. gondii-infected LEW rats than in those of the infected BN rats. 
Using selected NR8383 cell clones expressing the GIMAPs, we infected the cells with 
tachyzoites of the T. gondii Type I RH strain, and at different time points of culture, we 
quantified the growth of the parasites in the cultures by real-time PCR, targeting the 
amplification of the T. gondii 529 gene. We found that, while the parasites proliferated 
progressively with time in NR8383 cells with the empty expression vector, there were significant 
(P < 0.05) reductions in the growth of the parasites in cells overexpressing GIMAP 4, 5, or 6 
individually (Figure 3.5). In comparison to overexpression of the other GIMAPs, overexpression 
of GIMAP 6 had the most significant inhibitory effect on parasite growth at 24 h (Figure 3.5A), 
while at later time points of 48 h and 72 h, GIMAP 4 had the most profound inhibitory effect on 
T. gondii growth (Figure 3.5B and C). Further, overexpression of each of the GIMAP 5 variants 
exhibited inhibitory effect on parasite growth, with GIMAP 5_201 variant being more effective 
at 72 h than at earlier time points (Figure 3.5) post-infection. 
 
3.3.3 GIMAP 4, 5, and 6 localize to the parasitophorous vacuole membrane.  
We performed immunofluorescence assays to analyze the localization of overexpressed 
GIMAPs in T. gondii-infected NR8383 cells after 4 h of infection. We found that individual 
GIMAP 4, 5, and 6 all abundantly and densely colocalized with the T. gondii GRA5 protein 
(Figure 3.6A), a marker for the parasitophorous vacuole membrane (Lecordier, Mercier, Sibley, 
& Cesbron-Delauw, 1999). Both variants of GIMAP 5, the GIMAP 5_201 and the GIMAP 
5_203 variants, were found to colocalize with GRA5 with a similar intensity and pattern. In 
NR8383 cells expressing the empty vector as a control, low intensity signals that could be 
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attributed to the endogenous expression of GIMAP 4, 5, and 6 were detected, but they only 
partially colocalized with the T. gondii GRA5 protein (Figure 3.6B).  
Similarly, in T. gondii-infected LEW rats' primary peritoneal cells, we found that GIMAP 
4, 5, or 6 individually abundantly and densely colocalized with the T. gondii GRA5 protein 
(Figure 3.7A). On the other hand, in T. gondii-infected BN rat peritoneal cells, GIMAP 5 and 
GIMAP 6 were undetectable, while GIMAP 4 was barely detectable (Figure 3.7B), consistent 
with the Western blotting results (Figure 3.4E). 
 
3.3.4 GIMAP 4, 5, and 6 induce lysosomal fusion to the parasite surface membrane.   
To determine whether the localization of overexpressed GIMAP 4, 5, or 6 on the PVM 
would induce the fusion of lysosomes to the parasites, we analyzed the distribution pattern of 
LAMP1, a lysosome-specific marker protein (Clough et al., 2016), in T. gondii-infected NR8383 
cells expressing the empty vector or the individual GIMAPs. We found that after 4 h of infection, 
while LAMP1 appeared diffusely distributed in the cytoplasm of the NR8383 cells with empty 
vector, LAMP1 densely colocalized with the T. gondii SAG1 protein and extended into the 
parasites in the cells expressing each of the GIMAPs (Figure 3.8). Over-expression of either 
variant of GIMAP 5 induced the translocation of LAMP1 to the parasite surface. Together, these 
findings indicate that the dense accumulation of GIMAP 4, 5, or 6 on the PVM induced the 
fusion of lysosomes to the PVM, with extension of the lysosomal content into the parasite inside 







 The disparity in the LEW and BN rats’ responses to T. gondii infection presents an ideal 
opportunity for elucidating host molecular mechanisms that are important in host resistance to T. 
gondii infection. The refractoriness of the LEW rat to toxoplasmosis has thus far been associated 
with a rat genomic locus named Toxo1 on chromosome 10 (Cavailles et al., 2014), but the 
mechanisms are still poorly defined. In other studies, two genes called NALP1 (NLRP1) and 
ALOX12 have been identified in the orthologous Toxo1 locus on chromosome 17 of the human 
genome and demonstrated to play roles in resistance to toxoplasmosis by mediating infected host 
cell death and inflammatory cytokine production (Witola et al., 2014; Witola et al., 2011). 
Cellular invasion by pathogens activates the NLRP1 inflammasome, which leads to initiation of 
pyroptosis, a caspase-1-dependent highly inflammatory cell death process often observed during 
infection with cytosolic pathogens (Tschopp et al., 2003) including T. gondii (Cavailles et al., 
2014; Cirelli et al., 2014). Despite these earlier observations, it is quite evident that the LEW rat 
engages undefined intertwined mechanisms to orchestrate the rapid and early killing of invading 
T. gondii (Cavailles et al., 2014; Cirelli et al., 2014). 
 Herein, we have performed global transcriptome analysis of the LEW versus the BN rat, 
with or without T. gondii infection, with the goal of unravelling underlying mechanisms for the 
LEW rat’s robust resistance to T. gondii infection. We identified genes of the GTPase immunity-
associated protein family, GIMAP 4, 5, and 6, that were significantly upregulated (FDR, 0.05) in 
the LEW rat (but not in the BN rat) in response to T. gondii infection. GIMAPs are relatively 
recently reported putative small GTPases that are conserved among mammalian species and 
higher plants (Krucken et al., 2004; Liu, Wang, Zhang, & Li, 2008; Nitta & Takahama, 2007). 
Human and rat genomes each have seven functional GIMAP genes clustered in chromosome 
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7q36.1 (Krucken et al., 2004) and chromosome 4 (Dion et al., 2005), respectively. Both human 
and rat GIMAPs are small proteins of about 34 kDa to 38 kDa (S. Filen & Lahesmaa, 2010). All 
GIMAPs contain an AIG domain (Reuber & Ausubel, 1996) and putative coiled-coil domains 
reminiscent of protein-protein interactions (S. Filen & Lahesmaa, 2010). GIMAP 5 and 6 have 
identical sequences in both LEW and BN rat, while GIMAP 4 in the BN rat has a 21-residue 
truncation in its carboxyl-terminal (Carter et al., 2007). 
 We engineered GIMAP 4, 5, and 6 from LEW rat for inducible overexpression in a T. 
gondii-susceptible macrophage cell line, NR8383. Overexpression of GIMAP 4, 5, and 6, 
individually, in T. gondii-infected NR8383 cells showed that all three GIMAPs colocalized with 
T. gondii GRA5 protein. Consistently, the endogenous GIMAP 4, 5, and 6 also colocalized with 
GRA5 in the T. gondii-infected LEW rats' primary peritoneal cells but were undetectable in the 
infected BN rats' primary peritoneal cells. GRA5 has been shown to specifically translocate to 
the PVM in T. gondii-infected host cells (Lecordier et al., 1999), and thus, antibodies directed 
against GRA5 are used in immunostaining assays to delineate the PVM (D. J. Ferguson, 2004). 
Therefore, our observation that GIMAP 4, 5, and 6 colocalized with GRA5 in T. gondii-infected 
NR8383 cells indicated that the GIMAPs accumulated on the PVM. Similarly, IFN--induced 
GTPases, IRGs in mice and GBPs in humans, have been shown to specifically translocate to the 
PVM in T. gondii-infected host cells (Boehm et al., 1998; Cheng et al., 1983). However, unlike 
GIMAPs, both IRGs and GBPs are larger GTPases, averaging about 47 kDa and 65 kDa, 
respectively (B. H. Kim et al., 2012). 
 NK cells and T lymphocytes activated by interleukin-12 produce IFN-, which, in turn 
induces the generation of IRGs and GBPs (Gazzinelli & Denkers, 2006). Interestingly, in the 
present study, by analyzing the RNA sequencing data, we observed that, despite having higher 
56 
 
expression of GIMAPs, the T. gondii-infected LEW rats had 3.4-fold lower expression of IFN- 
transcripts than the T. gondii-infected BN rats. Additionally, we did not observe significant 
differential expression of any IRG transcripts between the T. gondii-infected LEW and BN rats. 
Subsequently, we induced overexpression of GIMAP 4, 5, and 6 in a macrophage cell line 
(NR8383) in the absence of IFN--producing NK cells or T-lymphocytes, but we observed that 
each of the three GIMAPs translocated to the PVM. Together, these findings suggest that the 
expression of the GIMAPs and their targeting to the PVM are not driven by IFN-. 
 The mechanism by which PVM-docked IRGs kill intracellular T. gondii is by directly 
rupturing the PVM membrane, leading to the release of T. gondii tachyzoites into the host cell 
cytosol (Howard, Hunn, & Steinfeldt, 2011), where they are degraded (Ling et al., 2006). On the 
other hand, GBPs on the PVM restrict parasite growth through recruitment of antimicrobial 
molecules, including autophagy protein complex, inflammasome, and NADPH oxidase NOX2 
(MacMicking, 2012). In the present study, we observed that each of the overexpressed GIMAP 4, 
5, and 6 induced the translocation of the lysosomal marker protein LAMP1 onto the surface 
membrane of T. gondii tachyzoites in NR8383 cells. LAMP1 was observed not only to delineate 
the parasite surface but also to extend into the inside of the parasite, indicating lysosomal 
acidification of the parasite cytosol. A predominantly membrane-bound IRG (IRGM1) on a 
Mycobacterium bovis phagosome membrane, has been shown to interact with SNARE protein 
complexes leading to rapid fusion of the degradative lysosomes to the phagosome and 
destruction of the pathogen (Tiwari, Choi, Matsuzawa, Pypaert, & MacMicking, 2009). In the 
case of T. gondii, lysosomal fusion to the otherwise nonfusogenic PVM has been demonstrated 
to kill the parasites in the parasitophorous vacuole (Andrade et al., 2006). Indeed, we found that 
the growth of T. gondii Type I RH strain in NR8383 cells overexpressing GIMAP 4, 5, or 6 
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individually was restricted. This implies that the GIMAP-induced lysosome fusion to the PVM 
was associated with the restriction of intracellular T. gondii growth. While each of the candidate 
GIMAPs individually inhibited parasite growth, there were notable variations in their effects, 
with GIMAP 4 having the more profound inhibitory effect. It is likely that endogenous 
upregulation of GIMAP 4, 5, and 6 together results in additive inhibitory effects against parasite 
growth in the LEW rat cells. 
We have recently reported that, compared to the BN rat, the LEW rat maintains 
inherently higher levels of reactive oxygen species (ROS) that are associated with restriction of 
intracellular T. gondii growth (Witola, Kim, & Zhang, 2017). ROS in phagocytic cells have been 
shown to induce the recruitment of autophagy components to phagosomes, which may facilitate 
lysosomal fusion (Huang et al., 2009; Sanjuan et al., 2007). Together with our present 
observations, we postulate that T. gondii infection in the LEW rat augments the expression of 
GIMAPs that translocate to the PVM, where they recruit yet unknown additional components, 
facilitated by high ROS levels, leading to lysosomal fusion, disruption of the PVM, and killing of 
the parasites. The NLRP1 and ALOX12 genes, which have been shown to mediate the killing of 
T. gondii parasites and infected host cells by macrophages (Cavailles et al., 2014; Witola et al., 
2014; Witola et al., 2011), activate downstream proinflammatory effector molecules, which leads 
to restriction of parasite growth, while GIMAPs appear to directly target and destroy the PVM 
and kill the parasites in the PVM. Taken together, our present and previous findings imply that 
the LEW rat engages a multifaceted approach, culminating in the rapid killing of both the 





3.5 MATERIALS AND METHODS 
3.5.1 Parasite culture and purification. 
Human foreskin fibroblasts (HFF) were cultured to confluence in Iscove's modified 
Dulbecco's medium supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum, 1% 
(vol/vol) GlutaMax and 1% (vol/vol) penicillin-streptomycin- amphotericin B (Fungizone) (Life 
Technologies) at 37oC with 5% CO2. Tachyzoites of the Type I RH strain of T. gondii were 
maintained in the confluent HFF culture. To extract T. gondii tachyzoites, the infected HFFs 
were suspended in medium and passed through a 25-gauge needle twice, followed by filtering 
through a 3-μm-pore-size filter to isolate the parasites from the cell debris. Isolated parasites 
were washed three times in phosphate-buffered saline (PBS) and their concentration was 
determined using a hemocytometer. 
 
3.5.2 Rat infection assays, purification of peritoneal cells, and RNA extraction.  
The protocol approved by the University of Illinois at Urbana-Champaign Institutional 
Animal Care and Use Committee was followed in performing experimental procedures involving 
rats. Male Lewis (LEW) and Brown Norway (BN) rats, aged 4 weeks were obtained from 
Charles River. After 10 days of acclimatization, rats were divided into two groups (4 animals in 
each group) per rat strain. For each rat strain, the treatment group animals were each 
intraperitoneally inoculated with 3.5 x 106 freshly isolated T. gondii RH strain tachyzoites, 
constitutively expressing cytosolic yellow fluorescent protein (Cirelli et al., 2014), while the 
control group animals were inoculated with an equal volume of sterile PBS. After 24 h, the rats 
were sacrificed, and immediately, peritoneal lavage was performed to isolate peritoneal cells in 
RPMI medium. About 1 x 107 of the freshly isolated rat peritoneal cells were used for total RNA 
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extraction using the RNeazy mini kit (Qiagen). A Qubit 3.0 fluorometer RNA BR kit (Life 
technologies) and an Agilent 2100 Bioanalyzer (Agilent Technologies) were used to determine 
the quantity and quality of the RNA samples, respectively. The RNA samples were stored at -
80oC until use. 
 
3.5.3 Generation of RNA libraries and RNA sequencing.  
RNA library production and sequencing were done essentially as we have previously 
reported (Witola et al., 2017). Briefly, freshly extracted RNA samples were used to prepare RNA 
libraries at the Roy J. Carver Biotechnology Center’s High Throughput Sequencing and 
Genotyping Unit of the University of Illinois at Urbana-Champaign, using the Illumina's TruSeq 
Stranded mRNAseq Sample Prep kit (Illumina). The libraries were quantitated by fluorometry 
(Qubit), and their quality was determined using a Bioanalyzer. The libraries were then diluted to 
10 nM and quantified by quantitative PCR. Sequencing of the RNA libraries was done using a 
HiSeq SBS sequencing kit (v4) and a HiSeq2500 system (Illumina). Residual adapter content 
and low-quality bases on the generated sequences were trimmed using Trimmomatic (version 
0.33), while the bcl2fastq (v2.17.1.14) conversion software (Illumina) was used to generate and 
demultiplex Fastq files from the sequence data. An ASCII offset of 33, known as Sanger scores, 
was used to determine the quality scores line in Fastq files. Feature Counts in the Sub-read 
(v1.5.0) package were used to derive gene counts, while gene annotations, including gene 
ontology terms, were downloaded from Ensembl (release 84) for Rnor_6.0, and ToxoDB.org 
(release 28) for T. gondii GT1. The SAMtools (v1.3) idxstats tool was used to determine the 




3.5.4 Real-time PCR and Western blotting analyses of expression of candidate genes. 
 To confirm differential expression of candidate genes by real-time PCR and Western 
blotting, the LEW and BN rat infection assays described above were repeated, and after 24 h, the 
rats were sacrificed, and peritoneal cells were extracted in PBS. Additionally, for each rat, 2 cm 
of the ileum was resected, washed in PBS to remove the intestinal content, and then 
homogenized in the TRIzol reagent (Invitrogen). The homogenate was spun down, and the 
supernatant was used for RNA extraction following the TRIzol reagent homogenization 
procedure. About 1 × 107 freshly isolated peritoneal cells were also used for total RNA 
extraction with the TRIzol reagent. For each sample, 2 μg of RNA was used for the synthesis of 
first-strand cDNA using a SuperScript II reverse transcriptase kit (Invitrogen). The primer pairs 
used were RT-GIMAP 4-F and RT-GIMAP 4-R for the GIMAP 4 gene, RT-GIMAP 5-F and 
RT-GIMAP 5-R for the GIMAP5 gene, RT-GIMAP 6-F and RT-GIMAP 6-R for the GIMAP 6 
gene, and GAPDH-F and GAPDH-R for the rat glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) gene (Table 3.2). The primer pairs generated DNA fragments of 104 bp, 130 bp, 87 bp, 
and 300 bp for the GIMAP 4, GIMAP 5, GIMAP 6, and GAPDH genes, respectively. PCR 
products for each gene were fractionated on an agarose gel, and the DNA bands were extracted 
using a QIAquick gel extraction kit (Qiagen). The concentration of the purified DNA fragments 
was measured by use of a NanoDrop spectrophotometer (Fisher). Ten-fold serial dilutions of the 
extracted DNA fragments were made and used as quantification standards for real-time PCR. 
Each real-time PCR mixture contained 1 μl of cDNA template, 1 μl of primer mix (500 nM [each] 
primer), and 10 μl of SsoFast EvaGreen supermix (Bio-Rad), with the final volume made up to 
50 μl with nuclease-free water. The cycling conditions included an initial denaturation for 10 min 
at 98°C, 40 cycles at 98°C for 15 s and 60°C for 1 min, and a final melting curve step. Cycling 
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was performed using a 7500 real-time PCR system (Applied Biosystems). Transcript quantities 
were derived by the system software using the generated standard curves. The relative amount of 
the GIMAP gene transcripts was derived by dividing the concentration of the respective GIMAP 
gene by the concentration of the rat GAPDH gene from each cDNA sample. 
 For Western blotting, part of the extracted equal amounts of the rat peritoneal cells were 
lysed in Laemmli sample buffer. Equal amounts of the cell lysates were fractionated by SDS-
PAGE and transferred to nitrocellulose membranes. The primary antibodies used for blotting 
were goat anti-GIMAP 4 (sc-103519; Santa Cruz Biotechnology), goat anti-GIMAP 5 (sc-
164476; Santa Cruz Biotechnology), and goat anti-GIMAP 6 (sc-247002; Santa Cruz 
Biotechnology) for GIMAP 4, 5, and 6, respectively. The secondary antibodies used were 
donkey anti-goat IgG (H+L)-horseradish peroxidase (HRP) conjugate (A16005; Invitrogen). 
Signal generation was performed using Clarity Western enhanced chemiluminescence (ECL) 
substrate (Bio-Rad), and imaging was done using a FluoroChem R imager (Protein Simple). 
 
3.5.5 Generation of lentiviral particles for inducible expression of LEW rat GIMAP genes. 
About 1 μg of total RNA extracted from the LEW rat peritoneal cells using the RNeasy 
minikit was treated with DNase I (Invitrogen) to remove residual genomic DNA and used for 
cDNA synthesis with the SuperScript II reverse transcriptase kit (Invitrogen). Full coding 
sequences of the GIMAP 4, 5, and 6 genes were amplified from the LEW rat cDNA with a 
CloneAmp HiFi PCR premix kit (Clontech) using the respective primer sets (Table 3.2) and the 
amplicons were cloned into the pLVX-TetOne-Puro expression vector using an In-Fusion HD 
cloning system (Clontech) following the manufacturer's instructions. The recombinant pLVX-
TetOne-Puro expression vectors carrying the coding sequences were transformed in Stellar 
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competent Escherichia coli cells (Clontech) and purified using a NucleoBond Xtra Midi Plus kit 
(Clontech). After sequencing to confirm gene insert identity, the purified pLVX-TetOne-Puro 
expression plasmids were used with the Lenti-X Packaging Single Shots system (Clontech) to 
generate lentivirus particles in Lenti-X 293T cells (Clontech). Briefly, Lenti-X 293T cells were 
cultured to about 80% confluence in petri dishes (10-cm diameter) with 8 ml of Dulbecco 
modified Eagle medium supplemented with 4.5 mg/ml glucose, 4 mM L-glutamine, 1 mM 
sodium pyruvate, 1.5 mg/ml sodium bicarbonate, 10% (vol/vol) heat-inactivated fetal bovine 
serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. For each transfection, 7.0 μg of 
recombinant pLVX-TetOne-Puro expression plasmid in 600 μl of nuclease-free sterile double-
distilled water was added to a Lenti-X Packaging Single Shots system, the components were 
mixed, and the mixture was incubated at room temperature for 10 min. The whole mixture was 
added dropwise to one petri dish of a Lenti-X 293T cell culture and mixed by gentle rocking. 
The cells were incubated at 37°C with 5% CO2 for 8 h, after which the medium was changed, the 
cells were incubated for a further 48 h, and the culture medium was collected. The presence of 
lentivirus particles in the medium was determined using the Lenti-X GoStix reagent (Clontech) 
following the manufacturer's protocol. The lentiviral particles in the medium were concentrated 
using the Lenti-X concentrator reagent (Clontech) following the manufacturer's instructions. The 
concentrated viral titer was estimated using the Lenti-X GoStix reagent. The viral particles were 
aliquoted and stored at −80°C until use. 
 
3.5.6 Transduction of NR8383 cells with lentiviral particles. 
Lentiviral particles expressing the GIMAP transgenes or the empty pLVX-TetOne-Puro 
expression vector (control) were used to transduce NR8383 cells (CRL2192; ATCC). Briefly, 
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NR8383 cells were cultured to 70% confluence in petri dishes (10-cm diameter) containing Ham's 
F-12K medium supplemented with 2 mM L-glutamine, 1.5 g/liter sodium bicarbonate, and 15% 
(vol/vol) certified tetracycline-free fetal bovine serum (Clontech). Polybrene solution was added to 
the cell culture to a final concentration of 4 μg/ml and mixed by rocking the cells gently. About 
200 μl of thawed lentiviral aliquot (at a titer of about 105 inclusion-forming units) was added to 
the cells dropwise, and the cells and virus were mixed by rocking gently. The transduced cells 
were cultured overnight, after which the cells were selected with 12 μg/ml of puromycin (Clontech) 
for 3 weeks. Puromycin-resistant cells were cloned by limiting dilution. Selected clones were 
cultured in the absence or presence of 1 μg/ml doxycycline and then analyzed by Western blotting 
to determine the clones that induced the expression of the transgenes over a 24-h period. The 
primary antibodies used were goat anti-GIMAP 4 (sc-103519; Santa Cruz Biotechnology), goat 
anti-GIMAP5 (sc-164476; Santa Cruz Biotechnology), and goat anti-GIMAP 6 (sc-247002; Santa 
Cruz Biotechnology) for GIMAP 4, 5, and 6, respectively. The secondary antibodies used were 
donkey anti-goat IgG (H+L)-HRP conjugate (A16005; Invitrogen). Signal generation was 
performed using the Clarity Western ECL substrate (Bio-Rad), and imaging was done using the 
FluoroChem R imager (Protein Simple). 
 
3.5.7 Immunofluorescence assays.  
NR8383 cells overexpressing the GIMAP transgenes or the pLVX-TetOne-Puro empty 
vector were grown on coverslips in 24-well plates in supplemented Ham's F-12K medium and 
infected with T. gondii type I RH strain tachyzoites at a multiplicity of infection (MOI) of 1:10 
(parasites/cells). Similarly, 107 freshly isolated primary peritoneal cells from uninfected LEW 
and BN rats were seeded on coverslips in 24-well plates in supplemented Ham's F-12K medium 
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and infected with T. gondii type I RH strain tachyzoites at an MOI of 1:10. For 
immunofluorescence analysis, the cultures were fixed with 3% (wt/vol) formaldehyde in PBS for 
30 min at room temperature. Permeabilization of the cells was done with 0.2% Triton X-100 in 
PBS at room temperature for 10 min, followed by washing with PBS and incubation at 4°C 
overnight with blocking buffer (0.2% Triton X-100 and 3% bovine serum albumin in PBS) 
containing primary antibodies against the respective GIMAPs. The primary antibodies used were 
goat anti-GIMAP 4 (sc-103519; Santa Cruz Biotechnology), goat anti-GIMAP 5 (sc-164476; 
Santa Cruz Biotechnology), and goat anti-GIMAP 6 (sc-247002; Santa Cruz Biotechnology) for 
GIMAP 4, 5, and 6, respectively, or rabbit anti-LAMP1 (ab24170; Abcam) and mouse 
monoclonal antibody against T. gondii GRA5 (BIO.018.6; Biotem) or SAG1 (C65620M; 
Meridian Life Science). The secondary antibodies used were Alexa Fluor 488-conjugated donkey 
anti-mouse immunoglobulin antibody (A11001; Invitrogen), Alexa Fluor 594-conjugated donkey 
anti-goat immunoglobulin antibody (A11058; Invitrogen), and Alexa Fluor 594-conjugated goat 
anti-rabbit antibody (A-11037; Invitrogen). After washing the cells in blocking buffer to remove 
unbound primary antibodies, secondary antibodies diluted in blocking buffer at 1:300 were 
added and the mixture was incubated at room temperature for 1 h. The cells were then washed 
three times in PBS and air dried, and each coverslip was placed on a glass slide to overlay a drop 
of ProLong Gold antifade reagent with DAPI (4′,6-diamidino-2-phenylindole; Life Technologies) 







3.5.8 Determination of effect of GIMAPs on T. gondii growth in NR8383 cells.  
NR8383 cells engineered for inducible overexpression of individual GIMAP transgenes 
or the pLVX-TetOne-Puro empty vector were grown to confluence in supplemented Ham's F-
12K medium in 12-well plates. One day prior to infection, the medium was replaced with fresh 
medium containing 1 μg/ml doxycycline. After 24 h of culture in the presence of doxycycline, 
fresh medium with 1 μg/ml doxycycline was added, followed immediately by addition of 4 × 104 
freshly extracted T. gondii type I RH strain tachyzoites to each well. At time intervals of culture 
of 24 h, 48 h, and 72 h post-infection, genomic DNA was extracted from the whole culture of 
each well using PureLink genomic DNA kits (Invitrogen). The concentration of the extracted 
genomic DNA from each culture well was measured with a NanoDrop spectrophotometer (Fisher) 
and adjusted by dilution to make the concentrations uniform in all the samples. Quantification of 
the amount of the T. gondii 529 repetitive gene (GenBank accession number AF146527) and the 
rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene (GenBank accession number 
BC029618) was performed on equal amounts of DNA template using real-time PCR. The primer 
pairs used were 529-F and 529-R for the 529 repetitive gene and GAPDH-F and GAPDH-R for 
the GAPDH gene (Table 3.2). The primer pairs generated DNA fragments of 174 bp and 300 bp 
for the 529 repetitive and GAPDH genes, respectively. PCR products for each gene were 
fractionated on an agarose gel, and the DNA bands were extracted using a QIAquick gel 
extraction kit (Qiagen). The concentration of the purified DNA fragments was measured with a 
NanoDrop spectrophotometer (Fisher). Ten-fold serial dilutions of the extracted DNA fragments 
were made and used as quantification standards for real-time PCR. Each real-time PCR mixture 
contained 1 μl (containing a uniform concentration of DNA across all samples analyzed) of DNA 
template, 1 μl of primer mix (500 nM [each] primer), and 10 μl of SsoFast EvaGreen supermix 
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(Bio-Rad), with the final volume made up to 50 μl with nuclease-free water. The cycling 
conditions included an initial denaturation for 10 min at 98°C, 40 cycles at 98°C for 15 s and 
60°C for 1 min, and a final melting curve step. Cycling was performed using a 7500 real-time 
PCR system (Applied Biosystems). DNA quantities were derived by the system software using 
the generated standard curves. The relative amount of T. gondii was derived by dividing the 
concentration of T. gondii 529 repetitive gene by the concentration of the rat GAPDH gene from 
each DNA sample. Three independent experiments of this assay were performed, with each 
experiment being done in triplicate. 
 
3.5.9 Data analysis. 
 The R (v3.3.0) and Bioconductor packages (Gentleman et al., 2004) were used to 
preprocess the raw RNA sequencing data, while analysis was performed with EdgeR's (v3.14.0) 
negative binomial generalized linear model with likelihood ratio tests and tag-wise dispersion 
estimates (McCarthy et al., 2012; Robinson et al., 2010). One-way ANOVA was used to 
compare the data across and between groups, while the false discovery rate method (Benjamini 
& Hochberg, 1995) was used to perform multiple-hypothesis-test correction. A weighted gene 
correlation network analysis (WGCNA; v1.51) using the trimmed mean for M values (TMM) 
normalized log2 count per million (CPM) values was performed to compare gene expression 
patterns across treatment groups (Langfelder & Horvath, 2008; B. Zhang & Horvath, 2005). Heat 
maps were generated separately for rat and Toxoplasma genes with the ANOVA FDR (P< 0.05) 
using TMM-normalized log2 CPM values that were scaled to have a mean of 0 and a standard 
deviation of 1. All the sequencing data were analyzed using log2 scale values and then converted 
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from the log2 fold change (FC) to the regular FC. All other experimental data analyses were 
performed using a two-tailed Student's t test. P values of 0.05 or less were considered significant. 
 
3.5.10 Accession number.  
The entire series of RNA sequencing data reported in this study is publicly accessible in 
































Figure 3.1: Real time PCR analysis of the expression of GIMAPs in primary peritoneal cells 
from Lewis (LEW) and Brown Norway (BN) rats, with or without T. gondii Type 1 RH strain 
infection. LEW and BN rats were intraperitoneally inoculated with PBS (uninfected) or with T.  
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Figure 3.1: (cont.) 
gondii (infected), and after 24 h, rats were sacrificed and immediately, peritoneal cells were 
harvested and total RNA extracted. cDNA was synthesized from 1 μg of RNA and used for real 
time PCR quantitative analysis of (A) GIMAP 4, (B) GIMAP 5, and (C) GIMAP 6 transcripts. 
For each sample, GAPDH transcripts were also determined and the relative concentration of each 
GIMAP was derived by dividing with the concentration of GAPDH transcripts to normalize for 
loading. The data shown represent means for three independent experiments with standard error 
bars. There was observable significant (P < 0.05) difference (*) in the GIMAPs transcripts 














Figure 3.2: Real time PCR analysis of the expression of GIMAPs in primary intestinal epithelial 
cells from Lewis (LEW) and Brown Norway (BN) rats, with or without T. gondii Type 1 RH 
strain infection. LEW and BN rats were intraperitoneally inoculated with PBS (uninfected) or 
with T. gondii (infected), and after 24 h, rats were sacrificed and immediately, ileal epithelial  
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Figure 3.2: (cont.) 
cells were harvested, and total RNA extracted. cDNA was synthesized from 1 μg of RNA and 
used for real time PCR quantitative analysis of (A) GIMAP 4, (B) GIMAP 5, and (C) GIMAP 6 
transcripts. For each sample, GAPDH transcripts were also determined and the relative 
concentration of each GIMAP was derived by dividing with the concentration of GAPDH 
transcripts to normalize for loading. The data shown represent means for three independent 
experiments with standard error bars. There was no observable significant (P < 0.05) difference 


















Figure 3.3: Alignment of the amino acids sequences encoded by the GIMAP genes cloned from 
LEW rat cDNA for inducible over-expression in NR8383 cells. Amino acid sequences of 
GIMAP 4, GIMAP 5_201, GIMAP 5_203 and GIMAP 6 were aligned using Clustal O (version 
1.2.4). The AIG1-type G domain common to all GIMAPs is highlighted in grey. The motifs, G1, 
































Figure 3.4: Western blotting analysis of GIMAP proteins in rat peritoneal primary cells, and in 
transgenic NR8383 macrophage cell lines. Cloned NR8383 cells engineered for doxycycline- 
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Figure 3.4: (cont.) 
inducible over-expression of LEW rat-derived (A) GIMAP 4, (B) GIMAP 5_203, (C) GIMAP 
5_201, and (D) GIMAP 6, along with cells expressing the pLVX-TetOne-Puro empty vector 
(panels indicated as “Vector” in each figure), were cultured for 24 h in absence ( ̶ ) or presence 
(+) of 1 μg/ml doxycycline. After 24 h, the cells were harvested, and equal amounts of whole cell 
protein extracts were analyzed for expression of the respective transgenes. (E) Lewis (LEW) and 
Brown Norway (BN) rats were intraperitoneally inoculated with PBS (-) or T. gondii Type I RH 
strain (+), and after 24 h, peritoneal cells were isolated and Western blotting analysis for the 
expression of GIMAP 4, GIMAP 5 and GIMAP 6 was performed on protein lysates of equal 
number of cells. As a loading control, rat β-actin expression (lower panels) was analyzed in 














Figure 3.5: Real time PCR analysis of the growth rate of T. gondii in NR8383 cells engineered 
for overexpression of LEW rat-derived GIMAP 4, GIMAP 5_201, GIMAP 5_203 and GIMAP 6,  
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Figure 3.5: (cont.) 
or in NR8383 cells with the pLVX-TetOne-Puro empty plasmid (vector) as control. The NR8383 
cells were cultured in presence of 1 μg/ml doxycycline for 24 h to induce expression of the 
respective GIMAP transgene, after which they were infected with T. gondii and maintained in 
culture with doxycycline. At culture time points of (A) 24 h, (B) 48 h, and (C) 72 h, genomic 
DNA was extracted from whole cell cultures and equal amounts of DNA used as template for 
real time PCR quantification of the amount of T. gondii 529 repetitive and rat GAPDH gene 
fragments. The relative amount of T. gondii in each culture was derived by dividing the 
concentration of T. gondii 529 repetitive gene by the concentration of rat GAPDH gene. The data 
shown represent means for three independent experiments with standard error bars and levels of 
















Figure 3.6: Immunofluorescence co-localization of T. gondii GRA5 and GIMAP proteins in 
NR8383 cells infected with T. gondii Type I RH strain. (A) NR8383 cells engineered for  
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Figure 3.6: (cont.) 
inducible overexpression of GIMAP 4, 5 and 6, as well as (B) NR8383 cells with empty pLVX-
TetOne-Puro expression vector, were induced with doxycycline for 24 h, and thereafter, cultured 
with T. gondii tachyzoites for 4 h followed by immunofluorescence analyses using combinations 
of anti-GIMAP antibodies (Red stain, Alexa Fluor 594), anti-GRA5 antibody (Green stain, Alexa 
Fluor 488) and nucleus stain (DAPI). GIMAP 4, 5_201 and 6 densely co-localized with GRA5 
(Merge panels in A) in NR8383 cells expressing the respective transgenes, while in cells 







Figure 3.7: Immunofluorescence colocalization of T. gondii GRA5 and GIMAPs in rat primary 
peritoneal cells infected with T. gondii Type I RH strain. Primary peritoneal cells freshly isolated  
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Figure 3.7: (cont.) 
from Lewis rat (A), and Brown Norway rat (B), were cultured with T. gondii tachyzoites for 12 h 
followed by immunofluorescence analyses using combinations of anti-GIMAP antibodies (Red 
stain, Alexa Fluor 594), anti-GRA5 antibody (Green stain, Alexa Fluor 488) and nucleus stain 
(DAPI). Images of the cells were also captured by differential interference contrast (DIC). In 
Lewis rat GIMAP 4, 5 and 6 densely co-localized with GRA5 (Merge panels in A). In Brown 
Norway rat cells, very low fluorescence signal of GIMAP 4 was detectable that partially 





















Figure 3.8: Immunofluorescence colocalization of T. gondii SAG1 and lysosome marker protein 
LAMP1 in NR8383 cells infected with T. gondii Type I RH strain. (A) NR8383 engineered for 
inducible overexpression of GIMAP 4, 5_201 and 6, as well as the empty pLVX-TetOne-Puro 
expression vector, were induced with doxycycline for 24 h, and thereafter, cultured with T. 
gondii tachyzoites for 4 h followed by immunofluorescence analyses using combinations of anti-
LAMP1 antibody (Red stain), anti-SAG1 antibody (green stain) and DAPI nuclei stain (blue). In 
GIMAP 4, 5_201 and 6 expressing cells, LAMP1 co-localized with SAG1 (Merge panels), while 




Figure 3.8: (cont.) 
not appear to overlap with SAG1 (Merge panels). Images of the cells were also captured by 




Table 3.1: Differentially expressed GIMAP genes in LEW vs BN rats in response to T. gondii 
infectiona. 
 
aND: Not significantly different (p < 0.05); FDR: False Discovery Rate; BNToxo and LEWToxo: T. gondii-
inoculated BN and LEW rats; BNPBS and LEWPBS: PBS-inoculated BN and LEW rats.  
 
 
Table 3.2: Primers used in this study. 
 
aF: forward; R: reverse 
  
  Fold Change in expression (FDR) 











ENSRNOG00000008369 GIMAP 4 ND 4.603 (0.0001) 2.625 (0.05) ND 
ENSRNOG00000008416 GIMAP 5 ND 3.362 (0.01) 2.500 (0.05) ND 
ENSRNOG00000033338 GIMAP 6 ND 2.392 (0.01) 2.496 (0.05) ND 
Primersa Sequences (5’ – 3’) 
GIMAP 4-F CCCTCGTAAAGAATTCATGGAAGCCCAGTACAGT 
GIMAP 4-R GAGGTGGTCTGGATCCCTAGTCTCTCATAAACTGGTTGA 
GIMAP 5_201-F CCCTCGTAAAGAATTCATGGAGGACCATGGCTT 
GIMAP 5_201-R GAGGTGGTCTGGATCCTCATTTCCACCTGCCAAT 
GIMAP 5_203-F CCCTCGTAAAGAATTCATGGAAGGCCTTCAGAAGA 
GIMAP 5_203-R GAGGTGGTCTGGATCCTCATTTCCACCTGCCAAT 
GIMAP 6-F CCCTCGTAAAGAATTCATGAATTGGCTTTACAGTAAAAC 







RT-GIMAP 4-F CACTCGCTGTGTTGCTCTGA 
RT-GIMAP 4-R GAAGTTTCCGTGTGGCCTTG 
RT-GIMAP 5-F GCTTCCTAGTGGTGGACACG 
RT-GIMAP 5-R AGTTGGGTCACCAGCAACAA 
RT-GIMAP 6-F CAAAATCAGCGCTCGACCAG 
RT-GIMAP 6-R GGGGTGTCGATCACCTCAAG 
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CHAPTER 4: IDENTIFICATION OF INTERACTING PARTNERS OF GIMAP 4, 5, 
AND 6 IN RAT MACROPHAGES  
4.1 ABSTRACT 
Rat GIMAP 4, 5, and 6, whose expressions in the T. gondii-resistant Lewis (LEW) rat are 
significantly higher than in the susceptible Brown Norway (BN) rat after T. gondii infection, 
were demonstrated to inhibit the growth and proliferation of Type I RH strain of T. gondii. Thus, 
we determined their interacting protein partners in NR8383 macrophages in order to gain 
insights into the molecular networks that GIMAPs engage in mediating T. gondii infection. 
Using HA- or FLAG-tagged GIMAPs as baits, immunoprecipitation assays were performed to 
pull-down protein partners that complex with GIMAP 4, 5, or 6, followed by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) analysis. We found that GIMAP 6 
interacts with Tripartite Motif Protein 21 (TRIM21) that has E3 ubiquitin ligase activity, while 
GIMAP 4 and GIMAP 5 both interact with Vesicle-Associated Membrane Protein 8 (VAMP8), 
with GIMAP 4 also interacting with GIMAP 6. To determine the roles of TRIM21 and VAMP8, 
we performed siRNA knockdown assays for TRIM21 and VAMP8 in LEW rat primary peritoneal 
cells with T. gondii infection. Individual knockdown of TRIM21 and VAMP8 reduced the 
refractoriness of the LEW rat cells to T. gondii infection. TRIM21, through its E3 ligase activity is 
thought to facilitate tethering of effector molecules onto the T. gondii parasitophorous vacuolar 
membrane (PVM), leading to restriction of parasite growth. On the other hand, VAMP8 is a 
SNARE protein that localizes on lysosomal membranes and is required for phagosome-lysosome 
fusion. Thus, the interaction of both GIMAP 4 and GIMAP 5 on the PVM with VAMP8 suggests 
that they function to facilitate the fusion of lysosomes to the otherwise nonfusogenic PVM, leading 





We have reported that, compared to the Brown Norway (BN) rat, the Lewis (LEW) rat 
maintains inherently higher expression levels of cytochrome enzymes and higher cellular content 
of ROS that play a role in limiting intracellular Toxoplasma gondii growth and proliferation 
(Witola et al., 2017). Additionally, we have found that in response to T. gondii infection, the 
LEW rat expresses higher levels of Small GTPase Immunity Associated Proteins (GIMAPs) that 
localize to the T. gondii parasitophorous vacuolar membrane (PVM), and induce translocation of 
host cell lysosomes to the PVM, leading to the inhibition of intracellular growth of T. gondii (C. 
Y. Kim, Zhang, & Witola, 2018). By bioinformatic analysis, we found that GIMAP 4, 5, and 6 
contain a GTP-binding site motif A (P-loop) that is required for oligomerization of effector 
molecules to the PVM (Howard et al., 2011). Importantly, we found that these GIMAPs possess 
an LC3-interacting region (LIR) important for interaction with autophagy-related protein 8 
(Atg8), and for recruitment to membranes (Zhu et al., 2013). In addition, GIMAP 6 contains the 
N-myristoylation motif important for protein–protein interaction, and for membrane targeting 
(Farazi, Waksman, & Gordon, 2001). These features and properties of GIMAPs suggest that they 
mediate killing of intracellular T. gondii by engaging a network of physiological partners. 
Therefore, in this study, we endeavored to identify GIMAPs’ interacting partners in 
macrophages and characterize their roles in limiting T. gondii growth and proliferation. Our 
working hypothesis is that, starting early in infection, GIMAPs are recruited with their 
interacting partners to the PVM, where they effect killing of intracellular T. gondii. Thus, 
purification of protein complexes from macrophages using epitope-tagged GIMAPs as baits, 





4.3.1 Engineering NR8383 macrophage cells for inducible expression of HA- or FLAG-
tagged GIMAP 4, 5, 6.  
To minimize problems associated with nonspecific antibody reactions in 
immunoprecipitation assays for the identification of GIMAPs’ interacting partners, we generated 
NR8383 macrophage clones for inducible expression of FLAG-tagged GIMAP 4, FLAG-tagged 
GIMAP 5, and HA-tagged GIMAP 6, using the Lenti-X Tet-One-Puro Inducible Expression 
System (Clontech-Takara). Clones of transgenic NRA8383 cells were analyzed by western 
blotting using monoclonal antibodies against either the HA or the FLAG tag to detect the 
expression of the tagged GIMAP transgenes. FLAG-tagged GIMAP 4, FLAG-tagged GIMAP 5, 
and HA-tagged GIMAP 6 protein bands were found to be of the expected molecular sizes 
(Figure 4.1). 
 
4.3.2 Identification of binding partners of GIMAP 4, 5, and 6 by mass spectrometry. 
To determine the physiological interacting partners for GIMAP 4, 5, and 6, NR8383 
macrophage cells expressing FLAG-tagged GIMAP 4, FLAG-tagged GIMAP 5, or HA-tagged 
GIMAP 6 were induced to express their respective transgenes for 24 h and then maintained in 
culture for a further 12 h, with or without T. gondii Type 1 RH strain parasites. Whole cell 
cultures were harvested and subjected to immunoprecipitation assays (Figure 4.2), and the 
purified protein complexes were analyzed by liquid chromatography-tandem mass spectrometry 
(LC-MS/MS). LC-MS/MS data from uninfected cells showed that GIMAP 4 interacts with 
VAMP8, CD44, G3BP1, G3BP2 (Table 4.1, 4.2, and 4.3). These proteins had significantly 
higher LC-MS/MS scores indicating that they indeed complexed with GIMAP 4. Data generated 
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for proteins complexing with GIMAP 5, was analyzed with MaxQuant software to identify 
proteins that were present in both the T. gondii-infected and uninfected samples. The analysis 
showed that GIMAP 5 interacts with CD44 and PABPC1 in uninfected cells (Table 4.1 and 4.4). 
VAMP8, CD44, PABPC1, and OAS1b were found to interact with GIMAP 5 in infected cells 
(Table 4.4 and 4.5). GIMAP 6 in uninfected cells was found to interact with TRIM21, PDCD6, 
G3BP1, and GIMAP 4 (Table 4.1 and 4.6). In infected cells, GIMAP 6 interacts with CD44 
(Table 4.5 and 4.7).  Noteworthy, LC-MS/MS analysis revealed that uninfected NR8383 
overexpressing GIMAPs interacted with more proteins than those from infected cells. But when 
MaxQuant software was used in the analysis, most of those proteins identified in the uninfected 
cells were also found to be present in the infected cells as evidenced in the case of GIMAP 5. 
This could indicate that the presence of T. gondii proteins was complicating the analysis. 
Importantly, all those proteins identified with significant LC-MS/MS scores, either in the 
infected or uninfected cells expressing GIMAPs were all absent in the control cells expressing 
the empty vector (Table 4.8 and 4.9), indicating that they were indeed bona fide partners of 
GIMAPs. 
 
4.3.3 Endogenous expressions of TRIM21 and VAMP8 were effectively silenced by 
respective siRNAs.  
To assess the effectiveness of the depletion of the candidate interacting partners, the 
expression level of each gene was measured by comparing the gene specific siRNA-treated cells 
with the off-target siRNA-treated cells. Isolated primary peritoneal cells of LEW rat were 
transfected with siRNAs specific for TRIM21 or VAMP8. After 24 h, the levels of expression 
were analyzed using protein extracts from transfected primary cells. We found that the 
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expression of both TRIM21 and VAMP8 was significantly decreased at 24 h post-transfection 
(Figure 4.3). 
 
4.3.4 TRIM21 and VAMP8 knockdown increased T. gondii proliferation in primary 
peritoneal cells.  
To decipher the role of GIMAPs’ binding partners in inhibiting intracellular growth of T. 
gondii, we analyzed the effects of either TRIM21 or VAMP8 knockdown on T. gondii 
proliferation in primary peritoneal cells of LEW rat. The amount of parasites was comparable at 
2 h post-infection in the target-gene and off-target siRNA-treated LEW rat cells (Figure 4.4). On 
the other hand, from 12 h to 60 h post-infection, there were significantly more parasites in the 
TRIM21 and VAMP8 knockdown cell cultures than in the off-target siRNA-treated cells (Figure 
4.4). These findings indicate that TRIM21 and VAMP8, as GIMAPs interacting partners, 
contribute to the refractoriness of the LEW rat cells to T. gondii infection. 
 
4.4 DISCUSSION 
Using immunoprecipitation assays coupled with mass-spectrometry analysis, we have 
identified binding partners of rat GIMAP 4, 5, and 6 in NR8383 cells expressing tagged-
GIMAPs as baits. Among the identified proteins, VAMP8 was found to partner with GIMAP 4 
and GIMAP 5. As reported previously (C. Y. Kim et al., 2018), individual rat GIMAPs had 
inhibitory effects on parasite proliferation in GIMAP over-expressing NR8383 cells. We predict 
that these GIMAPs have additive effects if they over-expressed together. Rat GIMAP 4 and 
GIMAP 5, localized on the PVM, would recruit VAMP8, a tethering SNARE molecule localized 
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on the membranes of lysosomes. Mechanistically, this might facilitate lysosomal fusion to the 
PVM in T. gondii-infected cells and subsequent elimination of the parasites. 
Human GIMAP 6 has been shown to bind to GABARAPL2, one of the LC3 homologs. 
Bioinformatic analysis showed that rat GIMAP 4, 5, and 6 have LC3 interacting regions (LIR) 
for interaction with autophagy-related protein 8 (Atg8) to enable recruitment to autophagosomal 
membranes as a mechanism for elimination intracellular pathogens (Knodler & Celli, 2011; 
Pascall et al., 2013). 
TRIM21 as an E3 ubiquitin ligase is responsible for the deposition of Lys63-linked 
ubiquitin around vacuoles of Chlamydia trachomatis and type II T. gondii (Haldar et al., 2015). 
TRIM21 operates together with not only host GBP1 GTPase on the PVM of T. gondii but also 
with the inflammasome complex to recognize T. gondii (Foltz et al., 2017). In addition, TRIM21 
inhibits Salmonella typhimurium growth and marks adenoviruses for the proteasome dependent 
degradation. Additionally, TRIM21 upregulates transcription factors including IRF3, IRF5, IRF7, 
NF-κB and AP-1, subsequently leading to the production of proinflammatory cytokines 
(McEwan et al., 2013; Rakebrandt, Lentes, Neumann, James, & Neumann-Staubitz, 2014). 
TRIM21 knockout mice are susceptible to adenovirus infection, a property dependent on the 
capability of TRIM21 to restrict viral replication and to induce a cytokine response (Vaysburd et 
al., 2013). 
VAMP8 mediates endosomal fusion including phagosome-lysosome fusion (Antonin, 
Holroyd, Tikkanen, Honing, & Jahn, 2000). Leishmania expresses a metalloprotease GP63 that 
cleaves phagosomal SNAREs including VAMP8, to modulate host immune response (Matheoud 
et al., 2013). Together, our findings suggest that VAMP8, in unison with GIMAP 4 and GIMAP 
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5, mediate lysosomal fusion to the PVM in infected cells, and thus contributes to the 
refractoriness of the LEW rat to T. gondii infection. 
 
4.5 MATERIALS AND METHODS 
4.5.1 Parasites culture and purification.  
Human foreskin fibroblasts (HFF) were cultured to full confluency in Iscove's modified 
Dulbecco's medium supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum, 1% 
(vol/vol) Glutamax, and 1% (vol/vol) penicillin-streptomycin-fungizone (Life Technologies) at 
37oC with 5% CO2. Tachyzoites of Type I RH strain of T. gondii were maintained in the 
confluent HFF cells. To collect T. gondii tachyzoites, the infected HFF cells were suspended in 
medium and passed through a 25 G needle twice, and then passed through a sterile 3 μM filter to 
isolate parasites from cell debris. Isolated tachyzoites were rinsed three times in PBS and 
enumerated by hemocytometer. 
 
4.5.2 Generation of lentiviral particles for inducible expression of LEW rat GIMAP genes. 
Total RNA was extracted from the LEW rat peritoneal cells using the RNeazy mini kit 
(Qiagen), and treated with DNase-I (Invitrogen) to remove residual genomic DNA. 
Complementary DNA was synthesized with the SuperScript™ II Reverse Transcriptase kit 
(Invitrogen). Full coding sequences of GIMAP 4, 5 and 6 genes were amplified from the LEW 
rat cDNA with the CloneAmp HiFi PCR Premix kit (Clontech) using the respective primer sets 
incorporated with HA or FLAG-tag coding sequence (Table 4.10). The PCR amplicons 
incorporated with HA- or FLAG-tag (YPYDVPDYA, DYKDDDDK, respectively) sequences at 
either N-amino terminus or carboxyl terminus were cloned into the pLVX-TetOne-Puro 
91 
 
expression vector using the In-Fusion HD Cloning System (Clontech) following the 
manufacturer’s instructions. In detail, for tagging at the N-terminus, the HA- or FLAG-tag 
coding sequence was incorporated in the forward primer, in-frame with an upstream ATG (start 
codon) and a downstream coding sequence of the target gene. For tagging at the C-terminus, the 
FLAG or HA tag was incorporated in the reverse primer, in-frame with a downstream stop codon 
and an upstream coding sequence of the target gene. The recombinant pLVX-TetOne-Puro 
expression vectors carrying the full coding sequences incorporated with HA- or FLAG-tag were 
transformed in Stellar competent E. coli (Clontech). The purified pLVX-TetOne-Puro expression 
plasmids together with the Lenti-X Packaging Single Shots (Clontech) were used to produce 
lentivirus particles in Lenti-X 293T cells (Clontech). The mixtures of packing plasmids in Lenti-
X Packaging Single Shot containing respective genes were added to Lenti-X 293T cells culture. 
After 56 h of transfection, the lentiviral particles in the medium were concentrated using Lenti-X 
Concentrator reagent (Clontech) following the manufacturer’s instruction, followed by virus titer 
measurement using the Lenti-X GoStix reagent. 
 
4.5.3 Transduction of NR8383 cells with lentiviral particles. 
Lentiviral particles containing either HA- or FLAG- tagged GIMAP transgenes were 
used to transduce NR8383 cells (ATCC: CRL2192). NR8383 cells were cultured following the 
instructions provided by ATCC. About 105 IFU of lentiviral particles were used to transduce the 
NR8383 cells. The cells were transduced for 24 h followed by selection with 12 µg/ml of 
puromycin (Clontech) for about 3 weeks. Puromycin resistant cell clones selected by limiting 
dilution were cultured in absence or presence of doxycycline to a final concentration of 1 μg/ml 
and then analyzed by Western blotting to determine the inducibility of the expression of the 
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transgenes over a 24 h period. Primary antibodies were rabbit anti-FLAG M2 Antibody (14793S, 
Cell Signaling Technology), rabbit anti-HA antibody (3724, Cell Signaling Technology). 
Secondary antibodies were mouse HRP-conjugated anti-rabbit IgG (H+L) Secondary Antibody 
(62-6520, Invitrogen) and rabbit HRP-conjugated anti-rabbit IgG (H+L) Secondary Antibody 
(65-6120, Invitrogen). The antibodies were used at the manufacturers’ recommended dilution. 
Clarity Western ECL Substrate (Bio-Rad) were used for signal generation and images were 
captured by FluoroChem R imager (Protein Simple). 
 
4.5.4 Immunoprecipitation and mass spectrometry. 
About 1.2 x 108 of the NR8383 cells over-expressing FLAG- or HA-tagged GIMAPs, 
and wild-type NR8383 cells as control, were either uninfected or infected for 12 h with freshly 
extracted Type I RH strain T. gondii tachyzoites at a multiplicity of infection (MOI) of 1:1 
(parasite:cell). The purification of protein complexes was performed using anti-HA 
Immunoprecipitation Kit (IP0010-1KT, Sigma-Aldrich) or anti-FLAG Immunoprecipitation Kit 
(FLAGIPT1-1KT, Sigma-Aldrich) following the manufacturer’s protocol, to pull-down proteins 
complexing with the tagged GIMAPs. The protein eluates were analyzed by Western blotting 
using anti-HA or anti-FLAG antibodies to confirm presence of the respective tagged GIMAP 
protein in the eluates. For mass spectrometric analysis, eluted protein complexes were 
dissociated by boiling in RIPA buffer. Immunoprecipitated proteins were prepared for proteomic 
analysis by denaturation with 6 M guanidine HCl. The protein disulfide bonds were then reduced 
with 10 mM Tris(2-carboxyethyl) phosphine (TCEP), and the resulting free cysteine residues 
were alkylated with 40 mM 2-chloroacetamide. Following digestion with 750 ng of proteomics-
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grade trypsin, the peptides were desalted with StageTips and dried to completion in a vacuum 
centrifuge. 
The resulting peptide samples were resuspended in 5% ACN with 0.1% formic acid (FA) 
and injected into an UltiMate 3000 UHPLC system coupled online to a Thermo Orbitrap Fusion 
Tribrid mass spectrometer. The peptides were reversed-phase separated using a 15 cm Acclaim 
PepMap C18 column over the course of an hour using a gradient of 2% to 35% ACN in 0.1% FA. 
The mass spectrometer was operated in data-dependent mode with a cycle time of 3 s. The most 
abundant peptide precursor ions obtained from a full MS scan (300-1500 m/z; 120K resolution) 
were subjected to collision induced dissociation (35% NCE) to determine the peptide sequence. 
The isolation window was fixed at 1.6 Da, and the dynamic exclusion window was set to 60 s.  
The raw MS data was analyzed with either Mascot v. 2.5.1 or MaxQuant v. 1.6.0.16 against a 
custom database containing the GIMAP sequence of interest as well as the Rattus norvegicus and 
Toxoplasma gondii FASTA databases from NCBIprot or UniProt. Variable modifications of 
protein N-termini acetylation and methionine oxidation were specified along with a fixed 
modification of cysteine carbamidomethylation. For analysis by MaxQuant, the ‘match between 
runs function’ was enabled with a retention time window of 1 min to facilitate identification of 
proteins across samples at the same time. 
 
4.5.5 siRNA synthesis and transfection. 
siRNAs were designed and synthesized with Silencer® siRNA Construction Kit 
(AM1620, Ambion). Briefly, oligonucleotides of respective genes were designed as listed in 
Table 4.11. Each template oligonucleotide was hybridized to the T7 Promoter Primer. For each 
siRNA, two transcription reactions were assembled to synthesize the sense and antisense RNA 
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strands of the siRNA. Next, the sense and antisense transcription reactions were combined into a 
single tube and incubated at 37°C overnight. The following day, the synthesized dsRNA’s  5' 
overhangs on the leader sequence were removed by treatment with DNase and RNase prior to 
transfection. Final siRNAs were washed and eluted in nuclease-free water. Fresh primary 
peritoneal cells or NR8383 cells were plated in 24-well plates and transfected with respective 
siRNA using the Xfect RNA Transfection Reagent (631450, Takara Bio USA) for 24 or 48 h to 
knock-down respective genes. Specifically, 30 µM siRNA for individual genes diluted in Xfect 
Reaction Buffer. Xfect RNA Transfection Polymer was mixed with Xfect Reaction Buffer in a 
separate tube. The two tubes were mixed well by vortex and incubated for 10 minutes at room 
temperature to form nanoparticle complexes. The entire nanoparticle complex solution was 
added to the cell culture medium and the transfected plates were gently mixed and incubated at 
37 C, 5 % CO2 with humidity. After 4 h, the medium containing transfection complexes was 
replaced with fresh complete medium. The plates were incubated for a further 24 or 48 h, 
followed by lysis of the transfected cells and western blotting analysis to determine target gene 
knockdown. β-actin was used as loading control. Negative control #1 siRNA (AM4611, Ambion) 












4.6 FIGURES AND TABLES 
 
 
Figure 4.1: Western blotting analysis of the inducible expression of tagged GIMAPs transgenes 
in NR8383 cells. Cloned NR8383 cells engineered for doxycycline-inducible overexpression of 
LEW rat-derived FLAG-tagged GIMAP 4 (A), FLAG-tagged GIMAP 5 (B), and HA-tagged 
GIMAP 6 (C) were cultured for 24 h in presence (+) or absence (-) of 1 μg/ml doxycycline. After 
24 h induction with doxycycline, the cells were harvested and analyzed for the expression of the 
respective proteins using equal amounts of whole cell protein extracts by western blotting. β-

















Figure 4.2: Western blotting analysis of the expression of tagged GIMAP 4, 5, and 6 transgenes 
in NR8383 cells with or without T. gondii infection. Cloned NR8383 cells were cultured for 24 h 
with 1 μg/ml doxycycline, followed by 12 h culture with (+Toxo) or without (-Toxo) T. gondii. 
After 12 h infection, equal amounts of whole cell protein extracts were harvested and subjected 
to immunoprecipitation (IP) assays. IP eluates were analyzed by western blotting and expected 
molecular size bands were observed for FLAG-tagged GIMAP 4 (A), FLAG-tagged GIMAP 5 















Figure 4.3: Western blotting analysis of siRNA-based knockdown of TRIM21 and VAMP8 gene 
in NR8383 cells. Wildtype NR8383 cells were cultured and transfected with either TRIM21 (A) 
or VAMP8 (B) specific siRNAs (+), along with off-target siRNA (-) as control. About 24 h post-
transfection, the cells were harvested, and equal amounts of whole cell lysates were analyzed for 















Figure 4.4: Analysis of the effect of knockdown of TRIM21 and VAMP8 on the growth of T. 
gondii in LEW rat’s primary peritoneal cells. About 106 freshly harvested peritoneal cells of  
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Figure 4.4: (cont.) 
LEW rats were cultured and transfected with TRIM21 (A) or VAMP8 (B) target siRNAs for 24 h. 
For each treatment group, negative control cells were transfected with an off-target siRNA. 
About 24 h after transfection, the cells were infected with YFP-expressing T. gondii parasites at 
an MOI of 1:2 (1 parasite: 2 cells). Images of the cells were taken by fluorescence microscopy 





Table 4.1: List of GIMAP 4, 5, and 6’s interacting proteins identified by mass spectrometry from 
uninfected NR8383 cells expressing respective GIMAP. 
 
 
Table 4.2: Complete list of proteins interacting with GIMAP 4 identified by mass-spectrometry 
in FLAG-GIMAP 4 expressing NR8383 cells without T. gondii infection. 
 
Accession Score Mass Mat SMat Seq SSeq emPAI Description 
1 NP_034990.1 18795 17121 615 511 20 20 1140.02 
myosin light polypeptide 
6 isoform MLC3sm 
2 NP_080340.2 15805 19940 479 399 24 22 785.67 
myosin light chain, 
regulatory B-like 
3 NP_291024.1 14386 19824 425 367 20 18 187.25 
myosin regulatory light 
chain 12B 
4 NP_001094355.1 1532 19765 105 84 16 8 11.53 
myosin regulatory light 
polypeptide 9 
5 NP_001288215.1 12455 28760 724 545 41 37 453.22 
tropomyosin alpha-3 
chain Tpm3.3cy 




7 NP_036810.1 7063 28549 423 303 37 33 196.3 
tropomyosin alpha-4 
chain 
8 AAK54241.1 3660 28553 228 166 23 18 17.84 
tropomyosin alpha 
isoform 
9 NP_001292806.1 5746 227527 299 204 98 79 3.52 myosin-9 
10 NP_001011997.1 3632 39618 207 123 31 21 13.19 tropomodulin-3 
11 NP_112402.1 3564 53757 215 136 41 37 22.06 vimentin 




13 NP_001025192.1 1872 11685 81 62 14 14 137.66 
60S acidic ribosomal 
protein P2 
14 WP_094948603.1 1813 42052 87 56 19 16 5.05 actin, cytoplasmic 2 
15 WP_087507522.1 1249 42108 77 44 19 16 5.05 actin, cytoplasmic 2 
Baits Partners Full Names 
GIMAP 4 
VAMP8 vesicle-associated membrane protein 8 
CD44 CD44 antigen 
G3BP1 Ras GTPase-activating protein SH3-domain binding protein 
G3BP2 Ras GTPase-activating protein-binding protein 2 
GIMAP 5 
CD44 CD44 antigen 
PABPC1 polyadenylate-binding protein 1 
GIMAP 6 
TRIM21 tripartite motif containing 21 
PDCD6 programmed cell death protein 6 
GIMAP 4 GTPase of the immunity-associated protein 4 
G3BP1 Ras GTPase-activating protein SH3-domain binding protein 
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Table 4.2: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
16 NP_001007605.1 1478 11605 46 43 4 4 3.09 
60S acidic ribosomal 
protein P1 
17 P13383.3 1370 77158 84 62 28 26 3.15 Nucleolin 
18 XP_008764848.1 1015 80173 55 39 23 19 1.87 
PREDICTED: leucine-
rich repeat flightless-
interacting protein 2 
isoform X8 
19 AAA41369.1 950 14468 43 38 4 4 2.14 
immunoglobulin light 
chain, partial 
20 AAI00256.1 785 22453 50 29 8 5 2.05 Txndc12 protein, partial 
21 AAD00000.1 630 48611 97 53 10 9 1.18 
anti-NGF30 antibody 
heavy-chain, partial 
22 NP_001020591.1 568 36652 24 18 11 10 2.15 
lymphocyte-specific 
protein 1 
23 NP_003503.1 520 14097 12 11 2 2 0.8 histone H2A type 1-C 
24 EDL85640.1 335 14692 11 8 2 2 0.76 rCG51948, partial 
25 ABB03703.1 498 38257 37 24 15 9 2 GIMAP4 
26 NP_075622.1 461 16076 31 21 8 7 5.06 
40S ribosomal protein 
S19 
27 Q6P7C7.1 405 64489 41 24 7 6 0.58 
Transmembrane 
glycoprotein NMB 
28 NP_001734.1 383 16827 22 15 6 4 1.67 calmodulin-2 isoform 2 




30 NP_001026818.1 322 26743 31 18 13 8 2.49 
EF-hand domain-
containing protein D2 
31 XP_006247987.1 312 27011 10 8 6 6 1.54 
PREDICTED: THO 
complex subunit 4 
isoform X1 
32 NP_004441.1 273 12422 6 6 4 4 2.76 
enhancer of rudimentary 
homolog 
33 EDL79676.1 270 76740 8 7 6 5 0.32 
rCG26771, isoform 
CRA_b 
34 XP_006238168.1 229 23608 15 9 4 4 1.03 
PREDICTED: clathrin 
light chain A isoform X3 
35 NP_037124.1 225 32711 6 4 4 4 0.67 nucleophosmin 
36 Q10728.2 215 115669 7 5 6 5 0.2 
Protein phosphatase 1 
regulatory subunit 12A 
37 XP_001072089.1 215 22220 17 8 8 6 2.09 
PREDICTED: histone 
H1.3 
38 AAA41327.1 185 21832 11 8 9 6 2.14 histone (H1d) 
39 XP_001071565.2 159 21304 11 7 8 5 1.66 
PREDICTED: histone 
H1.2 
40 NP_001011965.1 184 31530 10 7 8 7 1.54 
erythrocyte band 7 
integral membrane 
protein 
41 NP_001009.1 178 17029 5 4 1 1 0.28 
40S ribosomal protein 




Table 4.2: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
42 NP_113907.1 171 26689 5 4 4 4 0.87 
methylosome subunit 
pICln 
43 NP_080239.1 167 18904 9 7 4 3 0.94 
40S ribosomal protein 
S10 
44 NP_001178544.1 151 84430 5 3 5 3 0.16 
LIM domain and actin-
binding protein 1 
45 NP_001004095.1 150 11229 4 4 3 3 2 protein S100-A11 
46 XP_003750915.1 142 75672 10 6 7 4 0.25 
PREDICTED: nuclear 
fragile X mental 
retardation-interacting 
protein 2 isoform X1 
47 NP_446083.1 139 10266 4 3 4 3 2.32 
barrier-to-
autointegration factor 
48 NP_003509.1 138 13898 5 4 3 2 0.81 
histone H2B type 1-
C/E/F/G/I 
49 NP_001007.2 135 14905 3 2 3 2 0.74 
40S ribosomal protein 
S12 
50 NP_001100058.1 133 26646 6 3 5 3 0.6 
MICOS complex subunit 
MIC19 
51 EDL99216.1 130 115415 2 1 2 1 0.04 
rCG22154, isoform 
CRA_a 
52 NP_001008281.1 126 35304 5 4 4 4 0.61 
leucine-rich repeat-
containing protein 59  
53 NP_062256.1 123 18809 9 5 6 4 1.43 
ATP synthase subunit d, 
mitochondrial 





55 NP_001100078.1 110 29592 3 3 2 2 0.33 
MICOS complex subunit 
Mic25 
56 NP_077073.1 109 82497 5 4 5 4 0.23 disabled homolog 2 
57 NP_446252.1 104 12008 27 9 4 3 1.8 thioredoxin 
58 NP_036710.1 103 20872 4 1 3 1 0.22 histone H1 
59 EDL85952.1 101 22456 3 2 3 2 0.45 
rCG37275, isoform 
CRA_b, partial 
60 AAG39111.1 101 10661 1 1 1 1 0.47 
allograft inflammatory 
factor-1 splice variant 
G1 
61 P10960.1 93 62908 2 2 2 2 0.14 Prosaposin 
62 NP_033105.1 91 14807 4 1 2 1 0.32 
60S ribosomal protein 
L22 isoform a 
63 EDM10520.1 84 6959 1 1 1 1 0.78 
rCG55259, isoform 
CRA_a 




65 XP_230637.6 84 157865 29 3 6 3 0.08 
PREDICTED: ribosome-




Table 4.2: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
66 NP_665726.1 80 16347 6 1 4 1 0.29 
cytochrome c oxidase 
subunit 5A, 
mitochondrial precursor 
67 NP_002128.1 80 36041 4 4 3 3 0.42 
heterogeneous nuclear 
ribonucleoproteins 
A2/B1 isoform A2 
68 AAD19638.1 79 34250 2 2 2 2 0.28 
nucleic acid binding 
factor pRM10 
69 NP_035488.1 77 25461 3 2 2 1 0.39 
serine/arginine-rich 
splicing factor 2 
70 NP_001008325.1 76 69137 2 2 2 2 0.13 
eukaryotic translation 
initiation factor 4B 
71 P00787.2 76 38358 1 1 1 1 0.12 Cathepsin B  
72 NP_001102887.1 72 22635 3 1 2 1 0.2 histone H1.5 




74 NP_001019.1 71 13791 11 4 3 3 1.46 
40S ribosomal protein 
S25 




76 P26051.2 68 56424 2 2 2 2 0.16 CD44 antigen 
77 NP_002097.1 67 13545 1 1 1 1 0.36 histone H2A.Z 
78 NP_114015.1 66 11370 5 1 2 1 0.44 
vesicle-associated 
membrane protein 8 
79 AAA42078.1 63 15556 6 2 3 2 0.7 ribosomal protein S17 
80 EDM05296.1 59 232197 9 2 5 2 0.04 
rCG33450, isoform 
CRA_a 
81 EDL83539.1 57 214835 2 1 2 1 0.02 
HLA-B associated 
transcript 2 
82 EDM11076.1 54 65634 2 2 2 2 0.14 
activated leukocyte cell 
adhesion molecule 
83 EDM09235.1 54 35380 6 2 2 2 0.27 
rCG46303, isoform 
CRA_c 
84 EDL86202.1 52 20986 1 1 1 1 0.22 
similar to Hypothetical 
protein CGI-99, isoform 
CRA_a 




86 EDM17201.1 50 51290 4 4 3 3 0.28 
rCG39872, isoform 
CRA_a 
87 NP_001014011.1 48 50796 1 1 1 1 0.09 
ras GTPase-activating 
protein-binding protein 2 







Table 4.2: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
89 XP_008766633.1 48 28875 1 1 1 1 0.16 
PREDICTED: BTB/POZ 
domain-containing 
protein KCTD2 isoform 
X1  
90 NP_001101546.1 48 125925 4 2 4 2 0.07 
unconventional myosin-
If 
91 NP_001123569.2 47 113070 4 1 4 1 0.04 ataxin-2-like protein 
92 CAA32873.1 47 42275 1 1 1 1 0.1 
107 kDa 
sialoglycoprotein, partial 
93 BAA05907.1 47 31182 4 3 4 3 0.5 RYB-a 
94 EDM05622.1 47 24679 2 1 2 1 0.18 
rCG34610, isoform 
CRA_a 
95 AAA02878.1 45 53134 1 1 1 1 0.08 88kDa protein 
96 P48721.3 44 74097 1 1 1 1 0.06 
Stress-70 protein, 
mitochondrial;  
97 NP_079904.1 43 10293 1 1 1 1 0.49 
cytochrome c oxidase 
subunit 6B1 
98 EDM12555.1 42 17031 7 2 2 1 0.28 
rCG47344, isoform 
CRA_b 
99 AAD02476.1 42 32672 3 2 2 2 0.29 
voltage dependent anion 
channel 
100 XP_002728474.1 41 7914 1 1 1 1 0.67 
PREDICTED: 40S 
ribosomal protein S28 
101 AAI66769.1 41 60260 2 1 2 1 0.07 Taf15 protein 
102 NP_001073162.1 40 30987 4 2 2 2 0.31 
serine/arginine-rich 
splicing factor 5 isoform 
1 
103 EDM02680.1 38 44990 7 4 5 4 0.45 
protein phosphatase 1B, 
magnesium dependent, 
beta isoform, isoform 
CRA_a 
104 NP_001020442.1 37 75553 11 2 7 2 0.12 
splicing factor, proline- 
and glutamine-rich 
105 NP_000975.2 37 17684 3 3 2 2 0.6 
60S ribosomal protein 
L23a 
106 NP_647543.1 36 11657 3 1 2 1 0.42 
high mobility group 
protein HMG-I/HMG-Y 
107 EDL80706.1 35 10543 1 1 1 1 0.47 





108 BAB03465.1 34 38339 4 1 3 1 0.12 
RNA binding protein 
p45AUF1 
109 NP_001102668.1 29 18006 1 1 1 1 0.26 
60S ribosomal protein 
L12 





AHNAK isoform X14 
105 
 
Table 4.2: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
111 AAB67609.1 28 11400 3 1 3 1 0.43 cytochrome b5 
112 NP_003008.1 27 19546 1 1 1 1 0.24 
serine/arginine-rich 
splicing factor 3  
113 NP_954677.1 27 145233 3 1 3 1 0.03 
WASH complex subunit 
2 
114 EDL97258.1 26 22633 3 1 2 1 0.2 
transcription factor A, 
mitochondrial, isoform 
CRA_b  
115 EDM12502.1 26 22715 1 1 1 1 0.2 
rCG48326, isoform 
CRA_b 
116 XP_017453307.1 26 15177 5 1 1 1 0.31 
PREDICTED: CMRF35-
like molecule 3 




118 XP_006225015.1 25 24424 1 1 1 1 0.19 
PREDICTED: 
TNFAIP3-interacting 
protein 3 isoform X5 
119 NP_001101456.2 25 102429 2 2 2 2 0.09 
serine/arginine repetitive 
matrix protein 1 
120 NP_742005.1 24 67612 3 1 3 1 0.06 calnexin precursor 
121 EDL84007.1 23 5883 1 1 1 1 0.97 
ATP synthase, H+ 
transporting, 
mitochondrial F0 
complex, subunit e, 
isoform CRA_a 
122 NP_001101323.1 22 46954 2 1 2 1 0.09 
LUC7-like 2 pre-mRNA 
splicing factor 
123 AAL57768.1 22 43044 1 1 1 1 0.1 
hypothetical RNA 
binding protein RDA288 
124 NP_062634.2 21 11962 1 1 1 1 0.41 C-Myc-binding protein 
125 NP_077239.1 21 18282 1 1 1 1 0.25 
ubiquitin-40S ribosomal 
protein S27a precursor 
126 AAB03185.1 20 280179 28 1 2 1 0.02 
mannose 6-
phosphate/insulin-like 
growth factor II receptor 
127 EDM00360.1 19 33636 1 1 1 1 0.13 
transcription factor Pur-
beta 
128 EDL93427.1 19 184569 3 1 2 1 0.02 
procollagen, type V, 
alpha 1 
129 NP_001034133.1 18 9075 1 1 1 1 0.56 
CDC42 small effector 
protein 1 
130 CAA31067.1 18 9660 2 1 1 1 0.53 
cytochrome c oxidase 
subunit VIa (85 AA), 
partial 




132 EDM18191.1 17 53191 3 1 1 1 0.08 
stromal interaction 





Table 4.2: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 





134 CAA52807.1 16 118815 1 1 1 1 0.04 myosin I heavy chain 
135 EDL89323.1 16 14301 1 1 1 1 0.33 
ATP synthase, H+ 
transporting, 
mitochondrial F1 
complex, delta subunit, 
isoform CRA_a 
136 AAI26089.1 16 33449 1 1 1 1 0.13 Nolc1 protein, partial 
137 NP_035870.1 15 27925 1 1 1 1 0.16 
14-3-3 protein zeta/delta 
isoform 1 




139 XP_017447687.1 15 413218 29 1 4 1 0.01 
PREDICTED: LOW 
QUALITY PROTEIN: 
spectrin beta chain, non-
erythrocytic 5 isoform 
X1 
140 EDM08336.1 15 101572 4 1 1 1 0.04 rCG54086 
141 XP_008757393.1 14 20586 3 1 1 1 0.22 
PREDICTED: 
secretoglobin, family 
1B, member 30 isoform 
X1 
142 EDM00117.1 14 10691 9 2 1 1 0.47 rCG36177 
143 EDL81711.1 13 8934 2 1 2 1 0.58 rCG64140 
144 XP_006225980.1 13 22726 2 1 1 1 0.2 
PREDICTED: LOW 
QUALITY PROTEIN: 
protein lin-28 homolog 
A-like isoform X2 
 
 
Table 4.3: Complete list of interacting partners for GIMAP 4 in FLAG-GIMAP 4-expressing 
NR8383 cells with T. gondii infection. 
 
 
Accession Score Mass Mat SMat Seq SSeq emPAI Description 
1 NP_034990.1 8668 17121 397 307 23 22 2362.55 
myosin light 
polypeptide 6 isoform 
MLC3sm 






2623 11605 57 40 5 4 3.09 










Table 4.3: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 




6 NP_036810.1 865 28549 99 50 25 16 9.47 
tropomyosin alpha-4 
chain 
7 AAK54241.1 522 28553 51 31 14 9 2.75 
tropomyosin alpha 
isoform 
8 NP_080340.2 1341 19940 50 37 15 12 17.49 
myosin light chain, 
regulatory B-like 
9 NP_291024.1 1179 19824 46 34 13 11 14.24 
myosin regulatory 




1082 39618 87 43 22 16 5.75 tropomodulin-3 
11 Q6P7C7.1 622 64489 58 36 7 6 0.58 
Transmembrane 
glycoprotein NMB 




430 11685 26 18 12 10 47.19 
60S acidic ribosomal 
protein P2 












16 AAA41369.1 344 14468 33 22 3 3 1.36 
immunoglobulin light 
chain, partial 






234 23608 17 7 8 4 1.03 
PREDICTED: clathrin 









193 42052 7 6 5 4 0.65 actin, cytoplasmic 2 
21 CAA31067.1 179 9660 3 3 1 1 0.53 
cytochrome c oxidase 











139 22220 29 11 9 6 2.09 
PREDICTED: histone 
H1.3 
24 AAA41327.1 137 21832 28 12 8 7 2.8 histone (H1d) 






139 26743 15 6 11 5 1.19 
EF-hand domain-





Table 4.3: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
27 KFH12240.1 136 26861 17 13 1 1 0.17 
putative ATP-
dependent DNA 
helicase II, 70 kDa 
subunit [Toxoplasma 
gondii VAND] 
28 EDL77037.1 114 63553 8 5 6 4 0.3 
leucine rich repeat (in 
FLII) interacting 
protein 2 
29 NP_003503.1 110 14097 4 3 3 3 1.41 histone H2A type 1-C 




109 27011 5 4 4 4 0.86 
PREDICTED: THO 
complex subunit 4 
isoform X1 
32 AAD00000.1 99 48611 7 5 3 3 0.3 
anti-NGF30 antibody 
heavy-chain, partial 
33 CAA44198.1 97 68482 9 6 5 3 0.2 Epithelin 1 & 2 
34 NP_001009.1 91 17029 4 2 1 1 0.28 
40S ribosomal protein 









36 EDM12555.1 86 17031 19 11 3 3 1.08 
rCG47344, isoform 
CRA_b 
37 BAA05907.1 85 31182 4 2 4 2 0.31 RYB-a 
38 AAA41108.1 53 35699 7 3 5 3 0.42 
enhancer factor-1-
alpha 
39 NP_033105.1 84 14807 4 2 3 2 0.75 
60S ribosomal protein 
L22 isoform a 
40 NP_001019.1 78 13791 10 5 4 2 0.82 
40S ribosomal protein 
S25 
41 NP_035488.1 74 25461 3 2 2 2 0.39 
serine/arginine-rich 
splicing factor 2 
42 P00787.2 68 38358 1 1 1 1 0.12 Cathepsin B 
43 P10960.1 64 62908 3 2 2 1 0.07 Prosaposin 




61 69137 3 2 2 2 0.13 
eukaryotic translation 
initiation factor 4B 
46 Q8K3K9.1 61 36085 7 6 5 4 0.79 
GTPase IMAP family 
member 4 
47 NP_004441.1 56 12422 3 2 2 2 0.94 
enhancer of 
rudimentary homolog 




Table 4.3: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
49 EDL98154.1 51 35995 2 1 2 1 0.12 
DEK oncogene (DNA 
binding), isoform 
CRA_c 
50 NP_036750.1 51 11997 1 1 1 1 0.41 protein S100-A4 





52 Q10728.2 43 115669 1 1 1 1 0.04 
Protein phosphatase 1 
regulatory subunit 
12A 
53 NP_446054.1 42 12487 1 1 1 1 0.39 
ATP synthase-
coupling factor 6, 
mitochondrial 
precursor 




55 NP_446083.1 41 10266 1 1 1 1 0.49 
barrier-to-
autointegration factor  
56 EDL80706.1 38 10543 7 3 4 3 2.2 





57 NP_037124.1 35 32711 2 1 2 1 0.14 nucleophosmin 









60 AAL29888.1 29 36760 2 1 2 1 0.12 
Fc gamma receptor II 
beta, partial 
61 KFH00302.1 28 84225 1 1 1 1 0.05 







28 36652 2 1 2 1 0.12 
lymphocyte-specific 
protein 1 
63 NP_647543.1 28 11657 1 1 1 1 0.42 
high mobility group 
protein HMG-I/HMG-
Y 
64 AAD02476.1 28 32672 2 1 2 1 0.14 
voltage dependent 
anion channel 






Table 4.3: (cont.) 
 
          
66 P16391.2 27 42089 1 1 1 1 0.11 
RT1 class I 
histocompatibility 
antigen, AA alpha 
chain 
67 EDM16428.1 27 77853 3 1 2 1 0.06 
metadherin, isoform 
CRA_a 
68 BAA00911.1 26 18827 1 1 1 1 0.25 
subunit d of 
mitochondrial H-ATP 
synthase 
69 NP_742005.1 26 67612 1 1 1 1 0.06 calnexin precursor 
70 NP_000984.1 25 14454 2 1 2 1 0.33 
60S ribosomal protein 




23 84430 3 1 3 1 0.05 






22 83635 3 1 1 1 0.05 
zinc transporter ZIP6 
precursor 
73 AAD19638.1 21 34250 1 1 1 1 0.13 
nucleic acid binding 
factor pRM10 




75 NP_002128.1 21 36041 2 1 2 1 0.12 
heterogeneous nuclear 
ribonucleoproteins 
A2/B1 isoform A2 
76 NP_058848.2 20 15557 2 1 2 1 0.31 
40S ribosomal protein 
S17 
77 NP_476455.1 19 22323 2 2 2 2 0.45 peroxiredoxin-1 
78 EDM00360.1 19 33636 2 1 2 1 0.13 
transcription factor 
Pur-beta 




80 EDM17201.1 17 51290 1 1 1 1 0.09 
rCG39872, isoform 
CRA_a 












83 EDL79533.1 15 37457 7 2 1 1 0.12 
rCG26615, isoform 
CRA_a 





Table 4.3: (cont.) 
 
          





86 EDL93088.1 14 115518 3 1 1 1 0.04 rCG22062, partial  
87 P56536.2 14 27376 1 1 1 1 0.16 
Kinesin heavy chain 
isoform 5C 
88 P06399.3 14 87373 2 1 2 1 0.05 
Fibrinogen alpha 
chain 




90 EDM16411.1 14 56442 8 1 1 1 0.08 
serine/threonine 
kinase 3 (STE20 
homolog, yeast)  







Table 4.4: Complete list of proteins interacting with GIMAP 5 in HA-GIMAP 5 expressing 
NR8383 cells with (+) or without (-) or T. gondii infection. 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 
1 E9PT29;A0A096MIX2;A0A096MJW9 Ddx17 77.558 By MS/MS By MS/MS 
2 A0A096MKG6;F1M6V1;Q6P747 Hp1bp3 9.2938 By MS/MS By MS/MS 
3 A0A0G2JSH5;P02770 Alb 177.62 By MS/MS By MS/MS 
4 A0A0G2JSW0;P18666;P13832 Myl12b;Rlc-a 90.899 By MS/MS By MS/MS 
5 A0A0G2JU96;A0A0G2JUA5  20.111 By MS/MS By MS/MS 
6 A0A0G2JUX5;Q68A21 Purb 62.793  By MS/MS 
7 F1LNF5;F1LPK3;A0A0G2JWG8;P15389 Scn5a 6.5197 By MS/MS  










313.44 By MS/MS By MS/MS 
10 D3ZFD0;A0A0G2JY08 Myo18a 323.31 By MS/MS By MS/MS 
11 A0A0G2JYW3;P08081 Clta 37.306 By MS/MS By MS/MS 
12 Q6IMY8;A0A0G2JZ52 Hnrnpu 59.485 By MS/MS By MS/MS 
13 A0A0G2JZS2;Q9EPH8;D3ZSR2;G3V9N0 Pabpc1 104.4 By MS/MS By MS/MS 
112 
 
Table 4.4: (cont.) 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 









RGD1559682;Ppia 6.3483 By matching By MS/MS 

















 323.31 By MS/MS By MS/MS 












Rpl27a 71.842 By MS/MS By MS/MS 
26 A0A0G2K9E8;Q63356 Myo1e 12.151 By MS/MS By MS/MS 








323.31 By MS/MS By MS/MS 
29 A0A0H2UHH9;D4ACJ1;P62850;D3ZFZ8 LOC100363469;Rps24 66.064 By MS/MS By MS/MS 



















162.05 By MS/MS By MS/MS 













275.94 By MS/MS By MS/MS 
37 A0A0H2UHU1;P61515;D4AAZ6;D4A7B1 Rpl37a-ps1;Rpl37a 277.32 By MS/MS By MS/MS 
38 A0A0H2UHV4;M0R7Z0;B2GUV7 Eif5b 323.31 By MS/MS By MS/MS 
39 X1WI37;A0A0H2UHX3;P62703;D3ZX01 LOC100362640;Rps4x 275 By MS/MS By MS/MS 
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Table 4.4: (cont.) 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 
40 A0A0H2UI11;P62893 Rpl39 13.006 By MS/MS By MS/MS 
41 A0A0U1RRV7;Q0ZFS8 Srsf3 13.373 By MS/MS By MS/MS 












300.94 By MS/MS By MS/MS 
45 Q5RK10;A0A1W2Q6L2;P35427 Rpl13a 145.78 By MS/MS By MS/MS 












29.954 By MS/MS By MS/MS 
48 A9UMV9 Ndufa7l 8.4427 By MS/MS By MS/MS 
49 F1LMT2;A9ZSY0 Cntln -2  By MS/MS 
50 B0K031;P05426;F1LUE9 Rpl7 114.51 By MS/MS By MS/MS 
51 D3Z8F3;B1WC13 LOC100151767 21.923 By MS/MS By MS/MS 
52 B1WC25 Tra2a 32.432 By MS/MS By MS/MS 
53 B2GUZ5 Capza1 35.713 By MS/MS By MS/MS 
54 B2GV01 Mta2 6.5821 By matching By MS/MS 
55 B2RYN3 Eef1e1 7.5796 By MS/MS By matching 
56 B2RYP6;G3V9R0 Luc7l2;Luc7l 13.983 By MS/MS By MS/MS 
57 B2RYQ5 Erh 61.222 By MS/MS By MS/MS 
58 B2RZ27 Sh3bgrl3 13.274 By MS/MS By MS/MS 
59 F1LQ14;D4A4W9;B2RZD4;P11250 Rpl34;Rpl34-ps1 45.84 By MS/MS By MS/MS 
60 D3ZSF9;B2RZD5 Rpl22l2;LOC688712 7.6994 By matching By MS/MS 




Rpl14;LOC306079 323.31 By MS/MS By MS/MS 
63 B5DFB2 Rbbp4 18.015 By MS/MS  
64 B6RK61 Myh7b 11.164 By MS/MS  
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Table 4.4: (cont.) 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 




LOC100361854;Rps26 53.784 By MS/MS By MS/MS 
67 D3Z8X4 Pole 8.6752 By matching By MS/MS 
68 D3ZAF6 Atp5j2 6.2666  By MS/MS 
69 D3ZAK6;P62845 Rps15-ps2;Rps15 13.232 By MS/MS By MS/MS 
70 D3ZBN0 Hist1h1b 102.05 By MS/MS By MS/MS 
71 D3ZBP3 Exosc2 6.335 By MS/MS By MS/MS 
72 D3ZCH5 LOC100359763 48.765 By MS/MS By MS/MS 
73 D3ZDS4 Emg1 6.3082  By MS/MS 






54.579 By MS/MS By MS/MS 







170.64 By MS/MS By MS/MS 








8.883 By MS/MS By MS/MS 




7.3014 By matching By MS/MS 














323.31 By MS/MS By MS/MS 
86 D3ZVW3 Zc3h4 7.747 By MS/MS  
87 D3ZXH7 Alyref 6.5797  By MS/MS 
88 D3ZYK9 Npm3 46.536 By MS/MS By MS/MS 
89 D3ZZ00;F1M9Q2;Q63563 Abcc9 11.346 By MS/MS By MS/MS 
90 D4A0E8 Prmt5 58.853 By MS/MS By MS/MS 
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Table 4.4: (cont.) 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 
91 D4A4W6 Slirp 116.05 By MS/MS By MS/MS 
92 D4A5I9 Myo6 73.77 By MS/MS By MS/MS 
93 D4A5T1 Sf3b5 6.8076 By MS/MS By MS/MS 
94 D4A644 Map7d1 24.028 By MS/MS By MS/MS 
95 D4A6A2;E9PSU5;Q6URK4 Hnrnpa3 323.31 By MS/MS By MS/MS 













81.049 By MS/MS By MS/MS 
99 D4A7N1 Chchd6 19.097 By MS/MS By MS/MS 
100 D4A7X9 Myo1f 323.31 By MS/MS By MS/MS 
101 D4A9D6 Dhx9 83.733 By MS/MS  
102 D4A9L2 Srsf1 11.278 By MS/MS By matching 




25.193 By MS/MS By MS/MS 




Ppp1r12a 20.11 By MS/MS By MS/MS 
107 E9PSX8 Sipa1 11.524  By MS/MS 
108 E9PU01 Chd4 11.148  By MS/MS 
109 F1LM33;Q5SGE0 Lrpprc 6.2922 By MS/MS By matching 
110 F1LME7 Phlda2 6.641  By MS/MS 
111 F1LN06;F1LRU8;F1LNW0;F1LSG7 Fgfr2 6.3606 By matching By MS/MS 
112 F1LNF0 Myh14 323.31 By MS/MS By MS/MS 
113 F1LPG2 Dock8 9.0434  By MS/MS 
114 F1LPS8 Pura 6.5042 By MS/MS By MS/MS 
115 F1LQS3;P21533;A0A0G2KBA1 Rpl6 169.22 By MS/MS By MS/MS 




Hnrnpm 323.31 By MS/MS By MS/MS 
118 F1M0U4 rCG_21092 6.3456 By MS/MS  
119 F1M168;P62859 LOC100360689;Rps28 6.2154 By MS/MS By MS/MS 
120 F1M5X4;F1M3E9 LOC100362687 89.816 By MS/MS By MS/MS 
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Table 4.4: (cont.) 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 
121 F1M3H8 Hnrnpa0 92.877 By matching By MS/MS 
122 F1M779;P11442 Cltc 7.7239 By MS/MS By MS/MS 
123 F1M853 Rrbp1 323.31 By MS/MS By MS/MS 
124 F1M953;P48721 Hspa9 7.0028  By MS/MS 
125 F7FHW2;Q5BKD0 Oas1k;Oas1b 6.607  By MS/MS 








LOC100911597;Myh9 323.31 By MS/MS By MS/MS 
129 G3V6S8;G3V798 Srsf6 21.21 By MS/MS By MS/MS 
130 G3V7C6;Q6P9T8;B4F7C2 Tubb4b;Tubb4a 171.67 By MS/MS By MS/MS 
131 G3V8L3;P48679 Lmna 150 By MS/MS By MS/MS 




Gimap5 13.453 By matching By MS/MS 
134 M0R6V0;P62870 Tceb2 120.87 By MS/MS By MS/MS 
135 M0R7B4 LOC684828 49.877 By MS/MS By MS/MS 




8.1563  By MS/MS 
138 O88656 Arpc1b 6.7163  By MS/MS 
139 O88764 Dapk3 6.1712 By MS/MS By MS/MS 
140 P02600;P16409 Myl1;Myl3 6.2364  By MS/MS 
141 Q6P6G9;Q5I0M7;P04256;D4ACJ7 Hnrnpa1;Hnrpa1 61.779 By MS/MS By MS/MS 
142 P06761 Hspa5 10.213 By MS/MS By MS/MS 
143 P07150 Anxa1 27.526  By MS/MS 
144 P08082 Cltb 12.469 By MS/MS By MS/MS 
145 R4GNK3;P11232 Txn1;Txn 6.2619 By MS/MS By matching 
146 P11240 Cox5a 12.092 By MS/MS By MS/MS 
147 P13084;D3ZXI2 Npm1 11.503 By MS/MS By MS/MS 
148 Q5U328;P13383 Ncl 106.81 By MS/MS By MS/MS 
149 Q6PDV6;P13471;F1MA00;D4A290 Rps14 234.66 By MS/MS By MS/MS 
150 P15865;P06349;D4A3K5 Hist1h1e 239.33 By MS/MS By MS/MS 
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Table 4.4: (cont.) 
 
 






Rpl9;LOC100911472 64.745 By MS/MS By MS/MS 
152 P17078;D3ZN79;F1M6G3 Rpl35;LOC686074 270.78 By MS/MS By MS/MS 
153 P19944;A0A0H2UHJ3 Rplp1 267.56 By MS/MS By MS/MS 
154 P19945 Rplp0 21.617 By MS/MS By MS/MS 
















258.77 By MS/MS By MS/MS 











58.328 By MS/MS By MS/MS 
160 P29314;A0A0G2K4C4;M0RB65 Rps9;LOC100364509 14.162 By MS/MS By MS/MS 
161 P29419 Atp5i 12.26 By MS/MS By MS/MS 




Vim 323.31 By MS/MS By MS/MS 
164 P31399 Atp5h 7.0437 By matching By MS/MS 






323.31 By MS/MS By MS/MS 
167 P45592 Cfl1 7.2335 By MS/MS By MS/MS 
168 P49242;M0R6L4;Q6TXJ6 Rps3a;LOC100365839 96.308 By MS/MS By MS/MS 






294.07 By MS/MS By MS/MS 




13.648 By MS/MS By MS/MS 




Table 4.4: (cont.) 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 




323.31 By MS/MS By MS/MS 
176 P62250;A0A1W2Q631;M0R4I3;M0R8S7 Rps16 89.357 By MS/MS By MS/MS 
177 P62275 Rps29 47.589 By MS/MS By MS/MS 
178 P62278;M0RCY2;F1LMB4 Rps13;LOC683961 122.11 By MS/MS By MS/MS 
179 P62282 Rps11 323.31 By MS/MS By MS/MS 
180 P62718;F1M0K6 Rpl18a 148.02 By MS/MS By MS/MS 
181 P62755;M0RD75 Rps6 323.31 By MS/MS By MS/MS 
182 P62804 Hist1h4b 51.769 By MS/MS By MS/MS 
183 P62832 Rpl23 41.665 By MS/MS By MS/MS 














323.31 By MS/MS By MS/MS 
187 P62907;D3Z9F6;F1LYQ7 Rpl10a 101.42 By MS/MS By MS/MS 
188 P62912;D4A412;D4A647 Rpl32 323.31 By MS/MS By MS/MS 
189 P62914;Q4V8I6;A0A0G2K3Y8;F1LVT8 Rpl11 323.31 By MS/MS By MS/MS 




323.31 By MS/MS By MS/MS 






96.071 By MS/MS By MS/MS 
194 P63259 Actg1 323.31 By MS/MS By MS/MS 
195 Q6PDW1;P63324 LOC100359593;Rps12 32.314  By MS/MS 
196 P63326 Rps10 8.2363 By MS/MS By MS/MS 
197 P81795;C9WPN6;A0A096MJB9 Eif2s3;Eif2s3y 42.414 By MS/MS By matching 
198 P83732;A0A0H2UH99;M0RBD1 Rpl24 120.79 By MS/MS By MS/MS 
199 P83883;F8WFR5 Rpl36a 26.605 By MS/MS By MS/MS 
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Table 4.4: (cont.) 
 
 
Protein IDs Gene names Score 
Identification Type 
(-) (+) 




63.249 By MS/MS By MS/MS 
202 Q01177 Plg 59.314  By MS/MS 
203 Q06647 Atp5o 12.827  By MS/MS 
204 Q09073 Slc25a5 184.26 By MS/MS By MS/MS 
205 Q09167 Srsf5 31.391 By MS/MS By MS/MS 
206 Q3KR55;Q7TP17 U2af1;U2af1l4 15.538 By MS/MS By MS/MS 
207 Q3MIE4 Vat1 20.881 By MS/MS By MS/MS 
208 Q3T1K5 Capza2 160.9 By MS/MS By MS/MS 
209 Q498E0 Txndc12 87.421 By MS/MS By MS/MS 
210 Q4FZY0 Efhd2 110.28 By matching By MS/MS 
211 Q4QQV6 Lsp1 323.31 By MS/MS By MS/MS 
212 Q7TPI7;Q4QR85 LOC100911453;Wdr77 19.559 By MS/MS By MS/MS 
213 Q4V7E8 Lrrfip2 6.3164 By MS/MS By MS/MS 
214 Q4V8I5 Arl6ip4 6.3655  By MS/MS 
215 Q505J8 Farsa 30.065  By MS/MS 
216 Q5FVC2;A0A1B0GWY5;A0A0G2K0V4 Arhgef2 165.1 By MS/MS By MS/MS 
217 Q5FVM4 Nono 8.2977 By MS/MS By MS/MS 
218 Q5M7V8 Thrap3 12.866 By MS/MS By MS/MS 
219 Q5RJP9 Srek1ip1 6.8583 By MS/MS By MS/MS 
220 Q5RKI5 Flii 61.046 By MS/MS By MS/MS 
221 Q5XHY0 Ddx18 6.1781 By MS/MS  
222 Q5XI04 Stom 191.7 By MS/MS By MS/MS 
223 Q5XI32 Capzb 116.75 By MS/MS By MS/MS 
224 Q66HK4;Q63187 Tceb3 7.229  By MS/MS 
225 Q63355 Myo1c 63.939 By MS/MS By MS/MS 
226 Q63610;A0A140TAF0 Tpm3 323.31 By MS/MS By MS/MS 
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Table 4.4: (cont.) 
 
 








104.21 By MS/MS By MS/MS 
228 Q66HF9 Lrrfip1 323.31 By MS/MS By MS/MS 
229 Q68FP1 Gsn 116.2 By MS/MS By MS/MS 
230 Q68FR9 Eef1d 6.5591 By MS/MS By MS/MS 
231 Q6AXW2;F1M547;F1M4Q6 Tmod3 323.31 By MS/MS By MS/MS 
232 Q6P685 Eif2s2 18.019 By MS/MS By MS/MS 
233 Q6P7C7 Gpnmb 52.336 By MS/MS By MS/MS 
234 Q6PDV7;D4A1P2 Rpl10;Rpl10l 99.304 By MS/MS By MS/MS 
235 Q6PDV8;P47198 Rpl22 128.74 By MS/MS By MS/MS 
236 Q794E4 Hnrnpf 21.616 By MS/MS By MS/MS 
237 Q7M0E3 Dstn 20.802 By MS/MS By MS/MS 
238 Q8K585 Hmga1 323.31 By MS/MS By MS/MS 
239 Q9ERL1 Cybb 7.2186 By matching By MS/MS 
240 Q9ESH6 Glrx 135.7 By MS/MS By MS/MS 
241 Q9JMJ4 Prpf19 21.127 By MS/MS By MS/MS 
242 Q9QYF3 Myo5a 6.25 By MS/MS  
243 Q9WUF4 Vamp8 7.9509  By MS/MS 
244 Q9Z1E1 Flot1 6.4632 By matching By MS/MS 
 
 
Table 4.5: List of GIMAP 4, 5, and 6’s interacting proteins identified by mass spectrometry from 
infected NR8383 cells expressing respective GIMAP. 
 
Baits Partners Full Names 
GIMAP 5 
VAMP8 vesicle-associated membrane protein 8 
CD44 CD44 antigen 
PABPC1 polyadenylate-binding protein 1 
OAS1b 2-5-oligoadenylate synthase 1B 
GIMAP 6 CD44 CD44 antigen 
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Table 4.6: Complete list of proteins interacting with GIMAP 6 in HA-GIMAP 6-expressing 
NR8383 cells without T. gondii infection. 
 
 
Accession Score Mass Mat SMat Seq SSeq emPAI Description 
1 EDM06755.1 15106 66289 614 478 23 21 3.92 
lectin, galactoside-










3184 42108 170 123 27 23 13.88 actin, cytoplasmic 2 
4 EDL96714.1 1958 51974 127 81 14 11 1.65 






3901 34183 263 182 25 25 30.12 
GTPase IMAP family 
member 6 
6 EDM17201.1 3442 51290 186 127 19 15 3.39 
rCG39872, isoform 
CRA_a 
7 AAI66769.1 188 60260 22 10 7 4 0.32 Taf15 protein 
8 NP_034990.1 1761 17121 119 85 14 13 78.03 
myosin light 
polypeptide 6 isoform 
MLC3sm 
9 NP_112402.1 1238 53757 97 65 26 24 6.11 vimentin 
10 NP_080340.2 1149 19940 61 54 8 8 5.52 
myosin light chain, 
regulatory B-like  
11 NP_291024.1 831 19824 42 37 7 7 4.35 
myosin regulatory 
light chain 12B 
12 NP_036750.1 983 11997 28 26 4 2 0.99 protein S100-A4 








gamma Fc region 
receptor II-b isoform 
X1 
15 AAL29888.1 152 36760 22 6 7 5 0.77 
Fc gamma receptor II 
beta, partial 






761 55175 52 36 16 12 1.5 
E3 ubiquitin-protein 
ligase TRIM21 
18 Q63610.2 687 29217 48 29 23 20 19.36 
Tropomyosin alpha-3 
chain 
19 NP_036810.1 293 28549 30 16 16 11 4.03 
tropomyosin alpha-4 
chain 
20 NP_035785.1 634 50095 40 30 20 17 3.18 tubulin beta-5 chain 








Table 4.6: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
23 NP_002128.1 487 36041 33 22 15 14 4.1 
heterogeneous nuclear 
ribonucleoproteins 
A2/B1 isoform A2  
24 AAD00000.1 408 48611 70 40 11 7 1.18 
anti-NGF30 antibody 
heavy-chain, partial 
25 NP_077327.1 300 71055 28 13 18 13 1.17 





287 11605 10 6 4 4 3.09 
60S acidic ribosomal 
protein P1 






263 39618 13 6 7 4 0.89 tropomodulin-3 
29 NP_073206.2 255 96081 10 9 10 9 0.49 major vault protein 
30 NP_003503.1 217 14097 6 6 3 3 1.41 histone H2A type 1-C 




212 21948 7 7 5 5 1.58 
programmed cell 




185 11685 11 9 9 7 10.78 
60S acidic ribosomal 
protein P2 
34 P00787.2 182 38358 3 2 3 2 0.24 Cathepsin B 








37 NP_035783.1 164 50788 10 7 8 7 0.79 
tubulin alpha-1A 
chain 




39 EDL30357.1 150 57210 14 4 7 4 0.34 
mCG17252, isoform 
CRA_c 
40 P08699.4 130 27241 9 5 7 4 0.85 Galectin-3 
41 P13383.3 120 77158 9 4 8 4 0.24 Nucleolin 
42 NP_004588.1 115 13632 7 4 3 3 1.48 
small nuclear 
ribonucleoprotein Sm 
D2 isoform 1 
43 P48721.3 112 74097 6 4 6 4 0.26 
Stress-70 protein, 
mitochondrial 










Table 4.6: (cont.) 
 




109 27011 4 3 4 3 0.59 
PREDICTED: THO 
complex subunit 4 
isoform X1 
47 NP_033105.1 108 14807 3 2 3 2 0.75 
60S ribosomal protein 
L22 isoform a 




















53 NP_001009.1 99 17029 1 1 1 1 0.28 
40S ribosomal protein 
S15 isoform 2 
54 EDL79676.1 98 76740 9 3 4 2 0.12 
rCG26771, isoform 
CRA_b 
55 NP_003086.1 96 9776 3 3 3 3 2.5 
small nuclear 
ribonucleoprotein F 
56 NP_001007.2 93 14905 3 2 3 2 0.74 
40S ribosomal protein 
S12 




89 23063 3 2 3 2 0.44 
40S ribosomal protein 




88 31156 6 4 2 2 0.31 





88 84430 4 2 4 2 0.11 
LIM domain and 
actin-binding protein 
1 
61 EDM08416.1 87 26006 2 2 2 2 0.38 
rCG24640, isoform 
CRA_a 







81 23608 6 2 5 2 0.42 
PREDICTED: clathrin 
light chain A isoform 
X3 










Table 4.6: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 















62 5310 1 1 1 1 1.1 
uncharacterized 
protein C7orf73 
homolog isoform 2 







61 227527 11 6 7 5 0.1 myosin-9 
70 EDM17995.1 59 62253 3 2 3 2 0.15 





57 75672 1 1 1 1 0.06 
PREDICTED: nuclear 
fragile X mental 
retardation-interacting 
protein 2 isoform X1 
72 AAD19638.1 57 34250 7 4 5 4 0.63 
nucleic acid binding 
factor pRM10 
73 AAA41369.1 57 14468 2 2 2 2 0.77 
immunoglobulin light 
chain, partial 
74 NP_076462.1 54 21534 2 2 2 2 0.47 PRA1 family protein 3 
75 NP_446252.1 53 12008 2 2 2 2 0.99 thioredoxin 
76 AAI00256.1 52 22453 2 2 2 2 0.45 
Txndc12 protein, 
partial 




78 EDM08063.1 52 23019 3 3 3 3 0.72 
rCG54023, isoform 
CRA_a 




46 19873 1 1 1 1 0.23 
PREDICTED: Ig 
heavy chain V region 
5-84-like isoform X1 
81 AAU06142.1 43 7553 2 1 2 1 0.71 
Fcgr3-related 
sequence, partial 
82 EDM03907.1 40 17549 1 1 1 1 0.27 rCG63495, partial 
83 NP_080239.1 40 18904 4 3 4 3 0.94 





Table 4.6: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
84 Q00729.2 39 14273 1 1 1 1 0.33 Histone H2B type 1-A 
85 NP_001014.1 38 13478 1 1 1 1 0.36 
40S ribosomal protein 
S20 isoform 2 
86 NP_780311.2 36 10170 3 2 3 2 1.23 
splicing factor 3B 
subunit 5 




88 NP_001019.1 36 13791 1 1 1 1 0.35 
40S ribosomal protein 
S25 
89 NP_062743.1 36 22418 1 1 1 1 0.2 
calcineurin B 








91 ACI04543.1 35 69582 1 1 1 1 0.06 
DEAD (Asp-Glu-Ala-
Asp) box polypeptide 
5, partial 
92 Q8K3K9.1 35 36085 1 1 1 1 0.12 
GTPase IMAP family 
member 4 
93 EDL91559.1 35 19343 1 1 1 1 0.24 
SEC13-like 1 (S. 
cerevisiae), isoform 
CRA_a 




33 26743 5 2 4 2 0.37 
EF-hand domain-
containing protein D2 
96 NP_001198.2 32 17688 2 1 2 1 0.27 
transcription factor 
BTF3 isoform B 




27 47248 1 1 1 1 0.09 
endoplasmic reticulum 
resident protein 44 
precursor 
99 EDL97026.1 26 10166 1 1 1 1 0.49 
rCG60540, isoform 
CRA_c  
100 NP_035870.1 25 27925 1 1 1 1 0.16 
14-3-3 protein 
zeta/delta isoform 1 
101 P32822.1 24 27543 2 1 2 1 0.16 Trypsin V-B 




103 AAA41108.1 23 35699 2 1 2 1 0.12 
enhancer factor-1-
alpha 
104 AAP92600.1 23 18074 1 1 1 1 0.26 Ab2-255 




Table 4.6: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 












108 Q6B4M5.2 20 37603 7 3 1 1 0.12 
Partitioning defective 
6 homolog alpha 






18 36652 1 1 1 1 0.12 
lymphocyte-specific 
protein 1 






18 97327 3 2 1 1 0.04 


























16 24395 1 1 1 1 0.19 
PREDICTED: histone 
H3.1 
117 EDM14803.1 16 62090 1 1 1 1 0.07 rCG50064 
118 NP_005608.1 15 16434 4 1 4 1 0.29 





15 44888 1 1 1 1 0.1 
PREDICTED: TAR 
DNA-binding protein 














14 98224 1 1 1 1 0.04 
splicing factor 3B 
subunit 2 
123 Q5I0J9.1 14 31411 1 1 1 1 0.14 
Putative L-aspartate 
dehydrogenase 




14 22220 8 1 2 1 0.21 
PREDICTED: histone 
H1.3 







Table 4.6: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
127 EDM17359.1 14 17630 1 1 1 1 0.27 
similar to hypothetical 
protein FLJ90652, 
isoform CRA_c 






129 Q9R1A0.2 13 38041 1 1 1 1 0.12 Cyclin-H 
130 AAB03702.1 13 26479 3 1 2 1 0.17 Ig kappa chain 
 
 
Table 4.7: Complete list of proteins interacting with GIMAP 6 in HA-GIMAP 6-expressing 
NR8383 cells with T. gondii infection. 
 
 
Accession Score Mass Mat SMat Seq SSeq emPAI Description 






1623 11605 60 43 6 4 3.09 
60S acidic ribosomal 
protein P1 
3 NP_001007.2 903 14905 29 26 3 3 3.02 
40S ribosomal protein 
S12 
4 EDL92448.1 315 12793 12 10 3 3 4.02 rCG51069, partial 
5 NP_112373.1 647 9236 41 24 8 7 81.92 













594 26743 30 25 7 5 1.19 
EF-hand domain-
containing protein D2 
9 EDM06755.1 527 66289 18 17 4 4 0.29 
lectin, galactoside-
binding, soluble, 3 
binding protein, 
isoform CRA_a 
10 NP_112402.1 527 53757 42 22 11 7 0.87 vimentin 
11 NP_034990.1 512 17121 54 35 9 8 10.33 
myosin light 
polypeptide 6 isoform 
MLC3sm 
12 Q63610.2 482 29217 26 16 6 4 1.37 
Tropomyosin alpha-3 
chain 
13 NP_037124.1 451 32711 13 11 4 3 0.67 nucleophosmin 





Table 4.7: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
15 P52944.4 259 36018 20 11 8 6 1.26 





243 23608 13 7 4 3 0.7 
PREDICTED: clathrin 
light chain A isoform 
X3 
17 NP_665726.1 214 16347 18 9 6 3 2.56 





















194 36652 13 8 9 5 0.99 
lymphocyte-specific 
protein 1 
22 KFH12240.1 190 26861 16 16 1 1 0.17 
putative ATP-
dependent DNA 
helicase II, 70 kDa 
subunit [Toxoplasma 
gondii VAND] 
23 EDM07863.1 179 78166 7 6 4 4 0.31 
rCG54533, isoform 
CRA_b 
24 AAH74001.1 89 103118 5 3 3 3 0.13 Actn1 protein 
25 P00697.2 160 17174 7 3 5 2 0.62 Lysozyme C-1 
26 Q5U301.1 160 96338 5 5 4 4 0.19 
A-kinase anchor 
protein 2 
27 EDL92042.1 148 70675 4 2 3 1 0.13 
similar to FLI-LRR 
associated protein-1, 
isoform CRA_c 
28 EDM10520.1 134 6959 3 3 1 1 0.78 
rCG55259, isoform 
CRA_a 
29 CAA31067.1 133 9660 2 2 1 1 0.53 
cytochrome c oxidase 





132 84430 10 5 3 2 0.16 
LIM domain and 
actin-binding protein 
1 


















Table 4.7: (cont.) 
 




97 39060 2 2 2 2 0.24 
macrophage-capping 
protein 











AHNAK isoform X8 
38 EDM09686.1 93 12231 2 2 2 2 0.96 
cysteine and glycine-
rich protein 1, isoform 
CRA_b 
39 NP_036810.1 91 28549 11 5 2 1 0.16 
tropomyosin alpha-4 
chain 
40 NP_058797.1 88 18091 2 2 2 2 0.58 
peptidyl-prolyl cis-




88 830895 6 3 3 2 0.02 
PREDICTED: protein 




87 39618 7 4 4 2 0.24 tropomodulin-3 
43 AAD00000.1 87 48611 4 3 2 2 0.19 
anti-NGF30 antibody 
heavy-chain, partial 
44 P18666.3 87 19883 3 2 1 1 0.23 
Myosin regulatory 
light chain 12B 
45 P24050.3 85 23035 1 1 1 1 0.2 
40S ribosomal protein 
S5 
46 EDL81653.1 84 10619 2 2 1 1 0.47 
rCG20695, isoform 
CRA_a 
47 EDM02205.1 79 34175 5 4 5 4 0.63 
PDZ and LIM domain 












71 52849 5 2 3 1 0.08 
hematopoietic lineage 
cell-specific protein 





51 NP_001060.1 67 50274 2 2 1 1 0.18 
tubulin beta-2A chain 
isoform 1 










66 25302 1 1 1 1 0.18 
coiled-coil domain-




Table 4.7: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 






from Lewis rat 
63 34183 3 3 3 3 0.45 Gimap6 
57 NP_071946.1 62 23479 1 1 1 1 0.19 cysteine-rich protein 2 
58 EDM08063.1 56 23019 5 4 3 2 0.44 
rCG54023, isoform 
CRA_a 
59 Q6P7C7.1 55 64489 6 2 3 1 0.14 
Transmembrane 
glycoprotein NMB 





61 NP_446213.1 52 61519 2 2 2 2 0.15 zyxin 
62 BAA00911.1 49 18827 1 1 1 1 0.25 






48 110746 2 2 2 2 0.08 
microtubule-
associated protein 4 
64 EDM16039.1 47 30897 1 1 1 1 0.15 
eukaryotic translation 








46 14626 1 1 1 1 0.33 
LIM domain-
containing protein 2 
66 NP_659554.1 46 43016 4 2 3 2 0.22 
plasminogen activator 
inhibitor 1 RNA-




44 98224 1 1 1 1 0.04 
splicing factor 3B 
subunit 2 
68 EDM02028.1 41 11143 2 1 1 1 0.45 
ATPase, H+ 
transporting, V1 
subunit E isoform 1, 
isoform CRA_b 
69 NP_116002.1 40 30351 1 1 1 1 0.15 
LIM and SH3 domain 
protein 1 
70 EDM12555.1 40 17031 2 2 1 1 0.28 
rCG47344, isoform 
CRA_b 
71 NP_001019.1 39 13791 1 1 1 1 0.35 
40S ribosomal protein 
S25 
72 EDM05731.1 38 49017 6 2 5 2 0.19 
rCG33781, isoform 
CRA_a 
73 EDL83814.1 37 31448 1 1 1 1 0.14 
polyglutamine binding 





Table 4.7: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 





75 AAH61541.1 36 53473 1 1 1 1 0.08 Pkm2 protein 
76 NP_058892.1 35 16817 8 1 3 1 0.28 
allograft inflammatory 
factor 1 
77 NP_079904.1 35 10293 3 2 3 2 1.21 
cytochrome c oxidase 
subunit 6B1 




79 EDM04418.1 32 36055 2 1 2 1 0.12 
reversion induced 
LIM gene, isoform 
CRA_a 
80 EDL77037.1 32 63553 2 1 2 1 0.07 










protein isoform X1 
82 AAG31606.3 29 66242 1 1 1 1 0.07 









H2B type 1 isoform 
X1, partial 




85 AAC08424.1 23 52708 1 1 1 1 0.08 cortactin isoform C 




















20 77337 15 5 2 1 0.06 
PREDICTED: LOW 
QUALITY 




Table 4.7: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
91 EDM05407.1 19 198599 6 1 3 1 0.02 
similar to novel 
protein (predicted) 
92 EDL76890.1 19 184042 4 2 4 2 0.05 
rCG25764, isoform 
CRA_a 
93 AAB23915.1 19 4964 2 1 2 1 1.2 
H(+)-ATP synthase 
subunit e 
94 NP_446148.1 19 16973 2 2 2 2 0.63 
RNA-binding protein 
3 
95 KFH00574.1 18 67227 2 1 2 1 0.06 




96 EDM11612.1 17 10338 3 1 3 1 0.49 
rCG30449, isoform 
CRA_c 































14 193119 2 1 2 1 0.02 
zinc finger protein 142 
[Rattus norvegicus] 
104 EDM13942.1 14 107370 1 1 1 1 0.04 
rCG21212, isoform 
CRA_b 
105 NP_081729.1 13 17260 2 1 2 1 0.27 
transcription factor 
BTF3 homolog 4 
106 KFH02899.1 13 0 1 1 1 1 - - 
107 NP_446054.1 13 12487 1 1 1 1 0.39 
ATP synthase-
coupling factor 6, 
mitochondrial 
precursor 




Table 4.8: Complete list of proteins identified by mass spectrometry in uninfected vector-
expressing NR8383 cells. 
 
 
Accession Score Mass Mat SMat Seq SSeq emPAI Description 
1 K2C6A_RAT 601 59213 22 20 5 5 0.43 
Keratin, type II 
cytoskeletal 6A 
2 K2C5_RAT 570 61788 27 22 8 6 0.51 
Keratin, type II 
cytoskeletal 5 
3 K2C73_RAT 183 60349 5 4 3 3 0.23 
Keratin, type II 
cytoskeletal 73 
4 K2C1B_RAT 167 57220 5 4 4 4 0.34 
Keratin, type II 
cytoskeletal 1b 
5 K2C1_RAT 162 64791 9 7 4 4 0.3 
Keratin, type II 
cytoskeletal 1 
6 K22E_RAT 80 69085 3 2 3 2 0.13 
Keratin, type II 
cytoskeletal 2 epidermal 
7 MYL6_RAT 232 16964 23 12 6 6 4.53 
Myosin light polypeptide 
6 
8 MRLCA_RAT 147 19883 5 4 5 4 1.31 
Myosin regulatory light 
chain RLC-A 
9 TPM4_RAT 137 28492 8 7 6 5 1.08 
Tropomyosin alpha-4 
chain 
10 TPM3_RAT 116 28989 9 5 8 5 1.06 
Tropomyosin alpha-3 
chain 
11 MYH9_RAT 93 226197 2 2 2 2 0.04 Myosin-9 
12 K1C10_RAT 90 56470 13 7 10 7 0.69 
Keratin, type I 
cytoskeletal 10 
13 K1C15_RAT 60 48840 4 1 3 1 0.09 
Keratin, type I 
cytoskeletal 15 
14 RLA1_RAT 60 11491 1 1 1 1 0.43 
60S acidic ribosomal 
protein P1 
15 RLA2_RAT 46 11685 5 2 4 2 1.02 
60S acidic ribosomal 
protein P2 
16 ANXA2_RAT 46 38654 2 1 1 1 0.11 Annexin A2 
17 CALM1_RAT 40 16827 3 1 1 1 0.28 Calmodulin-1 
18 S10A4_RAT 28 11769 2 1 2 1 0.42 Protein S100-A4 
19 K1C14_RAT 25 52651 4 2 3 2 0.17 
Keratin, type I 
cytoskeletal 14 
20 ACTB_RAT 22 41710 1 1 1 1 0.11 Actin, cytoplasmic 1 
21 VINC_RAT 21 116542 2 1 1 1 0.04 Vinculin 
22 RL38_RAT 20 8213 1 1 1 1 0.64 




Table 4.8: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
23 NOG1_RAT 16 74241 5 1 2 1 0.06 
Nucleolar GTP-binding 
protein 1 
24 SRSF5_RAT 15 30873 6 3 1 1 0.15 
Serine/arginine-rich 
splicing factor 5 
25 KCNH8_RAT 14 123153 15 1 1 1 0.03 
Potassium voltage-gated 




Table 4.9: Complete list of proteins identified by mass spectrometry in vector-expressing 
NR8383 cells with T. gondii infection. 
 
 
Accession Score Mass Mat SMat Seq SSeq emPAI Description 
1 MYH9_RAT 520 226197 23 16 19 14 0.3 Myosin-9 
2 MYL6_RAT 495 16964 42 26 9 7 6.06 
Myosin light polypeptide 
6 
3 MRLCA_RAT 368 19883 12 9 6 5 2.52 
Myosin regulatory light 
chain RLC-A 
4 RLA2_RAT 164 11685 5 5 4 4 3.09 
60S acidic ribosomal 
protein P2 
5 K2C5_RAT 162 61788 2 2 1 1 0.07 
Keratin, type II 
cytoskeletal 5 
6 CALM1_RAT 121 16827 3 3 2 2 0.64 Calmodulin-1 
7 TPM3_RAT 112 28989 14 7 8 6 1.38 
Tropomyosin alpha-3 
chain 
8 TPM4_RAT 88 28492 13 8 7 6 1.41 
Tropomyosin alpha-4 
chain 
9 H2A1C_RAT 100 14097 2 2 1 1 0.34 Histone H2A type 1-C 
10 ACTN1_RAT 84 102896 1 1 1 1 0.04 Alpha-actinin-1 
11 GFAP_RAT 81 49927 1 1 1 1 0.09 
Glial fibrillary acidic 
protein 
12 RLA1_RAT 68 11491 1 1 1 1 0.43 
60S acidic ribosomal 
protein P1 
13 DESM_RAT 63 53424 1 1 1 1 0.08 Desmin 
14 ACTB_RAT 53 41710 5 3 3 2 0.22 Actin, cytoplasmic 1 
15 RL12_RAT 41 17835 1 1 1 1 0.26 
60S ribosomal protein 
L12 
16 K2C1_RAT 41 64791 1 1 1 1 0.07 
Keratin, type II 
cytoskeletal 1 




18 BAF_RAT 31 10038 1 1 1 1 0.51 
Barrier-to-
autointegration factor 







Table 4.9: (cont.) 
 
 Accession Score Mass Mat SMat Seq SSeq emPAI Description 
20 VIME_RAT 26 53700 5 4 5 4 0.37 Vimentin 
21 LG3BP_RAT 24 63701 1 1 1 1 0.07 
Galectin-3-binding 
protein 
22 K1C10_RAT 20 56470 1 1 1 1 0.08 
Keratin, type I 
cytoskeletal 10 
23 RS19_RAT 19 16076 3 1 3 1 0.29 
40S ribosomal protein 
S19 





25 1433F_RAT 16 28194 1 1 1 1 0.16 14-3-3 protein eta 
26 IBP3_RAT 16 31659 2 1 1 1 0.14 
Insulin-like growth 
factor-binding protein 3 
27 KCNH8_RAT 15 123153 20 2 2 1 0.03 
Potassium voltage-gated 
channel subfamily H 
member 8 




29 INTU_RAT 14 105076 1 1 1 1 0.04 Protein inturned 





Table 4.10: List of primers used for cloning tagged GIMAPs*. 






Primers Sequences (5’ – 3’)  









GIMAP5_R GAGGTGGTCTGGATCCTCATTTCCACCTGCCAAT  







Table 4.11: List of oligo-nucleotides used for siRNA synthesis. 
*S: sense; AS: anti-sense 
 
  















CHAPTER 5: CONCLUSION 
Toxoplasma gondii is an obligate intracellular zoonotic protozoan parasite that is highly 
prevalent worldwide and a major cause of fetal malformations, pre-term deliveries, stillbirths and 
neonatal deaths in livestock, resulting in significant economic losses (Bartova, Sedlak, & Literak, 
2009; Dubey & Kirkbride, 1989). Infected livestock meat and products act as a source of T. 
gondii infection in humans (Cook et al., 2000), which is the reason why T. gondii is considered 
as the second leading cause of foodborne-related deaths in the United States (Scallan et al., 2011). 
T. gondii is unusual in that it parasitizes a diverse range of hosts and their various cell types, and 
is transmitted in diverse ways. It has both sexual and asexual stages in its life cycle, with the 
sexual stage only occurring in the intestines of the definitive host (cat), resulting in excretion of 
up to 20 million oocysts per day in feces of a cat with acute infection (Dubey, Miller, & Frenkel, 
1970). The excreted oocysts contaminate the environment leading to infection of a broad range 
of hosts (Frenkel, Dubey, & Miller, 1970; Tenter et al., 2000). When oocysts are ingested, 
sporozoites are released that then penetrate the host’s intestinal epithelial cells where they 
proliferate and differentiate into tachyzoites (Dubey, Speer, Shen, Kwok, & Blixt, 1997) which 
disseminate throughout the body via macrophages and dendritic cells during the acute stage of 
infection (Ueno et al., 2014). With pressure from the host immune response and other unknown 
factors, the proliferative tachyzoite stage differentiates into the slower-growing encysted 
bradyzoite stage that has a predilection to brain and muscle cells (Dubey et al., 1998). Both 
tachyzoites and bradyzoites are infectious when consumed by either the definitive or 
intermediate host. There is currently no medicine to eliminate T. gondii infections, nor is there a 
vaccine to prevent infection. 
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Progression of T. gondii infection in rats closely mirrors that in humans. Importantly, the 
refractoriness of the Lewis (LEW) rat to T. gondii infection when compared to the permissible 
Brown Norway (BN) rat, provides an opportunity to use the two rat strains as models for 
deciphering host molecular mechanisms that mediate resistance to T. gondii. Therefore, we 
determined the molecular networks and mechanisms that mediate the resistance of the LEW rat 
to T. gondii infection. Using an array of approaches, including T. gondii infection rat models 
(LEW and BN rats), RNA sequencing, bioinformatic analyses, forward and reverse genetic 
approaches, biochemical and immunological assays, and mass spectrometry, among others, we 
identified effector molecules and elucidated their modes of action in inhibiting T. gondii growth 
in the LEW rat. 
We found that, unlike the BN rat, the LEW rat cells have inherently high levels of 
reactive oxygen species (ROS) that are involved in killing of intracellular T. gondii parasites, and 
thus contribute to the natural resistance of the LEW rat to T. gondii infection. Further, we 
identified small GTPase Immunity Associated Proteins (GIMAPs), namely GIMAP 4, 5 and 6, 
that are upregulated in the LEW rat in response to T. gondii infection. By bioinformatic analysis, 
all those GIMAPs contain a GTP-binding site motif A (P-loop) that is required for 
oligomerization of effector molecules to the parasite parasitophorous vacuole membrane (PVM). 
Additionally, all those GIMAPs possess an LC3-interacting region (LIR) that is important for 
interaction with autophagy-related protein 8 (Atg8), for recruitment to phagosomal membranes. 
GIMAP 6 also contains a putative N-myristoylation motif that is important for protein–
protein/lipid interaction, and for membrane targeting of proteins. These characteristic features of 
GIMAPs indicated their potential to interact with other molecules and associate with 
membranous structures. Indeed, we demonstrated that over-expressed LEW rat-derived GIMAP 
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4, 5, and 6 in T. gondii-infected NR8383 cells (derived from a T. gondii-susceptible rat) each co-
localized with GRA5, a parasite PVM marker protein, suggesting their translocation to the PVM. 
Importantly, we found that overexpression of each candidate GIMAP in T. gondii-infected 
NR8383 cells induced translocation of LAMP1 (a lysosome marker protein) to the T. gondii 
surface membrane. We observed that these trafficking patterns of the GIMAPs were associated 
with inhibition of intracellular T. gondii growth, indicating that upregulation of GIMAP 4, 5, and 
6 contributes to the robust refractoriness of the LEW rat to T. gondii through induction of 
lysosomal fusion to the otherwise nonfusogenic PVM. 
To gain insights into the molecular networks that GIMAPs engage in mediating T. gondii 
infection, we determined their interacting protein partners in NR8383 macrophages expressing 
tagged GIMAPs. By coupling immunoprecipitation assays with liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) analysis, we identified Tripartite Motif Protein 21 (TRIM21) 
that has E3 ubiquitin ligase activity, as an interacting partner for GIMAP 6. Additionally, we 
found that GIMAP 4 and GIMAP 5 both interact with Vesicle-Associated Membrane Protein 8 
(VAMP8).  GIMAP 4 also interacts with GIMAP 6. We performed RNA interference knockdown 
assays in LEW rat primary peritoneal cells infected by T. gondii and observed that knockdown of 
TRIM21 and VAMP8 reduced the refractoriness of the LEW rat cells to T. gondii. TRIM21, 
through its E3 ligase activity, is thought to facilitate tethering of effector molecules onto the T. 
gondii PVM, leading to restriction of parasite growth. On the other hand, VAMP8 is a SNARE 
protein that has been shown to localize on lysosomal membranes and is required for phagosome-
lysosome fusion. These functional features of the GIMAPs’ interacting partners suggest that they 
function to facilitate the fusion of lysosomes to the otherwise nonfusogenic PVM, leading to 
parasite death in infected cells. 
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Based on our findings, GIMAPs appear to operate independent of IFNγ stimulation. This 
indicates that their mechanisms can be engaged very early in infection, and would thus curtail 
dissemination of parasites in the host. In conclusion, as illustrated in Figure 5.1 below, our 
studies have for the first time identified, characterized and validated the networks and 
mechanisms involving a novel class of immunity-associated GTPases (GIMAP4, GIMAP5 and 
GIMAP6, that have orthologs in humans and other mammals), and their interacting partners in 
mediating resistance to T. gondii infection. Together, these studies will provide impetus to 











5.1 FIGURES  
 
Figure 5.1: Possible molecular mechanisms mediating resistance to T. gondii infection in the 
Lewis rat. LEW rat maintains inherently high levels of intracellular reactive oxygen species that 
are associated with resistance to T. gondii. In addition, host cell signaling through the NLRP1 
inflammasome in LEW rat after T. gondii infection is reported to be associated with resistance to 
T. gondii. Signaling through NLRP1 inflammasome in LEW macrophages may elicit to 
upregulate GIMAP 4, 5, and 6 that ultimately orchestrate parasite growth inhibition. GIMAPs are 
then recruited to the intracellular PVM, facilitated by inherent high ROS levels in LEW rat cells, 
where they mediate parasite killing through mechanisms that likely involve direct 
parasitophorous vacuole membrane (PVM) disruption, lysosomal fusion, and/or autophagy, 







Alfadda, A. A., & Sallam, R. M. (2012). Reactive oxygen species in health and disease. J 
Biomed Biotechnol, 2012, 936486. doi: 10.1155/2012/936486 
Aliberti, J. (2005). Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma 
gondii. Nat Rev Immunol, 5(2), 162-170. doi: 10.1038/nri1547 
Aline, F., Bout, D., & Dimier-Poisson, I. (2002). Dendritic cells as effector cells: gamma 
interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of 
Toxoplasma gondii replication. Infect Immun, 70(5), 2368-2374.  
Andrade, R. M., Wessendarp, M., Gubbels, M. J., Striepen, B., & Subauste, C. S. (2006). CD40 
induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent 
fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest, 116(9), 2366-2377. 
doi: 10.1172/JCI28796 
Andreyev, A. Y., Kushnareva, Y. E., & Starkov, A. A. (2005). Mitochondrial metabolism of 
reactive oxygen species. Biochemistry (Mosc), 70(2), 200-214.  
Antonin, W., Holroyd, C., Tikkanen, R., Honing, S., & Jahn, R. (2000). The R-SNARE 
endobrevin/VAMP-8 mediates homotypic fusion of early endosomes and late endosomes. 
Mol Biol Cell, 11(10), 3289-3298.  
Bartova, E., Sedlak, K., & Literak, I. (2009). Toxoplasma gondii and Neospora caninum 
antibodies in sheep in the Czech Republic. Vet Parasitol, 161(1-2), 131-132. doi: 
10.1016/j.vetpar.2008.12.022 
Benjamini, Y., & Hochberg, Y. (1995). Controlling the False Discovery Rate - a Practical and 
Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-
Methodological, 57(1), 289-300.  
Blader, I. J., & Saeij, J. P. (2009). Communication between Toxoplasma gondii and its host: 
impact on parasite growth, development, immune evasion, and virulence. APMIS, 117(5-
6), 458-476. doi: 10.1111/j.1600-0463.2009.02453.x 
Bleeke, T., Zhang, H., Madamanchi, N., Patterson, C., & Faber, J. E. (2004). Catecholamine-
induced vascular wall growth is dependent on generation of reactive oxygen species. Circ 
Res, 94(1), 37-45. doi: 10.1161/01.RES.0000109412.80157.7D 
Boehm, U., Guethlein, L., Klamp, T., Ozbek, K., Schaub, A., Futterer, A., . . . Howard, J. C. 
(1998). Two families of GTPases dominate the complex cellular response to IFN-gamma. 
J Immunol, 161(12), 6715-6723.  
Bougdour, A., Durandau, E., Brenier-Pinchart, M. P., Ortet, P., Barakat, M., Kieffer, S., . . . 
Hakimi, M. A. (2013). Host cell subversion by Toxoplasma GRA16, an exported dense 
granule protein that targets the host cell nucleus and alters gene expression. Cell Host 
Microbe, 13(4), 489-500. doi: 10.1016/j.chom.2013.03.002 
Bowie, A., & O'Neill, L. A. (2000). The interleukin-1 receptor/Toll-like receptor superfamily: 
signal generators for pro-inflammatory interleukins and microbial products. J Leukoc 
Biol, 67(4), 508-514.  
Butcher, B. A., Fox, B. A., Rommereim, L. M., Kim, S. G., Maurer, K. J., Yarovinsky, F., . . . 
Denkers, E. Y. (2011). Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and 
STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS 
Pathog, 7(9), e1002236. doi: 10.1371/journal.ppat.1002236 
Butcher, B. A., Kim, L., Johnson, P. F., & Denkers, E. Y. (2001). Toxoplasma gondii tachyzoites 
inhibit proinflammatory cytokine induction in infected macrophages by preventing 
143 
 
nuclear translocation of the transcription factor NF-kappa B. J Immunol, 167(4), 2193-
2201.  
Buzoni-Gatel, D., & Werts, C. (2006). Toxoplasma gondii and subversion of the immune system. 
Trends Parasitol, 22(10), 448-452. doi: 10.1016/j.pt.2006.08.002 
Cambot, M., Aresta, S., Kahn-Perles, B., de Gunzburg, J., & Romeo, P. H. (2002). Human 
immune associated nucleotide 1: a member of a new guanosine triphosphatase family 
expressed in resting T and B cells. Blood, 99(9), 3293-3301.  
Carter, C., Dion, C., Schnell, S., Coadwell, W. J., Graham, M., Hepburn, L., . . . Butcher, G. W. 
(2007). A natural hypomorphic variant of the apoptosis regulator Gimap4/IAN1. J 
Immunol, 179(3), 1784-1795.  
Cavailles, P., Flori, P., Papapietro, O., Bisanz, C., Lagrange, D., Pilloux, L., . . . Cesbron-Delauw, 
M. F. (2014). A highly conserved Toxo1 haplotype directs resistance to toxoplasmosis 
and its associated caspase-1 dependent killing of parasite and host macrophage. PLoS 
Pathog, 10(4), e1004005. doi: 10.1371/journal.ppat.1004005 
Cavailles, P., Sergent, V., Bisanz, C., Papapietro, O., Colacios, C., Mas, M., . . . Fournie, G. J. 
(2006). The rat Toxo1 locus directs toxoplasmosis outcome and controls parasite 
proliferation and spreading by macrophage-dependent mechanisms. Proc Natl Acad Sci 
U S A, 103(3), 744-749. doi: 10.1073/pnas.0506643103 
Charvat, R. A., & Arrizabalaga, G. (2016). Oxidative stress generated during monensin treatment 
contributes to altered Toxoplasma gondii mitochondrial function. Sci Rep, 6, 22997. doi: 
10.1038/srep22997 
Cheng, Y. S., Colonno, R. J., & Yin, F. H. (1983). Interferon induction of fibroblast proteins 
with guanylate binding activity. J Biol Chem, 258(12), 7746-7750.  
Chew, W. K., Wah, M. J., Ambu, S., & Segarra, I. (2012). Toxoplasma gondii: determination of 
the onset of chronic infection in mice and the in vitro reactivation of brain cysts. Exp 
Parasitol, 130(1), 22-25. doi: 10.1016/j.exppara.2011.10.004 
Cirelli, K. M., Gorfu, G., Hassan, M. A., Printz, M., Crown, D., Leppla, S. H., . . . Moayeri, M. 
(2014). Inflammasome sensor NLRP1 controls rat macrophage susceptibility to 
Toxoplasma gondii. PLoS Pathog, 10(3), e1003927. doi: 10.1371/journal.ppat.1003927 
Clough, B., & Frickel, E. M. (2017). The Toxoplasma Parasitophorous Vacuole: An Evolving 
Host-Parasite Frontier. Trends Parasitol, 33(6), 473-488. doi: 10.1016/j.pt.2017.02.007 
Coers, J. (2013). Self and non-self discrimination of intracellular membranes by the innate 
immune system. PLoS Pathog, 9(9), e1003538. doi: 10.1371/journal.ppat.1003538 
Cohen, S. B., Maurer, K. J., Egan, C. E., Oghumu, S., Satoskar, A. R., & Denkers, E. Y. (2013). 
CXCR3-dependent CD4(+) T cells are required to activate inflammatory monocytes for 
defense against intestinal infection. PLoS Pathog, 9(10), e1003706. doi: 
10.1371/journal.ppat.1003706 
Cook, A. J., Gilbert, R. E., Buffolano, W., Zufferey, J., Petersen, E., Jenum, P. A., . . . Dunn, D. 
T. (2000). Sources of toxoplasma infection in pregnant women: European multicentre 
case-control study. European Research Network on Congenital Toxoplasmosis. BMJ, 
321(7254), 142-147.  
Creagh, E. M., & O'Neill, L. A. (2006). TLRs, NLRs and RLRs: a trinity of pathogen sensors 
that co-operate in innate immunity. Trends Immunol, 27(8), 352-357. doi: 
10.1016/j.it.2006.06.003 




Denkers, E. Y. (2010). Toll-like receptor initiated host defense against Toxoplasma gondii. J 
Biomed Biotechnol, 2010, 737125. doi: 10.1155/2010/737125 
Dinarello, C. A. (2005). Interleukin-1beta. Crit Care Med, 33(12 Suppl), S460-462.  
Ding, M., Kwok, L. Y., Schluter, D., Clayton, C., & Soldati, D. (2004). The antioxidant systems 
in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative 
injury. Mol Microbiol, 51(1), 47-61.  
Dion, C., Carter, C., Hepburn, L., Coadwell, W. J., Morgan, G., Graham, M., . . . Miller, J. R. 
(2005). Expression of the Ian family of putative GTPases during T cell development and 
description of an Ian with three sets of GTP/GDP-binding motifs. Int Immunol, 17(9), 
1257-1268. doi: 10.1093/intimm/dxh302 
Dubey, J. P. (1996). Pathogenicity and infectivity of Toxoplasma gondii oocysts for rats. J 
Parasitol, 82(6), 951-956.  
Dubey, J. P. (2008). The history of Toxoplasma gondii--the first 100 years. J Eukaryot Microbiol, 
55(6), 467-475. doi: 10.1111/j.1550-7408.2008.00345.x 
Dubey, J. P. (2014). The History and Life Cycle of Toxoplasma gondii. Toxoplasma Gondii: The 
Model Apicomplexan - Perspectives and Methods, 2nd Edition, 1-17. doi: 10.1016/B978-
0-12-396481-6.00001-5 
Dubey, J. P., & Dubey, J. P. (2010). Toxoplasmosis of animals and humans (pp. 1 online 




Dubey, J. P., Ferreira, L. R., Alsaad, M., Verma, S. K., Alves, D. A., Holland, G. N., & 
McConkey, G. A. (2016). Experimental Toxoplasmosis in Rats Induced Orally with 
Eleven Strains of Toxoplasma gondii of Seven Genotypes: Tissue Tropism, Tissue Cyst 
Size, Neural Lesions, Tissue Cyst Rupture without Reactivation, and Ocular Lesions. 
PLoS One, 11(5), e0156255. doi: 10.1371/journal.pone.0156255 
Dubey, J. P., & Jones, J. L. (2008). Toxoplasma gondii infection in humans and animals in the 
United States. Int J Parasitol, 38(11), 1257-1278. doi: 10.1016/j.ijpara.2008.03.007 
Dubey, J. P., & Kirkbride, C. A. (1989). Economic and public health considerations of 
congenital toxoplasmosis in lambs. J Am Vet Med Assoc, 195(12), 1715-1716.  
Dubey, J. P., Lindsay, D. S., & Speer, C. A. (1998). Structures of Toxoplasma gondii tachyzoites, 
bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol 
Rev, 11(2), 267-299.  
Dubey, J. P., Miller, N. L., & Frenkel, J. K. (1970). The Toxoplasma gondii oocyst from cat 
feces. J Exp Med, 132(4), 636-662.  
Dubey, J. P., Speer, C. A., Shen, S. K., Kwok, O. C., & Blixt, J. A. (1997). Oocyst-induced 
murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed 
Toxoplasma gondii oocysts. J Parasitol, 83(5), 870-882.  
Dupont, C. D., Christian, D. A., & Hunter, C. A. (2012). Immune response and 
immunopathology during toxoplasmosis. Semin Immunopathol, 34(6), 793-813. doi: 
10.1007/s00281-012-0339-3 
Endale, M., Aksoylar, H. I., & Hoebe, K. (2015). Central role of gimap5 in maintaining 




Evans, A. K., Strassmann, P. S., Lee, I. P., & Sapolsky, R. M. (2014). Patterns of Toxoplasma 
gondii cyst distribution in the forebrain associate with individual variation in predator 
odor avoidance and anxiety-related behavior in male Long-Evans rats. Brain Behav 
Immun, 37, 122-133. doi: 10.1016/j.bbi.2013.11.012 
Ewald, S. E., Chavarria-Smith, J., & Boothroyd, J. C. (2014). NLRP1 is an inflammasome sensor 
for Toxoplasma gondii. Infect Immun, 82(1), 460-468. doi: 10.1128/IAI.01170-13 
Farazi, T. A., Waksman, G., & Gordon, J. I. (2001). The biology and enzymology of protein N-
myristoylation. J Biol Chem, 276(43), 39501-39504. doi: 10.1074/jbc.R100042200 
Fentress, S. J., Behnke, M. S., Dunay, I. R., Mashayekhi, M., Rommereim, L. M., Fox, B. A., . . . 
Sibley, L. D. (2010). Phosphorylation of immunity-related GTPases by a Toxoplasma 
gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe, 
8(6), 484-495. doi: 10.1016/j.chom.2010.11.005 
Ferguson, D. J. (2004). Use of molecular and ultrastructural markers to evaluate stage conversion 
of Toxoplasma gondii in both the intermediate and definitive host. Int J Parasitol, 34(3), 
347-360. doi: 10.1016/j.ijpara.2003.11.024 
Ferguson, S. M., & De Camilli, P. (2012). Dynamin, a membrane-remodelling GTPase. Nat Rev 
Mol Cell Biol, 13(2), 75-88. doi: 10.1038/nrm3266 
Filen, J. J., Filen, S., Moulder, R., Tuomela, S., Ahlfors, H., West, A., . . . Lahesmaa, R. (2009). 
Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially 
regulated during human T helper cell differentiation. Mol Cell Proteomics, 8(1), 32-44. 
doi: 10.1074/mcp.M800139-MCP200 
Filen, S., & Lahesmaa, R. (2010). GIMAP Proteins in T-Lymphocytes. J Signal Transduct, 2010, 
268589. doi: 10.1155/2010/268589 
Foltz, C., Napolitano, A., Khan, R., Clough, B., Hirst, E. M., & Frickel, E. M. (2017). TRIM21 
is critical for survival of Toxoplasma gondii infection and localises to GBP-positive 
parasite vacuoles. Sci Rep, 7(1), 5209. doi: 10.1038/s41598-017-05487-7 
Fournie, G. J., Cautain, B., Xystrakis, E., Damoiseaux, J., Mas, M., Lagrange, D., . . . Saoudi, A. 
(2001). Cellular and genetic factors involved in the difference between Brown Norway 
and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. 
Immunol Rev, 184, 145-160.  
Franchi, L., Warner, N., Viani, K., & Nunez, G. (2009). Function of Nod-like receptors in 
microbial recognition and host defense. Immunol Rev, 227(1), 106-128. doi: 
10.1111/j.1600-065X.2008.00734.x 
Frenkel, J. K., Dubey, J. P., & Miller, N. L. (1970). Toxoplasma gondii in cats: fecal stages 
identified as coccidian oocysts. Science, 167(3919), 893-896.  
Gauuan, P. J., Trova, M. P., Gregor-Boros, L., Bocckino, S. B., Crapo, J. D., & Day, B. J. (2002). 
Superoxide dismutase mimetics: synthesis and structure-activity relationship study of 
MnTBAP analogues. Bioorg Med Chem, 10(9), 3013-3021.  
Gazzinelli, R. T., & Denkers, E. Y. (2006). Protozoan encounters with Toll-like receptor 
signalling pathways: implications for host parasitism. Nat Rev Immunol, 6(12), 895-906. 
doi: 10.1038/nri1978 
Gazzinelli, R. T., Mendonca-Neto, R., Lilue, J., Howard, J., & Sher, A. (2014). Innate resistance 
against Toxoplasma gondii: an evolutionary tale of mice, cats, and men. Cell Host 
Microbe, 15(2), 132-138. doi: 10.1016/j.chom.2014.01.004 
146 
 
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., . . . Zhang, J. 
(2004). Bioconductor: open software development for computational biology and 
bioinformatics. Genome Biol, 5(10), R80. doi: 10.1186/gb-2004-5-10-r80 
Gopal, R., Birdsell, D., & Monroy, F. P. (2011). Regulation of chemokine responses in intestinal 
epithelial cells by stress and Toxoplasma gondii infection. Parasite Immunol, 33(1), 12-
24. doi: 10.1111/j.1365-3024.2010.01248.x 
Gubbels, M. J., Li, C., & Striepen, B. (2003). High-throughput growth assay for Toxoplasma 
gondii using yellow fluorescent protein. Antimicrob Agents Chemother, 47(1), 309-316.  
Haldar, A. K., Foltz, C., Finethy, R., Piro, A. S., Feeley, E. M., Pilla-Moffett, D. M., . . . Coers, J. 
(2015). Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense 
by guanylate binding proteins. Proc Natl Acad Sci U S A, 112(41), E5628-5637. doi: 
10.1073/pnas.1515966112 
Halliwell, B. (2006). Oxidative stress and neurodegeneration: where are we now? J Neurochem, 
97(6), 1634-1658. doi: 10.1111/j.1471-4159.2006.03907.x 
Heinonen, M. T., Kanduri, K., Lahdesmaki, H. J., Lahesmaa, R., & Henttinen, T. A. (2015). 
Tubulin- and actin-associating GIMAP4 is required for IFN-gamma secretion during Th 
cell differentiation. Immunol Cell Biol, 93(2), 158-166. doi: 10.1038/icb.2014.86 
Ho, C. H., & Tsai, S. F. (2017). Functional and biochemical characterization of a T cell-
associated anti-apoptotic protein, GIMAP6. J Biol Chem, 292(22), 9305-9319. doi: 
10.1074/jbc.M116.768689 
Hoffmann, S., Batz, M. B., & Morris, J. G., Jr. (2012). Annual cost of illness and quality-
adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot, 
75(7), 1292-1302. doi: 10.4315/0362-028X.JFP-11-417 
Hornum, L., Romer, J., & Markholst, H. (2002). The diabetes-prone BB rat carries a frameshift 
mutation in Ian4, a positional candidate of Iddm1. Diabetes, 51(6), 1972-1979.  
Howard, J. C., Hunn, J. P., & Steinfeldt, T. (2011). The IRG protein-based resistance mechanism 
in mice and its relation to virulence in Toxoplasma gondii. Curr Opin Microbiol, 14(4), 
414-421. doi: 10.1016/j.mib.2011.07.002 
Hrycay, E. G., & Bandiera, S. M. (2015). Involvement of Cytochrome P450 in Reactive Oxygen 
Species Formation and Cancer. Adv Pharmacol, 74, 35-84. doi: 
10.1016/bs.apha.2015.03.003 
Huang, J., Canadien, V., Lam, G. Y., Steinberg, B. E., Dinauer, M. C., Magalhaes, M. A., . . . 
Brumell, J. H. (2009). Activation of antibacterial autophagy by NADPH oxidases. Proc 
Natl Acad Sci U S A, 106(15), 6226-6231. doi: 10.1073/pnas.0811045106 
Hunn, J. P., Feng, C. G., Sher, A., & Howard, J. C. (2011). The immunity-related GTPases in 
mammals: a fast-evolving cell-autonomous resistance system against intracellular 
pathogens. Mamm Genome, 22(1-2), 43-54. doi: 10.1007/s00335-010-9293-3 
Hunter, C. A., & Sibley, L. D. (2012). Modulation of innate immunity by Toxoplasma gondii 
virulence effectors. Nat Rev Microbiol, 10(11), 766-778. doi: 10.1038/nrmicro2858 
Jones, J. L., & Dubey, J. P. (2012). Foodborne toxoplasmosis. Clin Infect Dis, 55(6), 845-851. 
doi: 10.1093/cid/cis508 
Ju, C. H., Chockalingam, A., & Leifer, C. A. (2009). Early response of mucosal epithelial cells 




Keita, M., Leblanc, C., Andrews, D., & Ramanathan, S. (2007). GIMAP5 regulates 
mitochondrial integrity from a distinct subcellular compartment. Biochem Biophys Res 
Commun, 361(2), 481-486. doi: 10.1016/j.bbrc.2007.07.048 
Kempf, M. C., Cesbron-Delauw, M. F., Deslee, D., Gross, U., Herrmann, T., & Sutton, P. (1999). 
Different manifestations of Toxoplasma gondii infection in F344 and LEW rats. Med 
Microbiol Immunol, 187(3), 137-142.  
Kim, B. H., Shenoy, A. R., Kumar, P., Bradfield, C. J., & MacMicking, J. D. (2012). IFN-
inducible GTPases in host cell defense. Cell Host Microbe, 12(4), 432-444. doi: 
10.1016/j.chom.2012.09.007 
Kim, C. Y., Zhang, X., & Witola, W. H. (2018). Small GTPase Immunity-Associated Proteins 
Mediate Resistance to Toxoplasma gondii Infection in Lewis Rat. Infect Immun, 86(4). 
doi: 10.1128/IAI.00582-17 
Kim, K., & Weiss, L. M. (2004). Toxoplasma gondii: the model apicomplexan. Int J Parasitol, 
34(3), 423-432. doi: 10.1016/j.ijpara.2003.12.009 
Kim, L., Butcher, B. A., Lee, C. W., Uematsu, S., Akira, S., & Denkers, E. Y. (2006). 
Toxoplasma gondii genotype determines MyD88-dependent signaling in infected 
macrophages. J Immunol, 177(4), 2584-2591.  
Knodler, L. A., & Celli, J. (2011). Eating the strangers within: host control of intracellular 
bacteria via xenophagy. Cell Microbiol, 13(9), 1319-1327. doi: 10.1111/j.1462-
5822.2011.01632.x 
Krucken, J., Schroetel, R. M., Muller, I. U., Saidani, N., Marinovski, P., Benten, W. P., . . . 
Wunderlich, F. (2004). Comparative analysis of the human gimap gene cluster encoding 
a novel GTPase family. Gene, 341, 291-304. doi: 10.1016/j.gene.2004.07.005 
Langfelder, P., & Horvath, S. (2008). WGCNA: an R package for weighted correlation network 
analysis. BMC Bioinformatics, 9, 559. doi: 10.1186/1471-2105-9-559 
Lecordier, L., Mercier, C., Sibley, L. D., & Cesbron-Delauw, M. F. (1999). Transmembrane 
insertion of the Toxoplasma gondii GRA5 protein occurs after soluble secretion into the 
host cell. Mol Biol Cell, 10(4), 1277-1287.  
Leipe, D. D., Wolf, Y. I., Koonin, E. V., & Aravind, L. (2002). Classification and evolution of P-
loop GTPases and related ATPases. J Mol Biol, 317(1), 41-72. doi: 
10.1006/jmbi.2001.5378 
Lennon, S. V., Martin, S. J., & Cotter, T. G. (1991). Dose-dependent induction of apoptosis in 
human tumour cell lines by widely diverging stimuli. Cell Prolif, 24(2), 203-214.  
Li, Z., Zhao, Z. J., Zhu, X. Q., Ren, Q. S., Nie, F. F., Gao, J. M., . . . Lun, Z. R. (2012). 
Differences in iNOS and arginase expression and activity in the macrophages of rats are 
responsible for the resistance against T. gondii infection. PLoS One, 7(4), e35834. doi: 
10.1371/journal.pone.0035834 
Ling, Y. M., Shaw, M. H., Ayala, C., Coppens, I., Taylor, G. A., Ferguson, D. J., & Yap, G. S. 
(2006). Vacuolar and plasma membrane stripping and autophagic elimination of 
Toxoplasma gondii in primed effector macrophages. J Exp Med, 203(9), 2063-2071. doi: 
10.1084/jem.20061318 
Liu, C., Wang, T., Zhang, W., & Li, X. (2008). Computational identification and analysis of 
immune-associated nucleotide gene family in Arabidopsis thaliana. J Plant Physiol, 
165(7), 777-787. doi: 10.1016/j.jplph.2007.06.002 
MacMicking, J. D. (2012). Interferon-inducible effector mechanisms in cell-autonomous 
immunity. Nat Rev Immunol, 12(5), 367-382. doi: 10.1038/nri3210 
148 
 
Maraldi, T. (2013). Natural compounds as modulators of NADPH oxidases. Oxid Med Cell 
Longev, 2013, 271602. doi: 10.1155/2013/271602 
Martinon, F., Burns, K., & Tschopp, J. (2002). The inflammasome: a molecular platform 
triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell, 
10(2), 417-426.  
Matheoud, D., Moradin, N., Bellemare-Pelletier, A., Shio, M. T., Hong, W. J., Olivier, M., . . . 
Descoteaux, A. (2013). Leishmania evades host immunity by inhibiting antigen cross-
presentation through direct cleavage of the SNARE VAMP8. Cell Host Microbe, 14(1), 
15-25. doi: 10.1016/j.chom.2013.06.003 
McAuley, J. B. (2014). Congenital Toxoplasmosis. J Pediatric Infect Dis Soc, 3 Suppl 1, S30-35. 
doi: 10.1093/jpids/piu077 
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012). Differential expression analysis of 
multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res, 
40(10), 4288-4297. doi: 10.1093/nar/gks042 
McEwan, W. A., Tam, J. C., Watkinson, R. E., Bidgood, S. R., Mallery, D. L., & James, L. C. 
(2013). Intracellular antibody-bound pathogens stimulate immune signaling via the Fc 
receptor TRIM21. Nat Immunol, 14(4), 327-336. doi: 10.1038/ni.2548 
Melo, M. B., Jensen, K. D., & Saeij, J. P. (2011). Toxoplasma gondii effectors are master 
regulators of the inflammatory response. Trends Parasitol, 27(11), 487-495. doi: 
10.1016/j.pt.2011.08.001 
Mendez, O. A., & Koshy, A. A. (2017). Toxoplasma gondii: Entry, association, and 
physiological influence on the central nervous system. PLoS Pathog, 13(7), e1006351. 
doi: 10.1371/journal.ppat.1006351 
Meylan, E., Tschopp, J., & Karin, M. (2006). Intracellular pattern recognition receptors in the 
host response. Nature, 442(7098), 39-44. doi: 10.1038/nature04946 
Miller, R., Wen, X., Dunford, B., Wang, X., & Suzuki, Y. (2006). Cytokine production of CD8+ 
immune T cells but not of CD4+ T cells from Toxoplasma gondii-infected mice is 
polarized to a type 1 response following stimulation with tachyzoite-infected 
macrophages. J Interferon Cytokine Res, 26(11), 787-792. doi: 10.1089/jir.2006.26.787 
Montoya, J. G., & Liesenfeld, O. (2004). Toxoplasmosis. Lancet, 363(9425), 1965-1976. doi: 
10.1016/S0140-6736(04)16412-X 
Murray, H. W., Rubin, B. Y., Carriero, S. M., Harris, A. M., & Jaffee, E. A. (1985). Human 
mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-
independent activity against intracellular Toxoplasma gondii. J Immunol, 134(3), 1982-
1988.  
Nathan, C., & Shiloh, M. U. (2000). Reactive oxygen and nitrogen intermediates in the 
relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S 
A, 97(16), 8841-8848.  
Newman, Z. L., Printz, M. P., Liu, S., Crown, D., Breen, L., Miller-Randolph, S., . . . Moayeri, 
M. (2010). Susceptibility to anthrax lethal toxin-induced rat death is controlled by a 
single chromosome 10 locus that includes rNlrp1. PLoS Pathog, 6(5), e1000906. doi: 
10.1371/journal.ppat.1000906 
Ngo, H. M., Hoppe, H. C., & Joiner, K. A. (2000). Differential sorting and post-secretory 
targeting of proteins in parasitic invasion. Trends Cell Biol, 10(2), 67-72.  
Nishikawa, Y., Kawase, O., Vielemeyer, O., Suzuki, H., Joiner, K. A., Xuan, X., & Nagasawa, H. 
(2007). Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role 
149 
 
of nitric oxide and other soluble factors. Parasite Immunol, 29(7), 375-385. doi: 
10.1111/j.1365-3024.2007.00956.x 
Nitta, T., & Takahama, Y. (2007). The lymphocyte guard-IANs: regulation of lymphocyte 
survival by IAN/GIMAP family proteins. Trends Immunol, 28(2), 58-65. doi: 
10.1016/j.it.2006.12.002 
Oakhill, J. S., Marritt, S. J., Gareta, E. G., Cammack, R., & McKie, A. T. (2008). Functional 
characterization of human duodenal cytochrome b (Cybrd1): Redox properties in relation 
to iron and ascorbate metabolism. Biochim Biophys Acta, 1777(3), 260-268. doi: 
10.1016/j.bbabio.2007.12.001 
Okada, T., Marmansari, D., Li, Z. M., Adilbish, A., Canko, S., Ueno, A., . . . Igarashi, M. (2013). 
A novel dense granule protein, GRA22, is involved in regulating parasite egress in 
Toxoplasma gondii. Mol Biochem Parasitol, 189(1-2), 5-13. doi: 
10.1016/j.molbiopara.2013.04.005 
Oldham, W. M., & Hamm, H. E. (2006). Structural basis of function in heterotrimeric G proteins. 
Q Rev Biophys, 39(2), 117-166. doi: 10.1017/S0033583506004306 
Pascall, J. C., Rotondo, S., Mukadam, A. S., Oxley, D., Webster, J., Walker, S. A., . . . Butcher, 
G. W. (2013). The immune system GTPase GIMAP6 interacts with the Atg8 homologue 
GABARAPL2 and is recruited to autophagosomes. PLoS One, 8(10), e77782. doi: 
10.1371/journal.pone.0077782 
Peixoto, L., Chen, F., Harb, O. S., Davis, P. H., Beiting, D. P., Brownback, C. S., . . . Roos, D. S. 
(2010). Integrative genomic approaches highlight a family of parasite-specific kinases 
that regulate host responses. Cell Host Microbe, 8(2), 208-218. doi: 
10.1016/j.chom.2010.07.004 
Phan, L., Kasza, K., Jalbrzikowski, J., Noble, A. G., Latkany, P., Kuo, A., . . . Toxoplasmosis 
Study, G. (2008). Longitudinal study of new eye lesions in treated congenital 
toxoplasmosis. Ophthalmology, 115(3), 553-559 e558. doi: 10.1016/j.ophtha.2007.06.022 
Pilla-Moffett, D., Barber, M. F., Taylor, G. A., & Coers, J. (2016). Interferon-Inducible GTPases 
in Host Resistance, Inflammation and Disease. J Mol Biol. doi: 
10.1016/j.jmb.2016.04.032 
Pittman, K. J., & Knoll, L. J. (2015). Long-Term Relationships: the Complicated Interplay 
between the Host and the Developmental Stages of Toxoplasma gondii during Acute and 
Chronic Infections. Microbiol Mol Biol Rev, 79(4), 387-401. doi: 
10.1128/MMBR.00027-15 
Praefcke, G. J., & McMahon, H. T. (2004). The dynamin superfamily: universal membrane 
tubulation and fission molecules? Nat Rev Mol Cell Biol, 5(2), 133-147. doi: 
10.1038/nrm1313 
Rakebrandt, N., Lentes, S., Neumann, H., James, L. C., & Neumann-Staubitz, P. (2014). 
Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica. 
Pathog Dis, 72(2), 131-137. doi: 10.1111/2049-632X.12192 
Reuber, T. L., & Ausubel, F. M. (1996). Isolation of Arabidopsis genes that differentiate between 
resistance responses mediated by the RPS2 and RPM1 disease resistance genes. Plant 
Cell, 8(2), 241-249. doi: 10.1105/tpc.8.2.241 
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010). edgeR: a Bioconductor package for 
differential expression analysis of digital gene expression data. Bioinformatics, 26(1), 
139-140. doi: 10.1093/bioinformatics/btp616 
150 
 
Rodriguez-Antona, C., & Ingelman-Sundberg, M. (2006). Cytochrome P450 pharmacogenetics 
and cancer. Oncogene, 25(11), 1679-1691. doi: 10.1038/sj.onc.1209377 
Rosowski, E. E., Lu, D., Julien, L., Rodda, L., Gaiser, R. A., Jensen, K. D., & Saeij, J. P. (2011). 
Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma 
gondii dense granule protein. J Exp Med, 208(1), 195-212. doi: 10.1084/jem.20100717 
Saeij, J. P., Coller, S., Boyle, J. P., Jerome, M. E., White, M. W., & Boothroyd, J. C. (2007). 
Toxoplasma co-opts host gene expression by injection of a polymorphic kinase 
homologue. Nature, 445(7125), 324-327. doi: 10.1038/nature05395 
Sanjuan, M. A., Dillon, C. P., Tait, S. W., Moshiach, S., Dorsey, F., Connell, S., . . . Green, D. R. 
(2007). Toll-like receptor signalling in macrophages links the autophagy pathway to 
phagocytosis. Nature, 450(7173), 1253-1257. doi: 10.1038/nature06421 
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M. A., Roy, S. L., . . . 
Griffin, P. M. (2011). Foodborne illness acquired in the United States--major pathogens. 
Emerg Infect Dis, 17(1), 7-15. doi: 10.3201/eid1701.P11101 
10.3201/eid1701.091101p1 
Schnell, S., Demolliere, C., van den Berk, P., & Jacobs, H. (2006). Gimap4 accelerates T-cell 
death. Blood, 108(2), 591-599. doi: 10.1182/blood-2005-11-4616 
Scholthof, K. B. (2007). The disease triangle: pathogens, the environment and society. Nat Rev 
Microbiol, 5(2), 152-156. doi: 10.1038/nrmicro1596 
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., . . . Ragg, T. 
(2006). The RIN: an RNA integrity number for assigning integrity values to RNA 
measurements. BMC Mol Biol, 7, 3. doi: 10.1186/1471-2199-7-3 
Schwefel, D., Arasu, B. S., Marino, S. F., Lamprecht, B., Kochert, K., Rosenbaum, E., . . . 
Daumke, O. (2013). Structural insights into the mechanism of GTPase activation in the 
GIMAP family. Structure, 21(4), 550-559. doi: 10.1016/j.str.2013.01.014 
Schwefel, D., Frohlich, C., Eichhorst, J., Wiesner, B., Behlke, J., Aravind, L., & Daumke, O. 
(2010). Structural basis of oligomerization in septin-like GTPase of immunity-associated 
protein 2 (GIMAP2). Proc Natl Acad Sci U S A, 107(47), 20299-20304. doi: 
10.1073/pnas.1010322107 
Sepulveda-Arias, J. C., Kempf, M. C., Wiehr, S., Wedekind, D., Hedrich, H. J., Gross, U., & 
Herrmann, T. (2008). Control of Toxoplasma gondii infection by athymic LEW-Whn rnu 
rats. Parasite Immunol, 30(6-7), 323-333. doi: 10.1111/j.1365-3024.2008.01029.x 
Sergent, V., Cautain, B., Khalife, J., Deslee, D., Bastien, P., Dao, A., . . . Cesbron-Delauw, M. F. 
(2005). Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is 
intrinsic to bone marrow-derived cells. Infect Immun, 73(10), 6990-6997. doi: 
10.1128/IAI.73.10.6990-6997.2005 
Shapira, S., Speirs, K., Gerstein, A., Caamano, J., & Hunter, C. A. (2002). Suppression of NF-
kappaB activation by infection with Toxoplasma gondii. J Infect Dis, 185 Suppl 1, S66-
72. doi: 10.1086/338000 
Sheiner, L., & Soldati-Favre, D. (2008). Protein trafficking inside Toxoplasma gondii. Traffic, 
9(5), 636-646. doi: 10.1111/j.1600-0854.2008.00713.x 
Sher, A., Tosh, K., & Jankovic, D. (2017). Innate recognition of Toxoplasma gondii in humans 
involves a mechanism distinct from that utilized by rodents. Cell Mol Immunol, 14(1), 
36-42. doi: 10.1038/cmi.2016.12 
Sibley, L. D., & Boothroyd, J. C. (1992). Virulent strains of Toxoplasma gondii comprise a 
single clonal lineage. Nature, 359(6390), 82-85. doi: 10.1038/359082a0 
151 
 
Sibley, L. D., Khan, A., Ajioka, J. W., & Rosenthal, B. M. (2009). Genetic diversity of 
Toxoplasma gondii in animals and humans. Philos Trans R Soc Lond B Biol Sci, 
364(1530), 2749-2761. doi: 10.1098/rstb.2009.0087 
Sibley, L. D., Weidner, E., & Krahenbuhl, J. L. (1985). Phagosome acidification blocked by 
intracellular Toxoplasma gondii. Nature, 315(6018), 416-419.  
Sies, H. (2014). Role of metabolic H2O2 generation: redox signaling and oxidative stress. J Biol 
Chem, 289(13), 8735-8741. doi: 10.1074/jbc.R113.544635 
Sinai, A. P., & Joiner, K. A. (1997). Safe haven: the cell biology of nonfusogenic pathogen 
vacuoles. Annu Rev Microbiol, 51, 415-462. doi: 10.1146/annurev.micro.51.1.415 
Sokol, C. L., & Luster, A. D. (2015). The chemokine system in innate immunity. Cold Spring 
Harb Perspect Biol, 7(5). doi: 10.1101/cshperspect.a016303 
Stamm, O., Krucken, J., Schmitt-Wrede, H. P., Benten, W. P., & Wunderlich, F. (2002). Human 
ortholog to mouse gene imap38 encoding an ER-localizable G-protein belongs to a gene 
family clustered on chromosome 7q32-36. Gene, 282(1-2), 159-167.  
Steinfeldt, T., Konen-Waisman, S., Tong, L., Pawlowski, N., Lamkemeyer, T., Sibley, L. D., . . . 
Howard, J. C. (2010). Phosphorylation of mouse immunity-related GTPase (IRG) 
resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol, 
8(12), e1000576. doi: 10.1371/journal.pbio.1000576 
Sukhumavasi, W., Egan, C. E., & Denkers, E. Y. (2007). Mouse neutrophils require JNK2 
MAPK for Toxoplasma gondii-induced IL-12p40 and CCL2/MCP-1 release. J Immunol, 
179(6), 3570-3577.  
Tenter, A. M., Heckeroth, A. R., & Weiss, L. M. (2000). Toxoplasma gondii: from animals to 
humans. Int J Parasitol, 30(12-13), 1217-1258.  
Ting, J. P., Willingham, S. B., & Bergstralh, D. T. (2008). NLRs at the intersection of cell death 
and immunity. Nat Rev Immunol, 8(5), 372-379. doi: 10.1038/nri2296 
Tiwari, S., Choi, H. P., Matsuzawa, T., Pypaert, M., & MacMicking, J. D. (2009). Targeting of 
the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) 
promotes immunity to mycobacteria. Nat Immunol, 10(8), 907-917. doi: 10.1038/ni.1759 
Tschopp, J., Martinon, F., & Burns, K. (2003). NALPs: a novel protein family involved in 
inflammation. Nat Rev Mol Cell Biol, 4(2), 95-104. doi: 10.1038/nrm1019 
Ueno, N., Harker, K. S., Clarke, E. V., McWhorter, F. Y., Liu, W. F., Tenner, A. J., & Lodoen, 
M. B. (2014). Real-time imaging of Toxoplasma-infected human monocytes under fluidic 
shear stress reveals rapid translocation of intracellular parasites across endothelial 
barriers. Cell Microbiol, 16(4), 580-595. doi: 10.1111/cmi.12239 
Vaysburd, M., Watkinson, R. E., Cooper, H., Reed, M., O'Connell, K., Smith, J., . . . James, L. C. 
(2013). Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proc Natl 
Acad Sci U S A, 110(30), 12397-12401. doi: 10.1073/pnas.1301918110 
Virreira Winter, S., Niedelman, W., Jensen, K. D., Rosowski, E. E., Julien, L., Spooner, E., . . . 
Frickel, E. M. (2011). Determinants of GBP recruitment to Toxoplasma gondii vacuoles 
and the parasitic factors that control it. PLoS One, 6(9), e24434. doi: 
10.1371/journal.pone.0024434 
Wennerberg, K., Rossman, K. L., & Der, C. J. (2005). The Ras superfamily at a glance. J Cell 
Sci, 118(Pt 5), 843-846. doi: 10.1242/jcs.01660 
Wiseman, H., & Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: 
role in inflammatory disease and progression to cancer. Biochem J, 313 ( Pt 1), 17-29.  
152 
 
Witola, W. H., Kim, C. Y., & Zhang, X. (2017). Inherent Oxidative Stress in the Lewis Rat Is 
Associated with Resistance to Toxoplasmosis. Infect Immun, 85(10). doi: 
10.1128/IAI.00289-17 
Witola, W. H., Liu, S. R., Montpetit, A., Welti, R., Hypolite, M., Roth, M., . . . McLeod, R. 
(2014). ALOX12 in human toxoplasmosis. Infect Immun, 82(7), 2670-2679. doi: 
10.1128/IAI.01505-13 
Witola, W. H., Mui, E., Hargrave, A., Liu, S., Hypolite, M., Montpetit, A., . . . McLeod, R. 
(2011). NALP1 influences susceptibility to human congenital toxoplasmosis, 
proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic 
cells. Infect Immun, 79(2), 756-766. doi: 10.1128/IAI.00898-10 
Yamamoto, M., Ma, J. S., Mueller, C., Kamiyama, N., Saiga, H., Kubo, E., . . . Takeda, K. 
(2011). ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor 
ROP18. J Exp Med, 208(7), 1533-1546. doi: 10.1084/jem.20101660 
Yarovinsky, F. (2014). Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol, 
14(2), 109-121. doi: 10.1038/nri3598 
Yarovinsky, F., & Sher, A. (2006). Toll-like receptor recognition of Toxoplasma gondii. Int J 
Parasitol, 36(3), 255-259. doi: 10.1016/j.ijpara.2005.12.003 
Zenner, L., Estaquier, J., Darcy, F., Maes, P., Capron, A., & Cesbron-Delauw, M. F. (1999). 
Protective immunity in the rat model of congenital toxoplasmosis and the potential of 
excreted-secreted antigens as vaccine components. Parasite Immunol, 21(5), 261-272.  
Zhang, B., & Horvath, S. (2005). A general framework for weighted gene co-expression network 
analysis. Stat Appl Genet Mol Biol, 4, Article17. doi: 10.2202/1544-6115.1128 
Zhang, S. M., Loker, E. S., & Sullivan, J. T. (2016). Pathogen-associated molecular patterns 
activate expression of genes involved in cell proliferation, immunity and detoxification in 
the amebocyte-producing organ of the snail Biomphalaria glabrata. Dev Comp Immunol, 
56, 25-36. doi: 10.1016/j.dci.2015.11.008 
Zhu, Y., Massen, S., Terenzio, M., Lang, V., Chen-Lindner, S., Eils, R., . . . Brady, N. R. (2013). 
Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-
survival mitophagy versus apoptosis. J Biol Chem, 288(2), 1099-1113. doi: 
10.1074/jbc.M112.399345 
Zimmermann, S., Murray, P. J., Heeg, K., & Dalpke, A. H. (2006). Induction of suppressor of 
cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in 
macrophages by blocking IFN-gamma signaling. J Immunol, 176(3), 1840-1847.  
 
 
